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Abstract 
The bacterial flagellum is an important appendage at the bacterial cell surface, not only for 
motility, but for adherence to host cells, and therefore has an extensive role in bacterial 
colonisation and virulence. A number of pathogenic bacteria modify their flagellins with 
nonulosonic acids, such as Aeromonas, Campylobacter and Helicobacter species, via an O-
linked glycosylation process. This modification is essential for their ability to form flagella, thus 
having implications in pathogen virulence. However, the role of flagellin glycosylation is 
currently undetermined. 
The mesophilic aeromonad, Aeromonas caviae, forms a constitutively expressed polar 
flagellum necessary for motility in liquid environments. It is thought to be a good model for 
glycosylation as it decorates its flagellins solely with pseudaminic acid, and contains a 
genetically simple system for this process to occur. The work in this thesis has explored the 
pathway, and role of flagellin glycosylation in this microorganism.  
The function of a putative deglycosylation enzyme (AHA0618) and its possible role in the fine 
tuning of flagellin glycosylation was examined, where it was concluded that this protein is 
likely to be involved in peptidoglycan crosslinking at the cell wall, and not the flagellin 
glycosylation pathway. This demonstrates that subtle changes to bacterial cellular morphology 
are able to affect bacterial behaviour.   
Additionally, investigations into the sites of flagellin glycosylation via mass spectrometric 
methods concluded that the sites of modification on A. caviae flagellins can vary. However, 
certain residues were found to be predominantly glycosylated, suggesting partial selectivity to 
the glycosylation process via the putative glycosyltransferase, Maf1. 
Finally, protein interaction studies have provided evidence that glycosylation is likely to occur 
in the cytoplasm before binding of the flagellin-specific chaperone and flagellin export. 
Moreover, Maf specificity investigations, together with these interaction studies have 
suggested that the Maf proteins may be recognising and docking to the N-terminal region of 
the flagellins. 
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Chapter 1: Introduction 
 
1.1 – The genus Aeromonas 
The genus Aeromonas belongs to the family Aeromonadaceae (similar to Vibrionaceae), along 
with fellow genera Tolumonas and Oceanomonas, within the class of Gammaproteobacteria 
(Janda and Abbott, 2010). The genus consists of 25 species of Gram-negative, facultative 
anaerobic, rod-shaped bacteria that are ubiquitous in nature, but are generally associated with 
fresh or brackish water. They can be placed into two main groups, one being the motile 
mesophilic aeromonads that have optimal growth at temperatures between 30 and 37ᵒC, and 
the other being the non-motile psychrophilic aeromonads (ie. Aeromonas salmonicida) that 
grow optimally between 22 and 28ᵒC (Janda and Abbott, 2010; Parker and Shaw, 2011).  
1.1.1 – Host interactions 
Aeromonads are associated with disease in a variety of hosts, with the psychrophilic A. 
salmonicia subsp. salmonicida being a particular problem in fish disease (Beaz-Hidalgo and 
Figueras, 2013). A. salmonicida is able to cause the ulcerative disease, furunculosis, in 
economically important fish, such as: Atlantic salmon, channel catfish, halibut, turbot, Atlantic 
cod and many more, making it a problem in aquaculture worldwide (Beaz-Hidalgo and 
Figueras, 2013). 
Mesophilic aeromonads are also able to cause fish disease, the infection of which displays 
similar symptoms to furunculosis and is known as ‘motile Aeormonas septicaemia’. A. 
hydrophila has always been considered the main mesophilic aeromonad responsible for these 
infections, however, it is now clear that due to inaccurate identification methods the presence 
of this aeromonad has been overestimated (Beaz-Hidalgo et al., 2010). Other mesophilic 
aeromonads have now been isolated from a variety of fish infections with the most prevalent 
being: A veronii, A. sobria, A. bestiarum, A. piscicola (Beaz-Hidalgo et al., 2010; Beaz-Hidalgo 
and Figueras, 2013). Ultimately many infections result in fish death which has caused major 
financial losses in fish farming and any infected fish that are ingested have the potential to 
infect the recipient and cause further spread of disease.  
Furthermore, mesophilic aeromonads are associated with human infections, such as 
gastrointestinal disease, as well as less common extraintestinal disease (wound and burn 
infections), in both immunocompromised and immunocompetent individuals (Parker and 
Shaw, 2011). Previously, misidentification of Aeromonas isolates led to Aeromonas hydrophila 
again to be thought of as one of the more important species linked with human disease; 
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however, it is now accepted that a number of other mesophilic aeromonads are able to cause 
disease, with Aeromonas caviae, A. veronii and A. hydrophila, being the most frequently 
isolated from patients, and therefore the most clinically significant (Janda and Abbott, 2010; 
Lowry et al., 2014a; Parker and Shaw, 2011). Animal studies have shown that these species 
persistently colonise immunocompromised mice compared to other mesophilic Aeromonas 
species (Lye et al., 2007).  
Gastrointestinal diseases, such as gastroenteritis and traveller’s diarrhoea (Vila et al., 2003), 
are the most common diseases associated with Aeromonas infections, especially in the very 
young and usually in warmer months of the year. Early studies by Namdari and Bottone (1990) 
found A. caviae to be the sole pathogen isolated from 82% of paediatric patients studied, who 
showed symptoms such as watery diarrhoea, and Wilcox et al. (1992) also found A. caviae to 
be a particular pathogen isolated from children showing signs of gastroenteritis. Other studies, 
such as Guerra et al. (2007) from South Brazil, have shown A. hydrophila to be the most 
frequently isolated aeromonad in diseases connected with acute diarrhoea, but agree that 
prevalence is especially high in children.  
Aeromonas species have also been found to infect wounds in both healthy individuals and 
those with underlying health problems. These infections usually occur when an individual is 
injured in an aquatic environment, and can lead to mild cellulitis, or more serious diseases 
such as necrotising fasciitis, which can result in mortality (Parker and Shaw, 2011). Although 
mesophilic aeromonads are generally associated with enteric disease, their widespread 
involvement in wound infections is becoming clear; for example Aeromonas species were the 
most commonly isolated organisms from soft tissue and skin infections from survivors of the 
2004 Thailand tsunami (Hiransuthikul et al., 2005), and A. hydrophila has been isolated from 
the wound infections from a number of animal-bite survivors around the world (bear, 
crocodile, alligator, shark, tiger)  (Abrahamian and Goldstein, 2011; Easow and Tuladhar, 
2007). Furthermore, a nationwide study of Aeromonas infections in France over a six month 
period also found wound infections to be the most common diseases linked with mesophilic 
aeromonads (Lamy et al., 2009). Additionally, Aeromonas infections of burns can occur, but 
are extremely rare, and these microorganisms are often overlooked as causative agents when 
treating patients. However they have been known to occur, especially after a burnt individual 
has been exposed to contaminated water or soil (Barillo et al., 1996; Kienzle et al., 2000; 
Ribeiro et al., 2010). 
As well as aeromonads having a detrimental effect in their host, their colonisation can also be 
beneficial, where the bacterium and host live together in a symbiosis. For example, Aeromonas 
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species, in particular A. veronii, have been identified as symbionts of the medicinal leech gut 
(Nelson and Graf, 2012). It has been suggested that aeromonads may be able to utilise 
nutrients released from other leech gut symbionts (a Rikenella-like bacterium) (Bomar et al., 
2011) and in return, aeromonads may protect the leech from colonisation by pathogenic 
microorganisms, aid in the digestion of a blood meal or provide optimal nutrition for the leech 
with the release of nutrients (Bomar et al., 2011; Nelson and Graf, 2012; Silver et al., 2007). 
Furthermore, studies by Osei-Poku et al. (2012), have demonstrated that Aeormonas spp. are 
the most prevalent bacteria in the gut microbiota of wild Kenyan mosquitoes (around one 
third of the bacteria present).  
Therefore it is clear that aeromonads have the ability to colonise a wide variety of 
environments, under many different circumstances, and can adapt to interact with their hosts 
in multiple ways. 
1.1.2 – Colonisation factors 
There are a number of virulence and colonisation factors that allow aeromonads to persist in 
their specific niche, and for clinically relevant species to allow them to infect their hosts. These 
consist of secreted factors that are exported via specific secretion systems and cause toxicity; 
and adherence factors, such monomeric proteins and appendages on the cell surface that are 
involved in motility and host cell interactions (Lowry et al., 2014a; Tomas, 2012). 
1.1.2.1 – Secreted factors 
Secreted virulence determinants are exported via one of the five secretion systems that have 
been identified in aeromonads, out of the six that are currently known about in Gram negative 
bacteria (Type 1, 2, 3, 4 and 6). Very little is known about the type 1 secretion system and its 
effector proteins in aeromonads, however the type 2 system, which has so far only been 
studied in A. hydrophila, is thought to export proteins such as: haemolysin, amylases, 
proteases and DNases (Li et al., 2011; Seshadri et al., 2006); homologues of this system have 
also been identified in the genomes of other Aeromonas species, such as the psychrophilic A. 
salmonicida subspecies salmonicida (Reith et al., 2008). The type 4 system is able to conjugally 
transfer DNA to other aeromonads, as well as transport effector proteins into host cells, and it 
is therefore thought to be responsible for the spread of antibiotic resistance amongst strains 
(Rangrez et al., 2006).  
In particular, type 3 and type 6 secretions systems (T3SS and T6SS respectively), which are 
both able to transfer virulence determinants directly into target eukaryotic cells, are involved 
in pathogenicity.  
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In the T3SS (the injectosome), five effectors proteins have so far been identified.  Two of which 
are the ADP-ribosylating toxins: AexT (present in A. salmonicida) (Dacanay et al., 2006; Reith et 
al., 2008) and AexU (identified in A. hydrophila) (Sha et al., 2007; Sierra et al., 2007), that are 
able to disrupt the host cytoskeleton, leading to apoptosis. These proteins are directly involved 
in colonisation and infection as mutational studies have demonstrated that aexT deficient A. 
salmonicida subsp. salmonicida were unable to induce toxicity in a fish cell-line (RTG-2) (Braun 
et al., 2002). Additionally, an A. hydrophila aexU mutant was found to be less virulent than the 
wild type when infection studies were carried out in a mouse model (Sha et al., 2007). 
The final three effectors of the T3SS are: AopH (tyrosine phosphatase), AopO (serine/threonine 
kinase) and AopP (NFκB inhibitor), which are likely to disrupt host-cell signalling pathways, and 
have also been identified in A. salmonicida species (Dacanay et al., 2006; Reith et al., 2008). 
The T6SS has been studied in clinical isolate of A. hydrophila, and has so far been found to 
export four effector proteins (Suarez et al., 2008; Suarez et al., 2010). One of these proteins is 
the haemolysin coregulator protein (Hcp) which is thought to be involved in preventing the 
bacterium being phagocytosed by host macrophages and is also able to induce apoptosis in 
host cells (Suarez et al., 2008). The other virulence determinants identified of this secretion 
system are: Vgr1, 2 and 3; and so far only the role of Vgr1, an ADP-ribosylating toxin, has been 
determined (Suarez et al., 2008; Suarez et al., 2010). 
1.1.2.2 – Adherence factors 
Aeromonads also possess many adherence factors on their cell surfaces (filamentous and non-
filamentous) that contribute to colonisation and host infection. For example, the 
lipopolysaccharide (LPS) O-antigen (O-Ag) has been shown to be important for aeromonad 
adherence and virulence, with mutational studies in A. piscicola AH-3 (previously classified as 
A. hydrophila) serotype O:34 demonstrating that strains unable to produce the O-Ag have an 
impaired ability to adhere to Hep-2 cells and are less virulent in fish and mice compared the 
wild type (Canals et al., 2006b). In addition, a number of outer-membrane proteins (OMPs) are 
also important in Aeromonas spp. for adherence to target cells. VapA is the most abundant 
OMP, making up the S-layer, which is a crystallised layer of proteins covering the entire 
bacterium (Lowry et al., 2014a). In species that can produce an S-layer, VapA makes up a 
substantial amount of their outer-membrane protein content (up to 60%). Studies in A. 
salmonicida have shown that VapA is directly associated with black rockfish colonisation, and 
have provided evidence that the S-layer here may be involved in host immune evasion, as the 
strains studied were able to evade opsonisation (Han et al., 2011).  Furthermore, in the 
absence of filamentous adhesins, a 43 kDa OMP protein has also been found to be important 
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for the adherence of A. caviae strains to Hep-2 cells (Rocha-De-Souza et al., 2001), 
demonstrating that there are many factors that can contribute to Aeromonas colonisation. It is 
unknown as to why some Aeromonas strains are more pathogenic than others; intruigingly, a 
new set OMP proteins, which show homology to the Lig invasins in highly pathogenic 
Leptospira species (Cerqueira et al., 2009; Choy et al., 2007), have been identified in the 
genomes of A. caviae (Sch3) (Shaw unpublished) and A. hydrophila (ATCC 7966) (Seshadri et 
al., 2006). These Lig proteins are currently unstudied in Aeromonas but are characteristic of 
extremely virulent Leptospira species, and therefore may be the reason why some mesophilic 
aeromonads are more invasive than others (Cerqueira et al., 2009; Choy et al., 2007).  
Filamentous adhesins, such as pili are also involved in aeromonad colonisation. The type 4 
MSHA (mannose-sensitive haemagglutinin)-like pilus, in particular, has a major role in 
mesophilic aeromonad adherence, and is also involved in biofilm formation (Hadi et al., 2012). 
Pili are also present in psychrophilic aeromonads, and although they have a role in adherence, 
they are not essential for colonisation (Boyd et al., 2008). 
Flagella are also filamentous appendages on the bacterial cell surface, primarily allowing 
bacterial motility through aqueous environments, or movement across solid surfaces. Around 
60% of mesophilic aeromonads, such as clinically relevant A. hydrophila and A. caviae species, 
possess dual flagella systems; a constitutively expressed polar flagellum, for motility in liquid 
environments (Fig. 1.1), and inducible peritrichous flagella (lateral flagella) for movement 
across solid surfaces (Gavin et al., 2002; Kirov et al., 2002; Rabaan et al., 2001). Flagella are not 
only required for motility but also have an important role in cellular adherence (Haiko and 
Westerlund-Wikstrom, 2013), with mutational studies with A. caviae establishing that both 
flagella systems participate in the adherence and invasion of Hep-2 cells (Gavin et al., 2002; 
Rabaan et al., 2001). 
Some Aeromonas species, such as A. caviae and A. hydrophila, are also able to post-
translationally modify some of their surface proteins with sugar groups. One example of which 
is the O-linked glycosylation of the polar flagellins, which are the main component of the polar 
flagellar filament. Studies carried out in A. caviae and A. hydrophila have demonstrated that 
this modification is essential for the production of a functional flagellar filament (Canals et al., 
2006c; Canals et al., 2007; Parker et al., 2012; Tabei et al., 2009), and therefore has 
implications in aeromonad virulence; although the precise role of glycosylation remains 
unclear. The pathway of flagellin glycosylation in A. caviae Sch3 is particularly intriguing as it 
possesses the smallest set of genes required for flagellin glycosylation currently identified in 
bacteria (Tabei et al., 2009). 
6 
 
This chapter will focus on polar flagellar-mediated motility of Aeromonas spp. and the 
glycosylation of bacterial surface proteins (in particular the flagellins). 
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Figure 1.1 – A transmission electron micrograph from Parker & Shaw (2011) displaying 
Aeromonas caviae Sch3 and its constitutively expressed polar flagellum. 
 
 
  
(Parker & Shaw, 2011) 
8 
 
1.2 – Aeromonas motility 
1.2.1 – Polar Flagellum 
The polar flagellum in mesophilic aeromonads (Fig. 1.1) is constitutively expressed, 
unsheathed and encoded for by over 50 genes within five gene clusters in the genome (Lowry 
et al., 2014a). This flagellum is required for motility in aqueous environments, and through the 
process of chemotaxis allows the movement towards nutrients and away from less desirable 
locations (Baker et al., 2006; Terashima et al., 2008). During chemotaxis, chemical gradients 
are sensed through transmembrane receptors called methyl-accepting proteins (MCPs), which 
transmit these signals to the Che proteins in the bacterial cytoplasm; the Che proteins then act 
to alter flagellar rotation in response to attractant levels through binding to the flagellar motor 
(Baker et al., 2006). This allows bacteria to move in a ‘random biased walk’ with a series of 
runs and tumbles. Chemotaxis has been extensively studied in E. coli which possesses 
peritrichous flagella. During runs, flagella rotate anticlockwise allowing the peritrichous 
arrangement to form a bundle at one pole of the cell which acts to push the bacterial cell 
forward. In order to change direction, the cells have to stop, or ‘tumble’, before setting off on 
another run; this is achieved by the chemotactic machinery signalling to the flagellar motor to 
change direction (clockwise rotation) which disrupts the bundle formation (Baker et al., 2006). 
Mesophilic aeromonads, however, possess only a single polar flagellum and therefore do not 
run and tumble by the same mechanisms due to their inability to form flagellar bundles. 
Although unstudied in Aeromonas, chemotaxis is likely to show similarity to the well-studied 
system in the polar flagellated bacterium Rhodobacter sphaeroides (Porter et al., 2008). Here 
instead of altering the direction of flagellar rotation, the chemotactic system acts to stop the 
flagellar motor in order for the bacterium to tumble and reorient themselves before setting off 
on another run (Porter et al., 2008). 
The flagellum is made of three major components: the basal body, the hook and the flagellar 
filament (Fig. 1.2). The basal body spans the bacterial cell envelope and is composed of the rod 
and a series of rings (Fig. 1.2), within which resides a motor (made up of a stator and a rotor 
for flagellar rotation) and a narrow channel of around 2 nm (rod) which allows the export of 
unfolded flagellar subunits for the assembly of this nanomachine. The cytoplasmic ring (C-ring) 
is located within the bacterial cell and is composed of FliG, FliM and FliN, which together make 
up the rotor component of the flagellar motor. This part of the motor is also what controls 
flagellar rotation, and so responds to signals from the bacterial chemotactic system (Roberts et 
al., 2010). The other component of the motor, the stator, is produced from four proteins in 
Aeromonas spp.: PomA and PomB (which are paralogs of MotA and MotB from E. coli and 
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Salmonella); and MotX and MotY, which are not present in E. coli and Salmonella systems, but 
are present in other bacteria such as Vibrio spp. MotX and MotY have been found to form a 
new ring, named the T-ring, in the polar flagellar basal body of Vibrio spp., located below the 
periplasmic ring (P-ring, discussed below) (Molero et al., 2011; Terashima et al., 2006; 
Wilhelms et al., 2009). The T-ring was found to be essential for incorporating the stator into 
the basal body (Terashima et al., 2006). The rotor and stator components of the motor work 
together to harness the electrochemical energy of a proton or ion-motive force and generate 
torque; this then drives the rotation of the bacterial flagellum (Sowa and Berry, 2009). In the 
case of the Aeromonas polar flagellum, a sodium ion gradient is utilised. It is thought that the 
ions bind to the stator, and induce a conformational change which is then conferred to the 
rotor, allowing flagellar rotation (Sowa and Berry, 2009; Xing et al., 2006). In addition, some 
aeromonads also appear to have two sets of Pom proteins (PomAB and PomA2B2), with studies 
in A. piscicola AH-3 demonstrating that only one set are required for motility in liquid culture 
(Wilhelms et al., 2009). However, it was observed that PomA2B2 are more sensitive to lower 
sodium ion concentrations (Wilhelms et al., 2009). 
The C-ring is then linked to the membrane-supramembrane ring (MS-ring), which the rod is 
anchored to (Fig. 1.2). In Gram negative bacteria two further rings are present, the 
peptidoglycan ring (P-ring) and the lipopolysaccharide ring (L-ring), which allow the rod to 
penetrate the bacterial cell wall (Fig. 1.2) (Chevance et al., 2007).  
Attached to the rod is the hook, or the universal joint, which provides a flexible link from the 
engine of the flagellum to the helical flagellar filament, enabling work from the motor to be 
transmitted to the propeller (Fig. 1.3) (Samatey et al., 2004). The hook allows different flagellar 
arrangements, such as peritrichous or lophotrichous flagella, to function correctly as a bundle 
(Terashima et al., 2008).  
The flagellar filament is joined to the hook via hook-filament junction proteins, and extends 
15-20 μm from the cell surface (Samatey et al., 2001; Yonekura et al., 2003). It is created from 
thousands of monomer proteins (flagellins) which polymerise to form a helical, hollow tube 
that has a filament diameter of around 12-25 nm and a lumen diameter of around 2 nm (Fig. 
1.2) (Samatey et al., 2001; Yonekura et al., 2003). A cap protein is also present at the tip of the 
filament (known as FlaH in aeromonads) and is required for the efficient polymerisation of the 
flagellins (Fig. 1.2) (Yonekura et al., 2000). Cap proteins are also present in the early stages of 
flagellar assembly to control rod and hook formation. A dedicated T3SS, located within the 
basal body, is responsible for the export of all subunits of the bacterial flagellum.  
10 
 
The aeromonad polar flagellar filament is generated from the copolymerisation of two 
flagellins, FlaA and FlaB (Fig. 1.3); no dominant flagellin is present in this system as a mutation 
in one flagellin gene does not abolish motility, but instead mutants are able to form normal 
flagellar filaments from the remaining flagellin and display only slightly impaired motility 
(Rabaan et al., 2001). This differs to other polar flagellated bacteria, such as H. pylori, that 
form flagella from two flagellin subunits which are present in the filament in different amounts 
(Kostrzynska et al., 1991). The minor flagellin, FlaB, makes up the proximal end of the filament 
(close to the basal body), whereas the major subunit, FlaA, forms the majority of the filament 
and is necessary for the formation of a functional flagellum (Kostrzynska et al., 1991).  The 
stoichiometry of FlaA and FlaB in the flagellar filament of Aeromonas, however, is currently 
unknown. 
Flagellin monomers are composed of three domains: the N-terminal domain which may 
contain a signal for protein export, a central D2/D3 region which is variable and is also  
glycosylated in a number of aeromonads, and the chaperone binding domain (CBD) which is 
essential for flagellin recognition by the flagellin-specific chaperone, FlaJ (Parker et al., 2014). It 
has also been found that the D0 regions of the flagellins are directly involved in Toll-like 
receptor 5 (TLR-5) recognition of the flagellins by the host innate immune system (Fig. 1.3) 
(Hayashi et al., 2001). 
As previously mentioned, some mesophilic aeromonads (such as A. caviae and A. hydrophila) 
post-translationally modify their flagellins on their D2/D3 domains, through the O-linked 
glycosylation of serine or threonine residues with nonulosonate sugars. This modification is 
essential for aeromonad flagellar assembly and motility (Canals et al., 2006c; Canals et al., 
2007; Parker et al., 2012; Tabei et al., 2009) and is also important for the flagellation of a 
number of other pathogenic bacteria, such as Helicobacter and Campylobacter spp. (Josenhans 
et al., 2002; Schirm et al., 2003; Thibault et al., 2001). Bacterial protein glycosylation will be 
discussed in sections 1.3 and 1.4 in more detail, with a focus on O-linked glycosylation. 
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Figure 1.2 – A schematic diagram of the bacterial flagellum, displaying the proteins present in 
the Aeromonas polar flagellum. OM = outer membrane; PG = peptidoglycan; IM = inner 
membrane. 
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Figure 1.3 – (A) This diagram depicts unfolded FlaA and its major domains from Aeromonas 
caviae Sch3: the N-terminal domain (NTD) (from amino acids around 1-146), the central D2/D3 
domain (from amino acids around 146-232) and the chaperone binding domain (CBD) (from 
amino acids around 232-306). FlaA is 31.8 kDa (when post-translational modifications are not 
taken into account) composed of 306 amino acids.  FlaB shows similar domains, however, 
contains 305 amino acids resulting in a 31.7 kDa protein when post-translational modifications 
are taken into account. (B) Diagrammatic representation of a flagellin monomer once it has 
folded. (C) A cross-section of the bacterial flagellum and where the D0, D1, D2 and D3 regions 
of the flagellins reside once they are incorporated into the flagellar filament. The D0 and D1 
regions form the filament core, whereas the D2 and D3 regions form the filament surface. 
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1.2.2 – Lateral Flagella 
The inducible, lateral flagellar system, which is found in a peritrichous arrangement around the 
bacterial cell, allows aeromonad movement in environments where the polar flagellum cannot 
function effectively; such as for movement across solid surfaces or through viscous solutions 
(Kirov et al., 2002). Dual flagellar systems are also found in a number of other bacteria, but 
those found in Aeromonas species show most similarity to the systems described for V. 
parahaemolyticus, whose polar and lateral flagella are entirely distinct (Stewart and McCarter, 
2003). Lateral flagella synthesis is regulated in response to environmental conditions, with the 
induction of gene expression being mainly associated with growth in viscous solutions or on 
solid surfaces (Kearns, 2010; Kirov et al., 2002); however, the precise mechanisms of how 
bacteria sense surfaces and transduce these signals through their cell envelopes to affect gene 
expression is poorly understood (Kearns, 2010). One theory from early work in V. 
parahaemolyticus is that the polar flagellum is a mechanosensor, and when its movements are 
restricted from coming into contact with a surface this may alter the ion flux through the 
flagellar motor which the bacterial cell could then sense, and, in turn, alter lateral flagellar 
gene expression (Kawagishi et al., 1996).  Expression of the genes associated with polar and 
lateral flagellar systems have previously been linked in V. parahaemolyticus, as constitutive 
expression of lateral flagella occurs when there are defects in the polar flagellum (McCarter et 
al., 1988). This is not the case in Aeromonas however, and so how they sense their 
environment, and coordinate polar and lateral gene expression, may differ (Altarriba et al., 
2003; Canals et al., 2006a).  The lateral flagellar system has been well studied in A. piscicola 
AH-3, which possesses 38 genes, known as the laf genes, in a single region of the chromosome 
required for lateral flagellar assembly (Canals et al., 2006a). 
Lateral flagella are formed from a T3SS system, similarly to the polar flagellum, and the 
filaments are unsheathed and produced from repeating units of the flagellin, LafA. However, in 
some aeromonads, such as A. caviae Sch3, two flagellins have been identified (similarly to in 
the polar system), known as LafA1 and LafA2 (Gavin et al., 2002). In contrast to the polar 
system, the lateral system makes use of a proton motive force (pmf) for flagellar rotation, and 
therefore possesses a different stator complex, LafT and LafU (Gavin et al., 2002; Wilhelms et 
al., 2009). 
There is also some evidence to suggest that the lateral flagellins may also be glycosylated 
(Wilhelms et al., 2012), which will be further discussed in section 1.4. 
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1.2.3 – Export and assembly 
The bacterial flagellum is assembled by the ordered export of its subunits through a dedicated 
T3SS (apart from the P and L-rings which are exported by the sec system) (Evans et al., 2014).  
The export and assembly process has been most studied in E. coli and Salmonella, and involves 
subunits meeting at the export apparatus located at the base of the flagellum (Evans et al., 
2014). Subunits are exported in an unfolded state and these initial stages of export are 
energised by ATP hydrolysis and the pmf (Minamino and Namba, 2008). The transmembrane 
domains of six proteins: FlhA, FlhB, FliO, FliP, FliQ and FliR, all form the export gate, which 
resides below the MS-ring and extrudes into the cytoplasm (Fig. 1.4) (Chen et al., 2011). This 
export gate can transition from an open and closed state, by aligning with the pore of the MS-
ring when export is triggered. Below the export gate, the cytoplasmic domain of FlhA (FlhAc) 
forms a homononomeric ring, which forms a platform connected to the export gate via the 
linker regions between the two FlhA domains (Fig. 1.4) (Abrusci et al., 2013; Chen et al., 2011). 
The export gate, together with the FlhAc platform, forms an ‘export cage’. Furthermore, 
located below the export cage, is an ATPase complex which is anchored to the C-ring of the 
basal body (Evans et al., 2014). This complex is formed from the homohexameric association of 
the ATPase, FliI, and two other proteins: FliJ (the central ATPase stalk) and FliH (the stator for 
anchoring the ATPase complex) (Abrusci et al., 2013; Evans et al., 2014; Ibuki et al., 2011). It is 
thought that when active, the stalk of the ATPase spans the gap between itself and the export 
cage, interacting with the FlhAc homononomeric ring to allow the next stages of subunit export 
to occur (Abrusci et al., 2013; Fraser et al., 2003a). 
Bacterial flagellar assembly is an ordered process, with early subunits, such as the rod and 
hook proteins, being required first, and the late subunits, such as the proteins for filament 
assembly, being required after. It is thought that both of these pathways, for the early and late 
subunits, are targeted to the ATPase (partially due to export sequences in the N –terminal 
regions of the subunits), before being presented to FlhAc of the export cage (Stafford et al., 
2007), due to interactions with FliJ of the ATPase complex with FlhAc (Abrusci et al., 2013; 
Fraser et al., 2003b). Ordered assembly at the FlhAc complex occurs, in part, due to chaperones 
and their subunits having different affinities for the hydrophobic pocket of FlhAc (Kinoshita et 
al., 2013). This is therefore thought to allow the export of the junction and cap proteins before 
the flagellins, which in turn allows the efficient polymerisation of the flagellar filament which 
requires the cap protein to be present (Yonekura et al., 2000).  
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Figure 1.4 – A schematic diagram of the export apparatus of the bacterial flagellum, displaying 
the export cage (FliOPQR, FlhAB) and the ATPase complex (FliHIJ), which are involved in 
subunit sorting, docking and export at the base of the flagellum. OM = outer membrane; PG = 
peptidoglycan; IM = inner membrane. 
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The details of the complete export process are not fully understood, however, it is known that 
the next stage of subunit export requires recruitment to FlhB of the export gate. This protein 
has a role in switching the specificity of the export gate, from the export of the early subunits, 
to export of the late subunits (Ferris and Minamino, 2006). FlhB is composed of a 
transmembrane and a cytoplasmic domain, connected via a flexible linker region. It is within 
this linker that FlhB undergoes cleavage essential for the export of the later subunits of the 
flagllum (Ferris et al., 2005; Fraser et al., 2003b). Mutational studies whereby FlhB can no 
longer undergo autocleavage locks the system for the permanent export of the early flagellar 
subunits (ie. rod and hook proteins) (Fraser et al., 2003b). The precise mechanism of export 
specificity switching is not wholly understood, however, it also involves the ‘molecular tape 
measure’ FliK, which can bind to FlhB and is thought to detect hook length, initiating the 
switching of FlhB subunit specificity once the hook has reached the correct length (Erhardt et 
al., 2010).  
The bacterial flagellum has been shown to grow at a constant rate, independent of filament 
length (Turner et al., 2012). Recent work by Evans et al. (2013) has proposed a chain 
mechanism of flagellar assembly that complements the observations by Turner et al. (2012), 
whereby the subunits move through the export gate, across the bacterial cell envelope and 
through the narrow tube of the filament, in an unfolded state, linked together in a chain. This 
is thought to occur through interactions of the opposing helices of each subunit with one 
another, allowing the subunits to travel through the tube of the flagellum, ending with the 
crystalisation of the subunits into the structure, beneath the cap proteins (Evans et al., 2013). 
The folding and incorporation of a subunit into the flagellar structure is theorised to generate a 
pulling force and drive the entry of the next subunit into the flagellar lumen (Evans et al., 
2013).  
1.2.4 – Gene expression and regulation 
For the production of bacterial flagella, the genes are transcribed in a hierarchical manner due 
to the presence of a plethora of subunits which are required at different points of the 
assembly process, with each tier of the hierarchy being sensitive to the proteins at the 
previous level. Furthermore, at each tier of the hierarchy, the genes possess different 
promoter classes, either class I, II or III promoters, which allows the ordered expression of 
these genes at each stage (ie. early, middle or late gene expression). In addition, Aeromonas 
possesses two flagellar systems, making flagellar gene expression far more complex than in 
bacteria with only one system. However, it is thought that the different flagellar systems in this 
organism are entirely distinct as mutations that cause defects in the polar flagellum biogenesis 
do not affect lateral flagellar gene expression, and vice versa (Canals et al., 2006a; Canals et al., 
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2006c). This contrasts to V. parahaemolyticus, where expression of the dual flagellar systems is 
directly linked; mutational studies have demonstrated that when expression of polar flagellar 
system is impaired, the lateral flagellar system becomes constitutively expressed (McCarter et 
al., 1988). The coordination of gene expression has been studied for both flagellar systems in 
A. piscicola AH-3 (Canals et al., 2006a; Canals et al., 2006c; Lowry et al., 2014a; Wilhelms et al., 
2013; Wilhelms et al., 2011).  
With regards to polar flagellar gene expression, there are four tiers to the transcriptional 
hierarchy (I-IV), whose expression are under the regulation of either sigma factor 28 (σ28) or 
sigma factor 54 (σ54) (Wilhelms et al., 2011). Level I encodes the σ54 dependent enhancer 
binding protein, FlrA, which is the master regulator of the polar flagellar genes and whose 
gene-expression is independent of both σ54 and σ28. Level II encodes genes whose expression is 
dependent on FlrA and σ54, such as: basal body components, the L and P rings, hook proteins, 
export apparatus, and FlrC, which is required for the expression of genes at the next level of 
the hierarchy (level III), along with its cognate kinase, FlrB. FlrC and σ54 then go on to activate 
the genes at level III, which include the polar flagellar-specific sigma factor (σ28 or FliA) and 
some of the motor proteins. Then, FliA initiates the expression of the genes at level IV, which 
include genes for the filament (FlaA/B), the flagellar cap (FlaH) and the flagellin-specific 
chaperone (FlaJ); along with an anti-sigma factor, FlgM, and additional motor proteins. FlgM 
negatively regulates the genes at level IV as its gene possesses a class II promoter. Therefore, 
FlgM brinds to FliA, preventing the early transcription of the later genes in this tier (ie. genes 
possessing class III promoters). Eventually, FlgM is exported, allowing the expression of the 
late genes by FliA in this tier (Wilhelms et al., 2011).  
As discussed in section 1.2.2, the lateral flagellar system is environmentally regulated, being 
induced when aeromonads come into contact with environments where the polar flagellum 
cannot function, such as on solid surfaces or within viscous solutions (Merino et al., 2006). The 
expression of the lateral system is also tiered, having three levels in total (Canals et al., 2006c; 
Wilhelms et al., 2013). Level I genes are dependent on sigma factor 70 (σ70) and encode the 
lateral flagellar system master regulator, LafK, and some structural components. The 
transcription of level I genes has been found to be constitutive in A. piscicola, however, 
translation only occurs when the bacteria encounter solid surfaces or viscous environments 
(Wilhelms et al., 2013). Level II gene expression is dependent on σ54 and LafK, which control 
the expression of the σ28 of this system (LafS), and some other structural genes. Lastly, 
expression of genes the final level (III) is controlled by LafS, and its anti-sigma factor, FlgM, 
which is transcribed in the final tier. Here, genes for polar flagellar filament production are 
transcribed (Canals et al., 2006c; Wilhelms et al., 2013). 
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Furthermore, cyclic-di-GMP signalling is also thought to be involved in regulating flagellar gene 
expression in aeromonads, which is well known for being involved in bacterial lifestyle 
decisions (such as sessile or motile lifestyles) (Lowry et al., 2014a). It is thought to modulate 
the activity of the master regulators and potentially interact with a PilZ domain-containing 
protein which has been identified in the A. caviae Sch3 genome (Shaw unpublished) likely to 
possess c-di-GMP binding capabilities. The homologue in E. coli (the PilZ domain-containing 
protein, YcgR) acts as a brake on the flagellar motor upon binding of this second messenger, 
preventing flagellar rotation and therefore favouring a sessile bacterial lifestyle when high 
levels of c-di-GMP are present (Lowry et al., 2014a).  
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1.3 – Protein Glycosylation 
Protein glycosylation was first identified in the 1930s when carbohydrate moieties were 
discovered on crystalline egg albumin (Neuberger, 1938). For a long time it was thought that 
only eukaryotes could post translationally modify their proteins and it was not until around 
four decades later when studies presented discoveries of prokaryotic protein glycosylation 
(Mescher and Strominger, 1976; Sleytr and Thorne, 1976). It is now accepted that glycosylation 
of proteins occurs in all the domains of life. 
There are two major types of linkages for the attachment of sugars to proteins: N-linkages and 
O-linkages (Fig. 1.5). N-linked glycosylation is where the sugar forms a bond with the amide 
nitrogen of an asparagine residue in a protein; while O-linked glycosylation is where the 
carbohydrate is linked to the hydroxyl group of a threonine or serine residue, and less 
commonly a tyrosine (Fig. 1.5) (Zarschler et al., 2010). Glycosylation is the most abundant and 
diverse post-translational modification present on eukaryotic proteins, and so the N- and O-
linked pathways have been extensively studied (Spiro, 2002; Schwarz and Aebi, 2011). 
1.3.1 – Eukaryotic protein glycosylation 
Over two-thirds of eukaryotic proteins that carry out a diverse range of functions within the 
cell are predicted to be glycosylated, which highlights the importance of this post-translational 
modification in Eukaryotic systems. 
N-linked glycosylation in Eukaryotes occurs on a vast array of proteins, at the specific 
consensus sequence: Asn-X-Ser/Thr (where X stands for any amino acid apart from proline) 
(Spiro, 2002). Generally, glycans are assembled on a lipid carrier on the cytosolic side of the 
endoplasmic reticulum (ER), via a team of glycosyltransferase enzymes. This glycan is then 
flipped across the membrane, into the ER lumen, via a flippase enzyme, where it is block 
transferred onto a target protein (at the correct consensus sequence) by an 
oligosaccharyltransferase. The glycan is transferred onto an unfolded protein, and can be 
modified further by further glycosyltransferases. This sequential processing step on the target 
protein is coupled to the protein’s secretion, allowing for cell-specific N-linked glycosylation 
(Schwarz and Aebi, 2011). One of the most widely distributed sugar decorating eukaryotic 
proteins is N-acetylglucosamine (GlcNAc) which is found on proteins both within the cytosol 
and at the cell surface, such as on: enzymes, immunoglobulins and lectins (Spiro, 2002; 
Schwarz and Aebi, 2011). This pathway of N-linked glycosylation has some similarities to the 
heavily studied prokaryotic process of N-linked glycosylation in C. jejuni; however, the sugars 
generated in each case are vastly different. Eukaryotes initially produce a highly conserved 
sugar for N-linked glycosylation which can then  
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Figure 1.5 – The major linkages formed during protein glycosylation. (A) N-linked glycosylation 
to an asparagine (Asn) residue (using N-acetlyglucosamine as an example sugar). (B) O-linked 
glycosylation to a serine residue (Ser) (using pseudaminic acid – Pse5Ac7Ac – as an example). 
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be diversified, in contrast to prokaryotes which produce an assortment of lipid-linked glycans 
(Schwarz and Aebi, 2011). 
In addition, GlcNAc can also be O-linked onto target proteins, a modification which is 
important for the correct functioning of some cytoskeletal and nuclear proteins (Spiro, 2002). 
Eukaryotic proteins can also be O-mannosylated, which has been found to be extremely 
important in fungi for maintaining the cell wall. Mutational studies have demonstrated that 
knockout mutations of genes involved in O-mannosylation are lethal to Saccharomyces 
cerevisiae (Lommel and Strahl, 2009). Furthermore, O-mannosylation of fungal surface 
proteins is also involved in virulence and has a potential role in the solubilisation of misfolded 
proteins, demonstrating the wide variety of roles of this modification (Lommel and Strahl, 
2009). In addition, with regards to humans, O-mannosylation is particularly important for the 
correct functioning of the dystrophin-glycoprotein complex in skeletal muscle; impaired ability 
to O-mannosylate this protein can lead to inherited muscular dystrophy (Blake et al., 2002). 
Glycans required for the O-linked glycosylation of proteins are, again, generally built onto a 
lipid carrier on the cytosolic side of the ER via glycosyltransferase enzymes. The sugar is then 
flipped into the lumen of the ER where it is transferred onto target proteins via an 
oligosaccharyltransferase. A consensus sequence for O-linked glycosylation has not yet been 
identified, so how these sugars are targeted to their proteins is not yet fully understood. 
Glycan diversification then takes place once it is covalently linked to the target protein, and 
this process can be carried out in the golgi where a number of glycosyltransferase enzymes 
reside (Lommel and Strahl, 2009). 
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1.3.2 – Bacterial glycosylation of surface proteins 
Over recent years, research has demonstrated that some bacteria modify their proteins and 
surface appendages via these glycosylation pathways. In some cases, these post-translational 
modifications appear to be essential for bacterial virulence and colonisation; however, the 
precise role of glycosylation has not yet been determined (Nothaft and Szymanski, 2010). 
Bacterial protein glycosylation can either occur in an oligosaccharyltransferase dependent or 
independent manner (Nothaft and Szymanski, 2010). N-linked glycosylation has been well 
characterised in the bacterium C. jejuni and involves a lipid carrier for the glycan to be built 
onto, which is then transferred onto the target protein in the periplasm in an 
oligosaccharyltransferase dependent manner. This pathway shows some similarities the N-
linked glycosylation present eukaryotes; however an alternative consensus sequence is 
present on target proteins (Glu-X-Asn-X-Ser/Thr, where X is any amino acid, except for proline) 
(Nothaft and Szymanski, 2010; Nothaft and Szymanski, 2013). Some atypical bacterial N-linked 
glycosylation pathways have also been identified. For example, in Haemophilus influenzae, 
some cell surface adhesins are modified with hexose residues via glycosyltransferase enzymes 
within the cytoplasm, and the consensus sequence for modification here is identical to that 
observed on target proteins in eukaryotes (Asn-X-Ser/Thr), despite this atypical pathway not 
being present within eukaryotic cells (Choi et al., 2010; Grass et al., 2010). 
O-linked glycosylation pathways have been studied in a variety of bacteria, with the 
modification of the bacterial flagellum being particularly associated with the virulence of 
number of pathogens, especially in Gram-negative species. Many Gram-negative bacteria have 
been found to glycosylate their flagellins with nonulosonic acids, which can be essential for 
flagellation and therefore virulence (such as Campylobacter, Helicobacter and Aeromonas 
species) (Fig 1.6) (Merino and Tomas, 2014). Flagellin glycosylation occurs in an 
oligosaccharyltransferase independent manner and the Maf (motility associated factor) 
proteins are a novel group of proteins that have been recognised as the putative flagellin-
specific glycosyltransferases (Karlyshev et al., 2002; Schirm et al., 2003; Canals et al., 2007; 
Parker et al., 2012).  
1.3.2.1 – Campylobacter 
The first bacterial N-linked glycosylation system was characterised in the gastrointestinal 
pathogen, C. jejuni (Szymanski et al., 1999) and has also been reconstituted in E. coli (Linton et 
al., 2005). The pgl locus contains the genes which encode the N-glycosylation system 
responsible for glycosylating over 60 C. jejuni periplasmic and membrane-bound proteins 
(Scott et al., 2011). The process of N-linked glycosylation here is oligosaccharyltransferase  
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Figure 1.6 – The structure of the common nonulosonic acids: N-acetyl neuraminic acid, 
pseudaminic acid and legionaminic acid. 
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dependent, with protein targets being modified with a heptasaccharide (Young et al., 2002) 
which is manufactured on the cytoplasmic side of the inner membrane (via glycosyltransferase 
enzymes), on a lipid precursor molecule (Linton et al., 2005). Once assembled, the glycan is 
‘flipped’ across the membrane via an ATP-dependent flippase enzyme (Alaimo et al., 2006) 
into the periplasm. Once in the periplasm, the sugar is block transferred onto the amide 
nitrogen of an asparagine residue located within a specific consensus sequence (Glu-X-Asn-X-
Ser/Thr) (Kowarik et al., 2006) on target folded proteins, via an oligosaccharyltransferase, 
which shows partial identity to the Eukaryotic version (Kowarik et al., 2006). In C. jejuni N-
linked glycosylation occurs on flexible loops of folded proteins, which is in contrast to the 
pathway of N-linked glycosylation in Eukaryotes where they modify unfolded proteins (Nothaft 
and Szymanski, 2010). N-glycosylation appears to be associated with pathogen virulence as 
mutational studies of the pgl locus revealed a decreased ability of C. jejuni to colonise chicks 
and bind to human epithelial cells (Karlyshev et al., 2004). This modification may also allow 
modulation of the host immune response, as the heptasaccharide on the C. jejuni cell surface 
is recognised by a dendritic cell receptor, the human macrophage galactose-type lectin (MGL) 
(van Sorge et al., 2009). A C. jejuni pglA mutant (where pglA encodes one of the 
glycosyltransferases required for building the heptasaccharide), which is unable to produce the 
glycan for N-linkage, has been shown to stimulate an increased cytokine response, with the 
release of interleukin 6 (IL-6), in dendritic cells, compared to the wild type strain (van Sorge et 
al., 2009). This therefore suggests that N-linked glycosylation at the cell surface may dampen 
down the host immune response (van Sorge et al., 2009).  
Furthermore, Campylobacter species are also capable of modifying their flagellins via O-linked 
glycosylation with a variety of nonulosonate sugars, which are all derived from pseudaminic 
acid or legionaminic acid (Fig. 1.6) (Logan et al., 2002; Logan et al., 2009; McNally et al., 2007; 
McNally et al., 2006; Thibault et al., 2001; Zampronio et al., 2011). The Maf proteins are the 
putative glycosyltransferase enzymes that directly modify the central region of the flagellins 
(the D2/D3 domain) (Karlyshev et al., 2002). This modification is essential for the formation of 
the Campylobacter polar flagellum, and is therefore implicated in the virulence of this 
pathogen and its ability to colonise the host gastrointestinal tract (Goon et al., 2003; Guerry, 
2007). Due to the presence of multiple sugars decorating the flagellum, the glycosylation 
islands required for sugar biosynthesis and flagellin modification are extremely vast and 
complex, and can encode up to seven maf homologues (Karlyshev et al., 2002). However, 
mutational studies in C. jejuni and C. coli have demonstrated that pseudaminic acid is the 
essential, base sugar, required for flagellation and can make up for the absence of the other 
nonulosonic acids (Goon et al., 2003; Logan et al., 2002; Thibault et al., 2001). The enzymes for 
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pseudaminic acid biosynthesis are encoded for by the Pse genes, which allow for the 
production of this sugar by a five step enzymatic pathway (Goon et al., 2003) (discussed in 
section 1.4); orthologues of these genes are also present in other bacteria, such as 
Helicobacter and Aeromonas species that are also capable of synthesising nonulosonic acids 
(Canals et al., 2007; Josenhans et al., 2002; Schoenhofen et al., 2006; Schirm et al., 2003) 
(Tabei et al., 2009). Although the precise role of flagellin glycosylation is unknown, there is 
some evidence to suggest that the expression of some Maf proteins may be phase variable, 
allowing Campylobacter to modify its flagellins with different nonulosonic acids during 
different stages of infection (van Alphen et al., 2008). Mutational studies have also 
demonstrated that the surface charge of the Campylobacter flagellum changes when the 
glycosylation status of the flagellum is altered, affecting the ability of a population to 
autoagglutinate and form biofilms (Howard et al., 2009). These changes were attributed to the 
loss of legionaminic acid on the C. jejuni flagellum, and were also shown to have a detrimental 
effect on the ability of this mutant strain to colonise chickens (Howard et al., 2009). Therefore, 
flagellin glycosylation here may allow Campylobacter species to alter their behaviour, in order 
to produce favourable interactions with each other or their environments, even perhaps 
during different stages of infection (further discussed in Chapter 4). 
1.3.2.2 – Helicobacter 
Some Helicobacter species, such as the gastric pathogen H. pylori, also O-glycosylate their 
flagellins, however the process is far simpler than in Campylobacter due to having less genetic 
diversity amongst species, and occurs solely with pseudaminic acid (Fig. 1.6) (Josenhans et al., 
2002; Schirm et al., 2003). Mutational analysis of genes thought to be involved in flagellin 
glycosylation have demonstrated that glycosylation is crucial for polar flagellar assembly and 
motility (Schirm et al., 2003); however why this is the case is not wholly understood. It is 
unlikely that H. pylori flagella are glycosylated to evade the host immune system, or for 
interactions with the external surroundings, as the flagella are sheathed (Geis et al., 1993) and 
so are already sheltered from antibodies. It is possible, however, that flagellin glycosylation 
here has a structural role and is necessary for the co-polymerisation of the flagellin monomers 
(FlaA and FlaB), or for interactions with the secretion machinery; however, these theories have 
not yet been investigated. Although H. pylori flagellins are only modified with pseudaminic 
acid, it is intriguing that two maf homologues have been identified in the H. pylori genome 
(Schirm et al., 2003; Tomb et al., 1997); the roles of these proteins have not yet been 
determined however. It is possible that both of these proteins are required for flagellin 
modification, or perhaps other proteins are modified via the Maf proteins here. Nevertheless, 
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their presence demonstrates the importance of O-linked glycosylation in H. pylori flagellation 
and virulence. 
In addition to the Maf proteins, a putative flagellin deglycosylation enzyme, named HP0518, 
has also been identified in H. pylori; a mutant of which is hypermotile and displays elevated 
levels of flagellin glycosylated (Asakura et al., 2010). It is possible that a glycosylation 
homeostasis pathway is in place to modulate how H. pylori flagellins are glycosylated, perhaps 
depending on the environment, in order to alter bacterial behaviour. However, flagellin 
deglycosylation pathways have not yet been identified in other bacteria. H. pylori flagellin 
glycosylation is further discussed in results Chapters: 3, 4 and 5. 
1.3.2.3 – Pseudomonas 
A number of pseudomonads are also capable of protein glycosylation. For example, the 
respiratory pathogen, Pseudomonas aeruginosa is able to modify cell surface appendages such 
as its type IV pilus and flagella (Nothaft and Szymanski, 2010).  
Pilin glycosylation is O-linked, but the pathway shows similarities to N-linked glycosylation in C. 
jejuni, as it is oligosaccharyltransferase dependent, and requires a trisaccharide to be built on 
the cytoplasmic side of the inner membrane before it is flipped into the periplasm and block 
transferred onto subunits of the pilus (Nothaft and Szymanski, 2010). This modification is not 
essential for the formation of the type IV pilus, however, glycosylation has been found to alter 
the hydrophobicity of the pilus surface and increase P. aeruginosa colonisation capabilities 
when analysed in a pneumonia mouse model of infection (Smedley et al., 2005). 
P. aeruginosa can also O-glycosylate its flagellins, however, this modification is not essential 
for flagellation and does not involved nonulonsonate sugars, in contrast to flagellin 
glycosylation observed in Campylobacter, Helicobacter and Aeormonas species. Two types of 
flagellins are present in P. aeruginosa strains, a-type and b-type, which are classed due to their 
molecular weight and their anti-sera specificity (Nothaft and Szymanski, 2010). P. aeruginosa 
possessing a-type flagellins have been found to modify them with heterogeneous rhamnose-
linked oligosaccharides, with some strains just modifying their flagellins with a single rhamnose 
moiety, and others modifying them with up to 11 additional monosaccharides (Schirm et al., 
2004). In contrast, strains containing b-type flagellins were found to modify them with less 
heterogeneous hexose residues linked to a 209 Da mass (to be determined) (Verma et al., 
2006).  
Studies by Arora et al. (2005) have demonstrated that P. aeruginosa glycosylation defective 
mutants have attenuated virulence in a burned mouse model of infection, compared to the 
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wild type strain. Therefore, despite not being essential for flagellation, these sugars still have a 
clear role in the virulence of this pathogen. Furthermore, bacterial flagellins are recognised by 
a toll-like receptor on the surface of host immune cells (TLR-5) (Hayashi et al., 2001) which 
induces the production of the proinflammatory cytokines. However, it has been suggested that 
the role of P. aeruginosa flagellin glycosylation is to aid this response, as studies have 
demonstrated that unglycosylated, mutant flagellins reduce IL-8 release considerably by the 
host immune cells (Verma et al., 2005). Glycosylated flagellins may therefore be the reason 
why hyper-inflammation is usually present in P. aeruginosa respiratory infections, especially in 
cystic fibrosis patients.  
Furthermore, the plant pathogen, P. syringae, is also able to O-glycosylate its flagellins with 
modified rhamnose residues (Takeuchi et al., 2003). Similarly to P. aeruginosa, this 
modification is not essential for flagellation, however, it does have a role in the pathogen 
virulence, as glycosylation defective mutants are less able to adhere to surfaces and cause 
disease (Taguchi et al., 2006). The glycosylated version of the P. syringae flagellum was also 
found to be more heat resistant than the unglycosylated form, which may prevent the 
flagellum from being broken down in the host (Taguchi et al., 2009). (Further discussed in 
Chapter 4) 
1.3.2.4 – Neisseria 
Pathogenic Neisseria species, such as N. meningitidis and N. gonorrhoeae, are able to O-
glycosylate the monomeric constituents of their type IV pili (the pilins), which are major 
virulence determinants for these bacteria (Mattick, 2002).  They contain a number of pilin 
glycosylation (pgl) genes required for pilin O-glycosylation of pili, and carry out this 
modification in a pathway related to that of the N-linked glycosylation pathway in C. jejuni, 
which involves a lipid-linked precursor (Aas et al., 2007). N. meningitidis produces a 
trisaccharide with diacetamido trideoxyhexose at the base; this sugar is synthesised on the 
cytoplasmic side of the inner membrane, similarly to pilin glycosylation in P. aeruginosa and N-
linked glycosylation in C. jejuni, before being flipped into the periplasm and transferred onto 
pilin via an oligosaccharyltransferase (Aas et al., 2007; Power et al., 2000). 
Neisseria spp. also glycosylate another protein via the same O-linked glycosylated pathway, 
called AniA (Ku et al., 2009; Vik et al., 2009). AniA is an outer-membrane nitrate reductase 
exposed at the cell surface and there is some evidence to suggest that glycosylation of this 
protein shields it from the host immune system (Ku et al., 2009; Vik et al., 2009). Although the 
role of pilin glycosylation in Neisseria is unknown, it may also be involved in host immune 
evasion.  
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1.3.2.5 – Gram-positive bacterial glycosylation 
Much work on bacterial glycosylation has been carried out in Gram-negative bacteria, 
however, there have now reports of Gram-positive bacteria also possessing machinery to 
glycosylate their proteins, a number of which modify proteins at the cell surface. For example 
some Clostridium species are able to O-glycosylate their flagellins, such as the clinically 
relevant C. botulinum and C. difficile (Twine et al., 2008; Twine et al., 2009). 
C. botulinum is able to modify its flagellins with nonulosonic acids (similarly to the 
glycosylation of many Gram-negative flagella), as well as hexnuronic acid (Twine et al., 2008). 
Glycosylation was not found to be required for flagellar assembly, although more strains 
isolated from infant patients were found to modify their flagella with nonulosonate sugars, 
compared to strains not associated with disease; demonstrating that this modification has a 
clear role in pathogenicity (Twine et al., 2008). 
In contrast to C. botulinum, the glycosylation of C. difficile flagellins with N-acetylglucosamine 
is essential for pathogen flagellation (Twine et al., 2009). Faulds-Pain et al. (2014) carried out 
recent studies altering the structure of this sugar at the C. difficile flagellar surface. Motility 
was not found to be required for colonisation, however, the structure of the glycan was, and 
when mutated, had a severe impact on the ability of this pathogen to colonise a mouse model 
of infection (Faulds-Pain et al., 2014). Furthermore, some mutations on the glycan structure 
also affected bacterial motility and caused cellular aggregation, demonstrating that altering 
flagellar glycosylation can affect bacterial behaviour (Faulds-Pain et al., 2014).  
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1.4 – Glycosylation in Aeromonas species 
Mesophilic aeromonads are also able to O-glycosylate structures at their cell surfaces, such as 
their flagella, and in addition their LPS O-antigens (O-Ag). A. caviae Sch3 (which will be focused 
on here) modifies its polar flagellum solely with pseudaminic acid (316 Da) (similarly to flagellin 
glycosylation in H. pylori) and possesses the simplest set of genes currently known for O-linked 
flagellin glycosylation (Fig. 1.7A) (Tabei et al., 2009). Within its polar flagellum locus is a single 
maf gene which encodes the putative flagellin-specific glycosyltransferase, Maf1 (Fig. 1.7A) 
(Parker et al., 2012; Parker et al., 2014). This modification is essential for the formation of the 
A. caviae polar flagellar filament. Other aeromonads also require glycosylation to form their 
flagella (Canals et al., 2006c), however, appear to have more complex polar flagellin 
glycosylation than A. caviae. For example, A. piscicola AH-3 have a more complicated 
glycosylation island, encoding two maf homologues, and additional genes that are not found in 
A. caviae (Fig. 1.7B) (Canals et al., 2007). In addition, flagellins have been found to be modified 
with a heptasaccharide which includes a 376 Da pseudaminic acid derivative (Wilhelms et al., 
2012); this therefore may explain the presence of these extra genes within the AH-3 genome 
(Canals et al., 2007).  Furthermore, recent work by Merino et al. (2014) has suggested that in 
A. piscicola AH-3, a lipid carrier protein (WecX) is involved in flagellin glycosylation, whereby 
pseudaminic acid is transferred onto the carrier, and the rest of the heptasaccharide is then 
built onto this sugar, before being block transferred onto the flagellin. This has not yet been 
reported for other O-linked flagellin glycosylation systems.  
Similarly to A. piscicola AH-3, the glycosylation island of A. hydrophila ATCC 7966 (Fig. 1.7C) is 
also more complex than that of A. caviae, also possessing multiple maf homologues and 
additional genes which may be required for the more complex glycosylation of its flagellins.  
Additionally, there is some evidence to suggest that the lateral flagellins are also glycosylated; 
however lateral flagellin glycosylation has not been studied as fervently as polar flagellin 
glycosylation. Both A. caviae and A. piscicola lateral flagellins were found to be larger than 
expected when analysed via SDS-PAGE, indicating that a post-translational modification may 
be present (Gavin et al., 2002). Studies by Wilhelms et al. (2012) have demonstrated that this 
size discrepancy in A. piscicola AH-3 is due to the occurrence of a pseudaminic acid derivative 
(376 Da) decorating the lateral flagellins. This modification was found to be essential for the 
lateral flagellation and therefore the swarming motility of A. piscicola AH-3 when in contact 
with solid surfaces (Wilhelms et al., 2012). Moreover, a maf homologue, maf5, has been 
identified in the lateral flagellar locus in A. piscicola; the mutation of which results in the 
abolition of lateral flagella (Canals et al., 2006a). 
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Figure 1.7 – The polar flagellar loci and glycosylation islands in Aeromonas species. Aeromonas caviae Sch3 (Tabei et al., 2009) contains the simplest glycosylation 
islands identified to date, whereas A. piscicola AH-3 (Canals et al., 2006b and 2006c) and A. hydrophila ATCC 7966 (Seshradri et al., 2006) display more complicated 
loci, with A. hydrophila in particular showing complexity, as the genes for pseudaminic acid biosynthesis, and the second maf homologue (maf2), here are 
surround by a series of currently uncharacterised genes. Within the genes for polar flagellar assembly, is also flaG which currently has an unknown function. 
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As A. caviae Sch3 glycosylates its polar flagellins exclusively with pseudaminic acid, and 
contains the simplest set of genes currently known to do this (Parker et al., 2012; Tabei et al., 
2009), it is an ideal model organism for the study of the O-linked glycosylation pathway.  
1.4.1 – The O-linked flagellin glycosylation pathway in A. caviae Sch3 
1.4.1.1 – Pseudaminic acid biosynthesis 
Pseudaminic acid (Pse5Ac7Ac), otherwise known as 5,7-diacetamido-3,5,7,9-tetradeoxy-L-
glycero-L-manno-nonulosonic acid, is a nonulosonic acid (nine carbon sugar) related to the 
sialic acids. These sugars are all -keto acids, which are a group of sugars well known for their 
important roles in a number of biological processes, such as the tricarboxylic acid cycle (TCA 
cycle) and glycolysis. The term ‘sialic acid’ relates to neuraminic acid and all N- or O-
substituted derivatives. They are the most naturally abundant -keto acids found in all 
domains of life, with the most common member of this group being N-acetylneuraminic acid 
(Neu5Ac) (Fig. 1.6) (Chen and Varki, 2010, Zunk and Kiefel, 2014). Some sialic acid derivatives , 
however (such as pseudaminic and legionaminic acid), appear to be exclusively found in 
bacteria, and have been linked with bacterial pathogenicity in a number of ways, making their 
biosynthetic pathways attractive therapeutic targets (Almagro-Moreno and Boyd, 2010). All 
sialic acid derivatives are synthesised in a similar way, whereby a nucleotide activated hexose 
residue is used as the precursor sugar. Then to this six carbon sugar a three carbon sugar is 
linked, which is generally a pyruvate derivative formed from the condensation of a six carbon 
compound to a three carbon compound. Therefore, these steps form the nine carbon skeleton 
of the nonulosonic acid. Furthermore, all nonulosonic acids are nucleotide activated before 
they are either transferred onto their target protein, or incorporated into a larger glycan 
structure (Almagro-Moreno and Boyd, 2010; Zunk and Kiefel, 2014). 
With regards to Pse5Ac7Ac biosynthesis, a set of genes known as the flm locus are required for 
the conversion of uridine diphosphate N-acetlyglucosamine (UDP-GlcNAc) to Pse5Ac7Ac in 
mesophilic aeromonads (Fig 1.7A & 1.8) (Canals et al., 2007; Gryllos et al., 2001). This locus 
was initially identified in A. caviae Sch3, but homologues of these biosynthetic genes have now 
been identified in all mesophilic species analysed, and their orthologues are also found in 
Campylobacter and Helicobacter species (Pse genes) (Beatson et al., 2011; Canals et al., 2007; 
Goon et al., 2003; Gryllos et al., 2001; Schoenhofen et al., 2006; Seshadri et al., 2006; Tabei et 
al., 2009). In A.caviae Sch3, Pse5Ac7Ac is produced from UDP-GlcNAc via a four step enzymatic 
pathway, carried out by the proteins: FlmA (a Pse5Ac7Ac nucleotide dehydratase and C-5 
epimerase), FlmB (a pyridoxal dependent aminotransferase), FlmD (containing a 
glycosyltransferase domain and a RimL-like acetyltransferase domain) and NeuB (a Pse5Ac7Ac 
synthetase) (Fig. 1.8). 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 – The four step pseudaminic acid biosynthetic pathway in Aeromonas caviae Sch3. 
Pse5Ac7Ac is produced from uridine diphosphate N-acetlyglucosamine (UDP-GlcNAc) by: the 
nucleotide dehydratase and C-5 epimerase, FlmA; the pyridoxal-dependent aminotransferase, 
FlmB (rearranges the entire molecule), the chimeric protein (of FlmD and FlmH in other 
aeromonads), FlmD, which contains a glycosyltransferase domain and a RimL-like 
acetyltransferase domain; and the pseudaminic acid synthetase, NeuB. Pse5Ac7Ac is activated 
via the addition of cytidine monophosphate (CMP) by NeuA (CMP-Pse5Ac7Ac synthetase). 
Once active, the sugar can then be transferred onto the LPS O-antigen via the use of a sugar-
antigen lipid carried (sugar-ALC); or onto the flagellins by the putative glycosyltransferase, 
Maf1. The figure also displays the orthologous proteins in Campylobacter (in the brackets). 
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Pse5Ac7Ac is then activated via the addition of cytidine monophosphate (CMP) by NeuA (a 
CMP-Pse5Ac7Ac synthetase) (Fig. 1.8).  
The flm locus of A. caviae Sch3 has been found to have a dual role, as it is involved in both LPS 
O-Ag biosynthesis and flagellar assembly (Gryllos et al., 2001; Tabei et al., 2009). Mutations in 
the flm locus cause a loss of both the LPS O-Ag (LPS profile altered) and the loss of the polar 
flagellar system (Tabei et al., 2009). There are also additional genes present in the locus, lst 
and lsg, which may be responsible for transferring the glycan group across the cytoplasmic 
membrane and onto the LPS (Fig. 1.7 and 1.8) (Tabei et al., 2009). Therefore, once active, the 
sugar can go down one of two pathways: either the pathway of flagellin glycosylation, or LPS 
biosynthesis. Maf1 is the putative glycosyltransferase thought to be responsible for the 
transfer of activated Pse5Ac7Ac onto flagellins (Parker et al., 2012; Parker et al., 2014). In 
contrast, mutations in the flm locus of A. piscicola AH-3 only cause the loss of the flagella 
systems; there is no effect on the LPS profile (Canals et al., 2007; Tabei et al., 2009). This 
suggests that the flm locus is only involved in the assembly of the bacterial flagellum here, with 
a separate locus being present for LPS O-Ag biosynthesis. Despite their differences, the flm 
genes of both A. caviae Sch3 and A. piscicola AH-3 are still able to complement corresponding, 
non-polar, mutations in the other bacteria (Canals et al., 2007). 
Furthermore, A. caviae may have acquired the minimum gene cluster for Pse5Ac7Ac 
biosynthesis, as in addition to the pathways for both flagellar assembly and LPS biosynthesis 
being merged, the protein FlmD appears to be a chimera of the FlmD and FlmH proteins 
present in other aeromonads (and in other bacteriam such as Campylobacter , PseG and PseH) 
(Tabei et al., 2009).  It is possible that this gene cluster was acquired laterally as the G+C 
content of the A. caviae Sch3 flm locus is lower (around 42%) than that of the A. piscicola AH-3 
locus, which is a characteristic 60% (similar to other aeromonads) (Tabei et al., 2009). 
1.4.1.2 – Flagellin glycosylation 
Once synthesised, Pse5Ac7Ac is transferred onto the polar flagellins by the putative 
glycosyltransferase, Maf1 (Parker et al., 2012; Parker et al., 2014). No consensus sequence has 
been identified for O-linked glycosylation, however A. caviae Sch3 flagellins have been found 
to be modified with six to eight sugars on serine/threonine residues within their D2/D3 domain 
(Tabei et al., 2009); although the precise sites of modification are unknown. This modification 
is essential for A. caviae flagellation and virulence, as when flm mutants incapable of 
modifying their flagellins were examined in a mouse model they were found to be less virulent 
than the wild type strain and could no longer produce a polar flagellum (Tabei et al., 2009). 
Furthermore, recent work by Parker et al. (2014), which includes some of the work carried out 
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here, has delved deeper into the flagellin glycosylation pathway of A. caviae Sch3 and 
demonstrated that Maf1 functions in the cytoplasm, glycosylating flagellins before the binding 
of the flagellin-specific chaperone, FlaJ. It was observed that unglycosylated flagellin can still 
be exported in A. caviae Sch3, therefore glycosylation is not required as a flagellin export 
signal, or for interactions with the export apparatus here (Parker et al., 2014). However,  it was 
demonstrated that FlaJ has less affinity for the unglycosylated flagellin, which is likely to 
promote the export of the glycosylated protein that can then be polymerised into a functional 
filament (Parker et al., 2014).  
The pathway of O-linked glycosylation is therefore very important for allowing this 
microorganism to thrive in its host and could potentially be a therapeutic target in the future; 
although the exact role of flagellin glycosylation is still to be determined. 
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1.5 – Project aims 
The main aims of this project have been to explore the pathway and role of flagellin 
glycosylation with pseudaminic acid in Aeromonas caviae Sch3; a bacterium that contains the 
simplest set of genes currently known to synthesise this sugar and modify these proteins. 
These investigations were split into three distinct sections: 
 
 A homologue of the putative deglycosylation enzyme, HP0518, known as AHA0618, 
was identified in A. caviae Sch3. Chapter 3 of this project investigates the potential 
existence of a flagellin deglycosylation pathway in A. caviae, whereby an A. caviae 
AHA0618 mutant was phenotypically analysed and the glycosylation status of the wild 
type and mutant flagellins compared.  Work here was published in Lowry et al., 
(2014b). 
 
 The exact sites of A. caviae Sch3 flagellin glycosylation are currently unknown, 
however work by Tabei et al. (2009) revealed that six to eight serine or threonine 
residues within the central region of the flagellins (D2/D3 domain) are occupied with 
pseudaminic acid. Chapter 4 of this work therefore explores the specific sites of 
flagellin glycosylation via mass spectrometric methods, and uses site-directed 
mutagenesis studies to determine the importance of the glycosylation sites identified 
on bacterial motility and flagellation. 
 
 Chapter 5 of this work investigates the function of the A. caviae Sch3 putative flagellin 
glycosyltransferase, Maf1, with a series of mini-projects: 
o The location of Maf1-specific flagellin glycosylation in the flagellar assembly 
pathway was investigated via the bacterial adenylate cyclase two-hybrid 
system (BACTH). 
o Studies were carried out to determine whether the flagellar cap (FlaH) is 
required for flagellin glycosylation. 
o The specificity of Maf1 was investigated via flagellin domain swapping studies 
with the D2/D3 regions from Aeromonas species flagellins. 
o A. caviae Sch3 was also explored as a model of O-linked glycosylation for the 
heterologous expression of H. pylori glycosylation (Maf) proteins.   
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Chapter 2 – Materials and methods 
 
2.1 – Strains and Plasmids 
Please refer to tables 2.1 and 2.2. 
Strain Relevant Characteristics Source/Reference 
 Aeromonas strains:  
Sch3N Aeromonas caviae, wild type, NalR Gryllos et al. (2001) 
JPS04 Sch3N AHA0618::Km Lowry et al. (2014b) 
JPS01 Sch3N maf1::Km Parker et al. (2012) 
AAR59 Sch3N flaH::Km Rabaan et al. (2001) 
AAR31 Sch3N flaA/B::Km/Cm Rabaan et al. (2001) 
Ae398 Aeromonas caviae, wild type Beatson et al. (2011)  
ATCC7966 Aeromonas hydrophila, wild type Seshadri et al. (2006) 
AH-3 Aeormonas piscicola, wild type 
 
Merino et al. (1991) 
 Escherichia coli strains:  
DH5  Cloning/storage strain:                            
F-, endA, hdsR17 (rk- mk+) supE44, thi-1, 
recA1 gyr-A96, φ80lacZ  
 
Invitrogen Life 
TechnologiesTM, UK 
BTH101 Reporter strain for the bacterial two-hybrid 
system:                                                
F-, cya-99, araD139, galE15, galK16, rpsL1 (Str 
r), hsdR2, mcrA1, mcrB1  
 
Euromedex 
S17-1 λ pir thi rspL (Str r) endA sbcB15 sbcC hsdR (rk
- mk
-) 
Δ (lac-proAB) [F' traD36 lacIq Δ(lacZ)M15 
proA+B+] 
 
Other strains: 
Herrero et al. (1990) 
26695 Helicobacter pylori, wild type Tomb et al. (1997) 
 
Table 2.1 – Strains 
NalR (Nalidixic acid resistance); Km (kanamycin cassette); Cm (chloramphenicol cassette) 
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Plasmid Relevant Characteristics Source/Reference 
pGEM-T Easy Cloning vector, AmpR Promega 
pSRK(Gm) Broad-host-range expression vector, 
GmR 
 
Khan et al. (2008) 
pSRK_AHA0618 
 
pSRK(Gm) derivative containing 
AHA0618 under the control of a lac 
promoter, GmR 
 
This work 
pSRK_HP0518 pSRK(Gm) derivative containing H. 
pylori (26695) HP0518 under the 
control of a lac promoter, GmR 
 
This work 
pSRK_flaA(Sch3N) pSRK(Gm) derivative containing A. 
caviae Sch3N flaA under the control 
of a lac promoter, GmR 
 
This work 
pSRK_flaA(ATCC7966) pSRK(Gm) derivative containing A. 
hydrophila ATCC7966 flaA under the 
control of a lac promoter, GmR 
 
This work 
pSRK_flaA(AH-3) pSRK(Gm) derivative containing A. 
caviae AH-3 flaA under the control 
of a lac promoter, GmR 
 
This work 
pSRK_maf1(H.p) pSRK(Gm) derivative containing H. 
pylori (26695) maf1 under the 
control of a lac promoter, GmR 
 
This work 
pSRK_maf2(H.p) pSRK(Gm) derivative containing H. 
pylori (26695) maf2 under the 
control of a lac promoter, GmR 
 
This work 
pBBR1MCS-5 Broad host range expression vector, 
GmR 
 
Kovach et al. (1995) 
pBBR1MCS-5_flaA pBBR1MCS-5 derivative containing 
Sch3N flaA under the control of its 
native promoter 
 
This work 
pBBR1MCS-5_flaA(Ae398) pBBR1MCS-5 derivative containing 
the A. caviae Ae398 flaA under the 
control of its native promoter 
 
This work 
pBBR1MCS-5_flaA(AH-3) pBBR1MCS-5 derivative containing 
the Aeromonas piscicola AH-3 flaA 
under the control of its native 
promoter 
 
This work 
pBBR1MCS-5_flaA(AH-3) pBBR1MCS-5 derivative containing 
the Aeromonas hydrophila 
ATCC7966 flaA under the control of 
its native promoter 
This work 
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Site-Directed Mutagenesis: 
 
  
pBBR1MCS-5_flaB pBBR1MCS-5 derivative containing 
Sch3N flaB under the control of its 
native promoter 
 
This work 
pBBR1MCS-5_flaB(T155A) 
 
pBBR1MCS-5 derivative containing 
Sch3N flaB with a Theronine155 to 
Alanine point mutation under the 
control of its native promoter 
 
This work 
 
pBBR1MCS-5_flaB(S159/161A) pBBR1MCS-5 derivative containing 
Sch3N flaB with two point 
mutations (Serine159/161Alanine) 
under the control of its native 
promoter 
 
This work 
 
pBBR1MCS-5_flaB(S167/169A) 
 
pBBR1MCS-5 derivative containing 
Sch3N flaB with two point 
mutations (Serine167/169Alanine) 
under the control of its native 
promoter 
 
This work 
 
pBBR1MCS-
5_flaB(S159/161/167/169A) 
 
pBBR1MCS-5 derivative containing 
Sch3N flaB with four point 
mutations 
(Serine159/161/167/169Alanine) 
under the control of its native 
promoter 
 
This work 
 
pBBR1MCS-5_flaB(S208/210A) pBBR1MCS-5 derivative containing 
Sch3N flaB with two point 
mutations (Serine208/210Alanine) 
under the control of its native 
promoter 
 
This work 
pBBR1MCS-5_flaB(L160A) pBBR1MCS-5 derivative containing 
Sch3N flaB with a Leucine160 to 
Alanine point mutation under the 
control of its native promoter 
 
This work 
pBBR1MCS-5_flaB(I168A) pBBR1MCS-5 derivative containing 
Sch3N flaB with a Isoleucine168 to 
Alanine point mutation under the 
control of its native promoter 
 
This work 
Bacterial two-hybrid: 
 
 
  
pUT18 High copy number BACTH vector, 
allows in-frame fusion of desired 
protein to N-terminal of T18 
EUROMEDEX 
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adenylate cyclase (CyaA) domain, 
AmpR 
 
pUT18_flaA pUT18 derivative containing Sch3N 
flaA, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18_flaA-CBD pUT18 containing Sch3N flaA-CBD 
(minus the chaperone binding 
domain), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18_flaA-D2/D3 pUT18 containing Sch3N flaA-D2/D3 
(minus the central D2/D3 domain of 
FlaA), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18_flaB pUT18 derivative containing Sch3N 
flaB, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18_flaJ pUT18 derivative containing Sch3N 
flaJ, inserted into EcoR1/BamHI site, 
AmpR 
 
This work 
pUT18_maf1 pUT18 derivative containing Sch3N 
maf1, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18C High copy number BACTH vector, 
allows in-frame fusion of desired 
protein to C-terminal of T18 
adenylate cyclase domain, AmpR 
 
EUROMEDEX 
pUT18C_flaA pUT18C derivative containing Sch3N 
flaA, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18C_flaA-CBD pUT18C containing Sch3N flaA-CBD 
(minus the chaperone binding 
domain), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18C_flaA-D2/D3 pUT18C containing Sch3N flaA-
D2/D3 (minus the central D2/D3 
domain of FlaA), inserted into 
EcoR1/BamHI site, AmpR 
 
This work 
pUT18C_flaB pUT18C derivative containing Sch3N 
flaB, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pUT18C_flaJ pUT18C derivative containing Sch3N This work 
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flaJ, inserted into EcoR1/BamHI site, 
AmpR 
 
pUT18C_maf1 pUT18C derivative containing Sch3N 
maf1, inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pKT25 Low copy number BACTH vector, 
allows in-frame fusion of desired 
protein to C-terminal of T25 
adenylate cyclase domain, KmR 
 
EUROMEDEX 
pKT25_flaA pKT25 derivative containing Sch3N 
flaA, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pKT25_flaA-CBD pKT25 containing Sch3N flaA-CBD 
(minus the chaperone binding 
domain), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pKT25_flaA-D2/D3 pKT25 containing Sch3N flaA-D2/D3 
(minus the central D2/D3 domain of 
FlaA), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pKT25_flaB pKT25 derivative containing Sch3N 
flaB, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pKT25_flaJ pKT25 derivative containing Sch3N 
flaJ, inserted into EcoR1/BamHI site, 
KmR 
 
This work 
pKT25_maf1 pKT25 derivative containing Sch3N 
maf1, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pKNT25 Low copy number BACTH vector, 
allows in-frame fusion of desired 
protein to N-terminal of T25 
adenylate cyclase domain, KmR 
 
EUROMEDEX 
pKNT25_flaA pKNT25 derivative containing Sch3N 
flaA, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pKNT25_flaA-CBD pKNT25 containing Sch3N flaA-CBD 
(minus the chaperone binding 
domain), inserted into EcoR1/BamHI 
site, AmpR 
 
This work 
pKNT25_flaA-D2/D3 pKNT25 containing Sch3N flaA- This work 
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D2/D3 (minus the central D2/D3 
domain of FlaA), inserted into 
EcoR1/BamHI site, AmpR 
 
pKNT25_flaB pKNT25 derivative containing Sch3N 
flaB, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pKNT25_flaJ pKNT25 derivative containing Sch3N 
flaJ, inserted into EcoR1/BamHI site, 
KmR 
 
This work 
pKNT25_maf1 pKNT25 derivative containing Sch3N 
maf1, inserted into EcoR1/BamHI 
site, KmR 
 
This work 
pUT18C-zip pUT18C derivative containing 
leucine zipper of GCN4 fused in-
frame to C-terminal of T18 fragment 
CyaA, AmpR 
 
EUROMEDEX 
(Karimova et al., 
1998) 
pKT25-zip pKT25 derivative containing leucine 
zipper of GCN4 fused in-frame to C-
terminal of T25 fragment CyaA, KmR 
 
EUROMEDEX 
(Karimova et al., 
1998) 
 
Table 2.2 – Plasmids 
KmR (kanamycin resistance), AmpR (ampicillin resistance), CmR (chloramphenicol resistance) 
and GmR (gentamicin resistance). Please refer to the appendix (page 221) for plasmid maps. 
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2.2 – Media and Antibiotics 
Please refer to tables 2.3 and 2.4. 
Type of Media Description 
Luria Broth (LB) 1% (w/v) tryptone (Oxoid), 0.5% (w/v) yeast 
extract (Oxoid), 1% (w/v) NaCl (Melford)                 
In dH2O 
LB Agar LB (as above)                       1.5% (w/v) agar 
(Oxoid)                   In dH2O 
Motility Agar 1% (w/v) tryptone (Oxoid), 0.5% (w/v) NaCl 
(Melford), 0.25% (w/v)agar (Oxoid)                  
 In dH2O 
Swarming Agar 0.6% (w/v) ‘Eiken’ agar, 0.8% (w/v) Nutrient 
broth (Difco), 0.5% (w/v) NaCl (Melford) 
In tap water 
Blood Agar Oxoid horse blood agar plates 
Brain-Heat Infusion Broth (BHIB) Difco BHI mix (40 g in 1 L dH2O) 
BHI agar BHIB containing 1.5% (w/v)  agar (Oxoid) 
MacConkey Agar For use in the bacterial two-hybrid system                    
Difco MacConkey agar mix (40 g in 1 L dH2O), 
supplemented with 1% (w/v) maltose 
(Melford) 
 
Table 2.3 – Media 
 
Table 2.4 - Antibiotics 
  
Antibiotic Final concentration 
Ampicillin (Melford) 
Chloramphenicol (Melford) 
100 μg/ml 
25 μg/ml 
Gentamicin (Melford) 25 μg/ml 
Kanamycin (Melford) 50 μg/ml 
Nalidixic Acid (Ducgefa Biochemie) 50 μg/ml 
Streptomycin (Melford) 50 μg/ml 
43 
 
2.3 – Solutions and Buffers 
 
Solution/Buffer Description 
Phosphate Buffered Saline (PBS) 10 X  - 137 mM NaCl (Melford), 27 mM KCl 
(Melford), 14 mM Na2HPO4 (Fischer), 43 mM 
KH2PO4 (Sigma) - Adjust to pH 7.4 
1 X - Dilute 10 X 1:9 in dH2O 
TAE buffer 50 X - 40 mM Tris (Fischer), 1.142% (w/v) 
Acetic acid (Melford), 1 mM EDTA (Melford) 
1 X - Dilute 50 X 1:49 in dH2O  
SDS-PAGE running buffer (1X) 200 mM Glycine (Sigma), 0.1% (w/v) SDS 
(Sigma), 25 mM Tris base (Fisher) 
Western blot transfer buffer 10 X - 25 mM Tris base (Fischer), 200 mM 
Glycine (Sigma) 
1 X - Dilute 10 X 1:9 in dH2O  and methanol 
(20% methanol overall) 
RF1 (production of chem comp cells) 100 mM KCl (Melford), 50 mM MnCl2.4H2O 
(Fischer), 30 mM KAc (Fischer), 10 mM 
CaCl2.2H2O (Sigma), 15% (v/v) glycerol 
(Sigma) 
RF2 (production of chem comp cells) 10 mM MOPS (Fischer), 10 mM KCl 
(Melford), 75 mM CaCl2  (Sigma), 15% (v/v) 
glycerol (Sigma) 
Ethidium bromide solution 15% (w/v) ethidium bromide (Invitrogen) in 
1% TAE buffer 
Laemmeli Buffer (protein loading) 62.5 mM Tris HCl (Invitrogen) 10% (v/v) 
glycerol (Sigma), 2% (w/v) SDS (Sigma),                  
0.01 mg/ml Bromophenol blue (Invitrogen),                              
5% (v/v) β-Mercaptoethanol (Melford) 
Nitrocellulose membrane blocking buffer 5% (w/v) skimmed milk powder (Marvel) in 1 
X PBS 
Lysozyme solution (for genomic DNA 
isolation) 
25 mM Tris-HCl (pH8) (Invitrogen)                              
25 mM EDTA (pH8) (Invitrogen)                                 
2 mg/ml Lysozyme (Sigma) 
 
Table 2.5 – Solutions and buffers 
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2.4 – Growth Conditions and Genetic Manipulations 
2.4.1 – Standard growth conditions 
Overnight subcultures were set up with 10 ml of the required growth media in a 25 ml sterile 
universal tube and inoculated with the chosen bacterial strain. A list of bacterial strains and 
plasmids used in this work are shown in tables 2.1 and 2.2. Both E. coli and A. caviae were 
generally grown at 37ᵒC, with agitation, or as directed.  
2.4.2 – Glycerol stocks 
Glycerol stocks were created by making an overnight subculture of the desired strain and 
pipetting 500 μl of the culture into a 1.5 ml microcentrifuge containing 500 μl of 50% glycerol 
(25% glycerol overall). Stocks were stored at -80⁰C.  
2.4.3 – Growth Curves 
Growth curves were carried out in triplicate, in BHIB, over the course of 7 hrs for the required 
strains. Overnight subcultures were set up of the desired strain and used to inoculate 50 ml 
flasks of BHIB the following day (1:100). The optical density was measured of each flask every 
hour by pipetting 1 ml samples into a 1 ml plastic cuvette (Sarstedt) and measuring the OD600 
on a Pharmacia LKB spectrophotometer. Average measurements were obtained for each time-
point (n=3) and GraphPad Prism was used to analyse the data collected. 
2.4.4 – Swimming motility assays 
Swimming motility assays were carried out by setting up an overnight subculture of the 
desired bacterial strain. Motility agar was melted using a bench top autoclave and allowed to 
cool to around 50ᵒC before pouring. If required, IPTG was added to the media at a final 
concentration of 1 mM. The assays were carried out on large square petri dishes (300 X 300 
mm) (Fischer) holding 250 ml of motility agar. 1 ml of the overnight subculture was pelleted 
(13000 X g) in a 1.5 ml microcentrifuge tube (Eppendorf) and the supernatant removed. The 
motility agar was inoculated by dipping a sterile cocktail stick into the remaining bacterial 
pellet and piercing the agar; large motility plates could fit between 16 – 24 individual 
inoculants on them. Motility plates were incubated aerobically, overnight, at room 
temperature. Plates were analysed by manually measuring the radius of any motility halos 
present, usually after 16 hr incubations (unless otherwise stated) and data was analysed with 
GraphPad Prism. 
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2.4.5 – Swarming motility assays 
 Swarming motility assays were carried out as above (section 2.4.3) but with swarming motility 
agar. 
2.4.6 – Bacterial adenylate cyclase two-hybrid system (BACTH system) 
The bacterial two-hybrid system was carried out using the Euromedex BACTH system kit 
following the protocol provided. The required BACTH plasmids (containing genes of interest) 
(plasmid diagrams in the appendix, page 221) were co-transformed into chemically competent 
E. coli BTH101 (section 2.4.15) and plated onto MacConkey agar supplemented with 1% (w/v) 
maltose for analysis of interactions. Plates were incubated for 1-3 days at 30ᵒC (incubation up 
to 5 days if necessary). 
2.4.7 – Isolation of Genomic DNA (Phenol/Chloroform Extraction) 
Bacteria were harvested from 10 ml BHIB overnight subcultures via centrifugation at 3,000 X g 
for 10 mins at 4ᵒC. Cell pellets were resuspended in 500 μl of lysozyme solution (Table 2.5), 
transferred to 1.5 ml microcentrifuge tubes and incubated at 37ᵒC for 1 hr. Following 
incubation, 50 μl of 10% (w/v) SDS was added and samples incubated for a further 15 mins at 
37ᵒC. Samples were then gently mixed (by inverting the tube) for 5 mins or until the solutions 
became less viscous. Subsequently, 300 μl of phenol/chloroform/isoamyl alcohol was added to 
the samples which were then gently mixed and centrifuged at 16,000 X g for 8 mins. The 
aqueous phase was removed following centrifugation and transferred to a fresh 
microcentrifuge tube. The aqueous phase of each sample was mixed with 200 μl of dH2O to 
decrease the viscosity and the Phenol/Chloroform step repeated. DNA precipitation was 
achieved by adding 1 volume of ice-cold isopropanol and 0.1 volumes of 3 M sodium acetate 
to the samples and incubating on ice for 10 mins. DNA was recovered via centrifugation at 
16,000 X g for 5 mins. The DNA pellet was washed with 70% (v/v) ethanol before being 
dissolved in 500 μl of elution buffer (Qiagen) for 2 hours at room temperature. DNase free 
RNase at a final concentration of 40 μg/ml was added to the samples and incubated at 37ᵒC for 
30 mins. Finally, the DNA was precipitated as before, washed with 70% (v/v) ethanol and 
dissolved in 100 μl of elution buffer.  
DNA precipitation was achieved by adding 0.1 volumes of 3 M sodium acetate and 1 volume of 
ice cold isopropanol and incubating on ice for 10 minutes. Genomic DNA was diluted to a 
concentration of 50 ng/μl for PCR reactions. 
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2.4.8 – Plasmid purification 
Plasmid purification was carried out from an overnight subculture of the bacterial strain 
containing the desired plasmid in LB. An Omega E.Z.N.A plasmid miniprep kit II was used to 
extract and purify the plasmid according to the manufacturer’s guidelines, from 1.5 ml of 
bacterial culture. Pure plasmids were eluted into a 1.5 ml microcentrifuge tube in 30 μl of 
elution buffer from the kit (unless otherwise stated) and stored at -20ᵒC. 
2.4.9 – Agarose gel electrophoresis 
To determine the size of DNA samples, agarose gel electrophoresis was used. TAE-based 1% 
agarose gels (Fischer) were produced and samples loaded onto the gel with Qiagen Gelpilot 
loading dye. Samples were run alongside a DNA ladder, such as Q step 4 DNA ladder (YorkBio), 
at 90 V for 1 hr with a BIO-RAD power pack. The gels were post-stained with ethidium bromide 
solution (table 2.5) for 10 mins to allow visualisation of DNA under UV light. 
2.4.10 – Gel extraction 
Gel extractions were carried out to isolate DNA fragments from an agarose gel after agarose 
gel electrophoresis with the use of QIAGEN gel extraction buffers according to the 
manufacturer’s guidelines.  
2.4.11 - Restriction digests 
Restriction digests were set up to check the size of plasmids or produce DNA 
fragments/plasmids with the required sticky ends for cloning. The digests were set up with the 
appropriate restriction enzyme and corresponding buffer according to the manufacturer’s 
guidelines (NEB). Typically 5 units of enzyme was used per 1 μg of DNA to be digested. The size 
of digested DNA was checked via agarose gel electrophoresis (section 2.4.9).  
2.4.12 – Ligation 
Ligation reactions were set up with T4 DNA ligase (Promega) and the corresponding buffer 
according to the manufacturer’s guidelines (Promega). 
The 10 μl reactions were carried out with insert DNA and vector DNA at a 3:1 molar ratio, using 
0.1-1 units of T4 DNA ligase. Reactions were incubated at room temperature for 16 hrs. 
2.4.13 – Conjugation 
The E. coli strain S17-1 λ pir (table 2.1) was used as the donor strain to conjugate the desired 
expression vector [such as pSRK(Gm) or pBBR1MCS-5 containing an insert] into an A. caviae 
(recipient) strain. 
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 In preparation for conjugative transfer, the expression vector was transformed into chemically 
competent E. coli S17-1 λ pir (section 2.4.15). Overnight subcultures were set up of the 
resulting E. coli S17-1 λ pir strains and the required A. caviae (recipient) strains. 
The 10 ml subcultures were centrifuged in sterile 15 ml falcon tubes for 8 mins (2,800 X g). The 
supernatant was removed and pellet resuspended in 5 ml of sterile PBS to remove any 
antibiotics present and centrifugation was carried out as before. The PBS wash step was 
repeated and the final E. coli S17-1 λ pir pellets were resuspended in 1 ml PBS (more/less 
depending on number of conjugations carried out). 
The recipient pellet was then resuspended in 0.5 ml of the E. coli S17-1 λ pir suspension and 
200 μl of the resulting suspension was plated onto a blood agar plate (Oxoid). Plates were 
incubated for 8 h at 37ᵒC. 
After incubation the bacterial lawn was scraped off the blood agar plate and resuspended in 1 
ml of sterile PBS and pipetted into a 1.5 ml microcentrifuge tube. The cell suspension collected 
was serially diluted 3 times (1:10/1:100/1:1000) into separate 1.5 ml microcentrifuge tubes 
(100 μl cell suspension added to 900 μl PBS). 
A volume of 200 μl from each cell suspension was spread onto BHI agar containing the 
appropriate antibiotics to select for A. caviae containing the vector. Plates were incubated 
overnight at 37ᵒC. 
An oxidase test (section 2.4.14) was carried out on resulting colonies to ensure the bacterial 
growth was Aeromonas and colony PCR (section 2.6.2.4) carried out where required to ensure 
the strain contained the desired gene. Suitable controls were carried out with empty 
expression vectors. 
2.4.14 – Oxidase test 
Oxidase tests were carried out on the resulting colonies from bacterial conjugation to test for 
the presence of Aeromonas caviae. Filter paper was soaked in 1% tetramethyl-p-
phenylenediamine dihydrochloride (electron donor) and a single bacterial colony was rubbed 
onto the paper using a sterile loop. A colour change (dark purple) can be visualised if the 
bacteria are oxidase positive (Aeromonas) or no colour change if oxidase negative (E. coli).  
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2.4.15 – Bacterial transformation into chemically competent E. coli 
2.4.15.1 - Production of chemically competent cells 
An overnight subculture was set up of the E. coli strain to be made chemically competent for 
the uptake of plasmid DNA. Subsequently, the subculture was used to inoculate a flask of LB 
(100 ml) (1:100) which was then incubated for around 2 hrs at 37ᵒC until an OD600 of 0.6 
(exponential phase of growth) was reached. Once at the desired OD600 the culture was 
incubated on ice for 15 mins, after which it was transferred to a 50 ml falcon tube and 
centrifuged at 2,800 X g for 10 mins at 5ᵒC. The supernatant was discarded and cell pellet 
gently resuspended in 20 ml of sterile ice-cold RF1 (table 2.5). The cell suspension was 
incubated on ice for 30 mins and then centrifuged at 2,800 X g for 10 mins at 5ᵒC. The 
supernatant was discarded and cell pellet gently resuspended in 700 μl of sterile ice-cold RF2. 
The chemically competent cells were then pipetted into separate 1.5 ml microcentrifuge tubes 
in 100 μl aliquots and stored at -80ᵒC. 
2.4.15.2 - Transformation 
Chemically competent cells to be transformed and plasmid DNA to be introduced into these 
cells were thawed on ice. The required amount of plasmid DNA (Generally 1 μl of a plasmid 
miniprep) was transferred into a sterile microcentrifuge tube and gently mixed with 100 μl of 
chemically competent cells. The DNA/cell mixture was incubated on ice for 30 mins before 
being heat shocked at 42⁰C for 1 min 30 secs. Cells were cooled on ice for a further 5 mins 
before 900 μl of LB was added to the samples. Cells were allowed to recover by incubation at 
37⁰C for 1 hr. 
Recovered cell samples were then centrifuged at 16,000 X g for 1 min and the supernatant 
discarded. Cell pellets were resuspended in 100 μl of fresh LB and plated onto agar plates 
containing suitable antibiotics to select for any transformants. The plates were incubated 
overnight at 37⁰C (unless otherwise stated). Where IPTG induction of plasmid genes was 
required, IPTG (Invitrogen) was added to the agar plates at a final concentration of 1 mM. 
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2.6 – Polymerase Chain reaction (PCR) 
Polymerase chain reaction (PCR) was carried out in 50 μl reactions, in thin-walled PCR tubes 
(Eppendorf) using a BIO-RAD T100TM Thermal Cycler (PCR machine). 
Different PCR conditions were utilised depending on the reaction being carried out. The 
general PCR reaction mixture used was as follows: 
 1 μl Forward primer (2 pmol/μl) 
 1 μl Reverse primer (2 pmol/μl) 
 1 μl Template DNA (50-200 ng) 
 1 μl 25 mM MgCl2 (Where necessary) 
 5 μl 10 X buffer (or 10 μl 5 X buffer for Q5 DNA polymerase) 
 2.5 μl 100% Dimethyl sulfoxide (DMSO) 
 1 μl dNTPs (10 mM stock, Roche) 
 1 μl polymerase (2.5 U per reaction) 
 Make up to 50 μl with molecular grade dH2O 
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2.6.1 – Primers 
Please refer to table 2.6 below. 
Primer Relevant Characteristics Reference 
JLP_28 5’ATATATATCATATGGTGGTGGTGAAGAAGTC 3’ (Forward) 
Insertion of AHA0618 into the expression vector pSRK(Gm), 
contains an NdeI restriction site 
This work 
 
JLP_29 5’TATTATGGATCCTCAGGGCTCGATGATGATGG 3’(Reverse) 
Insertion of AHA0618 into the expression vector pSRK(Gm), 
contains a BamHI restriction site 
This work 
 
JLP_108 5’CATATGAAAAAGGTATTACCGGCTTTATTAATG 3’(Forward) 
Insertion of H. pylori 26695 HP0518 into the expression vector 
pSRK(Gm), contains an NdeI restriction site 
This work 
JLP_109 5’GGATCCCTATTTTTCCATTATAATAGACACTTGATTGTT 3’ 
(Reverse) 
Insertion of H. pylori 26695 HP0518 into the expression vector 
pSRK(Gm), contains a BamHI restriction site 
This work 
RCL_53 5’GCGCCATATGAGTCTGTATATCAATACCAACGTTTC 3’ 
(Forward) 
Insertion of A. caviae Sch3N flaA into the expression vector 
pSRK(Gm), contains an NdeI restriction site 
This work 
RCL_54 5’ GCGCAAGCTTTTATTTCTGCAGCAGGGAG 3’ (Reverse) 
Insertion of A. caviae Sch3N flaA into the expression vector 
pSRK(Gm), contains a HindIII restriction site 
This work 
RCL_49 5’ GCGCCATATGGGTCTTTATATCAATACGAACGTTTC 3’ 
(Forward) 
Insertion of A. piscicola AH-3 flaA into the expression vector 
pSRK(Gm), contains an NdeI restriction site 
This work 
RCL_50 5’ GCGCAAGCTTTTAGCCTTGCAGCAGCG 3’ (Reverse) 
Insertion of A. piscicola AH-3 flaA into the expression vector 
pSRK(Gm), contains an HindIII restriction site 
This work 
RCL_51 5’ GCGCCATATGGCCATGTATATCAACACGAATACT 3’ 
(Forward) 
Insertion of A. hydrophila ATCC7966 flaA into the expression 
vector pSRK(Gm), contains an NdeI restriction site 
This work 
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RCL_52 5’ GCGCAAGCTTTTAACCCAGCAGGGACAG 3’ (Reverse) 
Insertion of A. hydrophila ATCC7966 flaA into the expression 
vector pSRK(Gm), contains an HindIII restriction site 
This work 
RCL_60 5’ GCGCCATATGATGGATATTTATCAAAAAAACTTGC 3’ 
(Forward) 
Insertion of H. pylori 26695 maf1 into the expression vector 
pSRK(Gm), contains an NdeI restriction site 
This work 
RCL_61 5’ GCGCGGATCCTTACCATTCTTTTAAAGCCATTT 3’ (Reverse) 
Insertion of H. pylori 26695 maf1 into the expression vector 
pSRK(Gm), contains an BamHI restriction site 
This work 
RCL_62 5’ GCGCCATATGCCCTTTTTAAAAGCCCTAGAAT 3’ (Forward) 
Insertion of H. pylori 26695 maf2 into the expression vector 
pSRK(Gm), contains an NdeI restriction site 
This work 
RCL_63 5’ GCGCGGATCCTCATGGTTGTTTGAGTTGC 3’ (Reverse) 
Insertion of H. pylori 26695 maf2 into the expression vector 
pSRK(Gm), contains an BamHI restriction site 
This work 
RCL_71 5’ GCGCAAGCTTGTCTTGTGAAAAGGCGCCG 3’ (Forward) 
Insertion of A. caviae Sch3N flaA into pBBR1MCS-5, including 
the native promoter and contains a HindIII restriction site 
This work 
RCL_72 5’ GCGCGGATCCCTTCAGAACCTTATTTCTGCAGCAG 3’ 
(Reverse) 
Insertion of A. caviae Sch3N flaA into pBBR1MCS-5 and 
contains a BamHI restriction site 
This work 
RCL_28 5’ GCGCAAGCTTGCCGTTAACTAAACATATCAGG 3’ (Forward) 
Insertion of A. caviae Ae398 flaA into pBBR1MCS-5, 
including the native promoter and contains a HindIII 
restriction site 
This work 
RCL_29 5’ GCGCGGATCCCATGTTGACGGTTTAACCG 3’ (Reverse) 
Insertion of A. caviae Ae398 flaA into pBBR1MCS-5 and 
contains a BamHI restriction site 
This work 
RCL_30 5’ GCGCAAGCTTCATCGAACATGAAAGACAATAAAG 3’ 
(Forward) 
Insertion of A. piscicola AH-3 flaA into pBBR1MCS-5, 
including the native promoter and contains a HindIII 
restriction site 
This work 
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RCL_31 5’ GCGCGGATCCCAACCGCCCTGTTTTC 3’ (Reverse) 
Insertion of A. piscicola AH-3 flaA into pBBR1MCS-5 and 
contains a BamHI restriction site 
This work 
RCL_32 5’ GCGCAAGCTTGGATCGTTCAACCTGTTC 3’ (Forward) 
Insertion of A. hydrophila ATCC7966 flaA into pBBR1MCS-5, 
including the native promoter and contains a HindIII 
restriction site 
This work 
RCL_34 5’ GCGCTCTAGACTATCTCATCACTGCGTTTC 3’ (Reverse) 
Insertion of A. hydrophila ATCC7966 flaA into pBBR1MCS-5 
and contains a XbaI restriction site 
This work 
 Site-Directed Mutagenesis Primers  
RCL_55 5’ GCGCAAGCTTAGGCAGACTCGTTCAAGCTGT 3’ (Forward) 
Insertion of A. cavie Sch3N flaB into pBBR1MCS-5 and 
contains a HindIII restriction site 
This work 
RCL_56 5’ GCGCGGATCCCTGCTCCTCATATCAATGATGTTG 3’ (Reverse) 
Insertion of A. cavie Sch3N flaB into pBBR1MCS-5 and 
contains a BamHI restriction site 
This work 
B T155A (R) 5’ CTAAACCCAATGGCCTGATTGGC 3’ (Reverse) 
To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporates a 
T155A site-directed mutation into FlaB. 
This work 
B T155A (F) 5’ 3’ GCCAATCAGGCCATTGGGTTTAG (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of flaB for overlap extension PCR. Incorporates a 
T155A site-directed mutation into FlaB. 
This work 
B S159/161A 
(R) 
5’ GGCTTGAGCCAAGGCAAACCCAA 3’ (Reverse) 
To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporates 
S159/161A site-directed mutations into FlaB. 
This work 
B S159/161A 
(F) 
5’ TTGGGTTTGCCTTGGCTCAAGCC 3’ (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of Sch3N flaB for overlap extension PCR. 
Incorporates S159/161A site-directed mutations into FlaB. 
This work 
B S167/169A 
(R) 
5’ CAATCCCAGCAATGGCGAACCCTC 3’ (Reverse) This work 
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To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporates 
S167/169A site-directed mutations into FlaB. 
B S167/169A 
(F) 
5’ GAGGGTTCGCCATTGCTGGGATTG 3’ (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of flaB for overlap extension PCR. Incorporates 
S167/169A site-directed mutations into FlaB. 
This work 
B L160A (R) 5’ GGCTTGAGACGCGCTAAACCCAA 3’ (Reverse) 
To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporates an 
L160A site-directed mutation into FlaB. 
This work 
B L160A (F) 5’ TTGGGTTTAGCGCGTCTCAAGCC 3’ (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of flaB for overlap extension PCR. Incorporates an 
L160A site-directed mutation into FlaB. 
This work 
B I168A (R) 5’ CAATCCCAGAAGCGCTGAACCCTC 3’ (Reverse) 
To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporate an 
I168A site-directed mutation into FlaB. 
This work 
B I168A (F) 5’ GAGGGTTCAGCGCTTCTGGGATTG 3’ (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of flaB for overlap extension PCR. Incorporates an 
I168A site-directed mutation into FlaB. 
This work 
B S208/210A 
(R) 
5’ CTCTGAGTAGCAATAGCGATGCCACC 3’ (Reverse) 
To be used in conjunction with RCL_55 to form the front 
section of flaB for overlap extension PCR. Incorporates 
S208/210A site-directed mutations into FlaB. 
This work 
B S208/210A 
(F) 
5’ GGTGGCATCGCTATTGCTACTCAGAG 3’ (Forward) 
To be used in conjunction with RCL_56 to form the back 
section of flaB for overlap extension PCR. Incorporates 
S208/210A site-directed mutations into FlaB. 
This work 
 Bacterial Two-Hybrid Primers 
All forward primers contain BamHI restriction sites and 
reverse primers contain EcoRI sites 
 
JLP_39 5’ GGATCCCATGAGTCTGTATATCAATACCAAC 3’ (Forward) 
Insertion of flaA, flaA-CBD and flaA-D2/D3, in to all four 
Lab 
collection 
54 
 
bacterial two-hybrid vectors (pUT18, pUT18C, pKT25 & 
pKNT25) 
JLP_40 5’ GAATTCTTATTTCTGCAGCAGGGAGA 3’ (Reverse) 
Insertion of flaA and flaA-D2/D3 into pUT18C and pKT25 (tag 
at N-terminal) 
Lab 
collection 
JLP_53 5’ GAATTCGAGTTCTGCAGCAGGGAGAG 3’ (Reverse) 
Insertion of flaA and flaA-D2/D3 into pUT18 and pKNT25 
(tag at C-terminal) 
Lab 
collection 
RCL_01 5’ GAATTCTTATGCATCGCGGATACGAGA 3’ (Reverse) 
Insertion of flaA-CBD into pUT18C and pKT25 (tag at N-
terminal) 
This work 
RCL_02 5’ GAATTCGATGCATCGCGGATACGAGA 3’ (Reverse) 
Insertion of flaA-CBD into pUT18 and pKNT25 (tag at C-
terminal) 
This work 
RCL_17 5’GGTTCTGCACCGCACCCAGTTCTGCTCGAGTACCGCTAAATGA
ACCATCAAG 3’ (Reverse) 
To be used with JLP_39 to create the front section of flaA-
D2/D3. The construct was then created via overlap extension 
PCR with the back sections of the gene 
This work 
RCL_18 5’CTGCTTGATGGTTCATTTAGCGGTACTCGAGCAGAACTGGGT
GCG 3’ (Forward) 
To be used alongside either JLP_40 or JLP_53 to create the 
back sections of flaA-D2/D3. Overlap extension PCR was 
then used with the front gene fragment to create flaA-
D2/D3 
This work 
JLP_47 5’ GGATCCCATGGCCATGTATATCAATACCAATAC 3’ (Forward) 
Insertion of flaB into all four bacterial two-hybrid vectors 
Lab 
collection 
JLP_48 5’ GAATTCTTAACCCAGCAGCTGCAG 3’ (Reverse) 
Insertion of flaB into pUT18C and pKT25 (tag at N-terminal) 
Lab 
collection 
JLP_52 5’ GAATTCGAACCCAGCAGCTGCAG 3’ (Reverse) 
Insertion of flaB into pUT18 and pKNT25 (tag at C-terminal) 
Lab 
collection 
JLP_41 5’ GGATCCCATGTACAAGCGCAATATCAAAGC 3’ (Forward) 
Insertion of flaJ into all four bacterial two-hybrid vectors 
This work 
RCL_20 5’ GAATTCTCATAGCTCACCCAACTGC 3’ (Reverse) This work 
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Insertion of flaJ into pUT18 and pKNT25 (tag at C-terminal) 
RCL_21 5’ GAATTCGATAGCTCACCCAACTGCTG 3’ (Reverse) 
Insertion of flaJ into pUT18C and pKT25 (tag at N-terminal) 
This work 
RCL_79 5’ ATATGGATCCCATGTCACTCAATATAGATGTAGCTTTG 3’ 
(Forward)  
Insertion of maf1 into all four bacterial two-hybrid vectors 
This work 
 
JLP_44 5’  GAATTCTTATTTTTTGAATAGTACAATAACTTCATTG 3’ 
(Reverse) 
Insertion of maf1 into pUT18C and pKT25 (tag at N-terminal) 
This work 
JLP_50 5’GAATTCGATTTTTTGAATAGTACAATAACTTCATTGTCTATC 3’ 
(Reverse) 
Insertion of maf1 into pUT18 and pKNT25 (tag at C-terminal) 
This work 
Table 2.6 – Primers 
Primers were obtained at an initial concentration of 100 pmol/μl. With regards to the bacterial 
two-hybrid primers: Reverse primers for the insertion of desired genes into pKNT25 and pUT18 
have the stop codon removed due to being able to make use of the adenylate cyclase domain 
stop codon downstream (tagged at the C-terminal). All forward primers possess an EcoRI 
restriction site (GAATTC) and all reverse primers a BamHI restriction site (GGATCC) at the 5’ 
end. Together these allow insertion of the amplified gene fragments into the bacterial two-
hybrid plasmids cut with these enzymes. 
JLP primers were created by Dr Jennifer L Parker. 
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2.6.2 – PCR cycles 
2.6.2.1 - Expand high fidelity PCR (Roche) 
The Roche Expand High Fidelity PCR kit was utilised due to being a mixture of 2 polymerases: 
one allowing high fidelity amplification of target genes due to its proofreading (3’-5’ 
exonuclease) activity and another for the addition of non-templated adenines to the PCR 
product (useful in TA-cloning). This allowed the amplified gene to be ligated into the storage 
vector, pGEM-T-EASY (Promega). A general PCR cycle was used to amplify target genes (see 
below) and was tailored according to the size of the gene and the primers used. An annealing 
temperature of 5ᵒC below the melting temperature (Tm) of the primers was used 
 Initial denaturation step - 94⁰C – 2 mins 
 Denaturation - 94⁰C - 15 secs 
 Annealing – 45 - 65⁰C  - 30 secs 
 Extension - 72⁰C - 1 min/kb 
 Denaturation - 94⁰C - 15 secs 
 Annealing (generally 1ᵒC increase) – 45- 68 - 30 secs 
 Extension - 72⁰C - 1 min/kb 
 Final elongation - 72⁰C - 2 mins 
2.6.2.2 – Q5 DNA polymerase (NEB) 
With Q5 DNA polymerase (NEB), again the PCR cycle was adjusted according to the size of the 
gene being amplified and to the Tm of the primers. NEB suggest an annealing temperature of 
3⁰C above the Tm (of the primer with the lowest Tm). The following PCR cycle was used: 
 Initial denaturation - 98⁰C – 30 secs 
 Denaturation - 98⁰C – 10 secs 
 Annealing – 50-72⁰C – 30 secs 
 Extension - 72⁰C – 30 secs/kb 
 Final extension - 72⁰C – 2 mins 
2.6.2.3 – Overlap extension PCR (for site-directed mutagenesis) 
Overlap extension PCR (OE-PCR) was carried out to introduce point mutations into proteins or 
to splice together different sections of a gene using Q5 DNA polymerase (section 2.6.2.2). Two 
rounds of PCR reactions were carried out:  
Round 1 – The first round of OE-PCR was carried out to amplify individually the desired 
sections of a gene to be spliced together. Generally two reactions were carried out, using the 
X 10 
X 20 
X 30 
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cycle described for Q5 DNA polymerase in section 2.6.2.2. Reverse primer 1 and forward 
primer 2 (please refer to figure 2.1) were designed containing overlapping tails complementary 
to the opposite PCR product, enabling the PCR products from round 1 to bind and become a 
single PCR product during round 2.  
Round 2 – PCR products from round 1 were both used as the template DNA in this round of 
OE-PCR (in equal quantities) with both of the outside primers (forward primer 1 and reverse 
primer 2) being used to produce one large PCR product (Fig 2.1). The following PCR cycle was 
used, with the annealing temperature and extension time depending on the size of the desired 
gene product and the Tm of the primers: 
 Initial denaturation - 98⁰C – 5 mins 
 Denaturation - 98⁰C – 10 secs 
 Annealing – 50-72⁰C – 30 secs 
 Extension - 72⁰C – 1 min/kb 
 Final extension - 72⁰C – 5 mins 
2.6.2.4 – Colony PCR 
Colony PCRs were carried out with Taq DNA polymerase (NEB). General PCR mixtures were set 
up on ice without any template DNA and a fresh bacterial colony of interest inoculated into the 
mixture using a sterile pipette tip. The following PCR cycle was used, with the extension time 
and annealing temperature adjusted where necessary depending on the gene being screened 
for and the Tm of the primers (annealing temperature of 5ᵒC lower than the Tm was used): 
 Initial denaturation - 95⁰C – 5 mins 
 Denaturation - 95⁰C – 15 secs 
 Annealing – 45-68⁰C – 30 secs 
 Extension - 68⁰C – 1 min/kb 
 Final extension - 68⁰C – 5 mins 
2.6.3 – PCR product purification 
PCR product size was checked by running 5 μl of the PCR reaction on an agarose gel (section 
2.4.9) and if correct was purified with QIAGEN buffers: buffer PB (binding buffer), buffer PE 
(wash buffer) and buffer EB (elution buffer), following the manufacturer’s guidelines. 
 
 
 
X 30 
X 30 
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Figure 2.1 – Overlap extension PCR (OE-PCR) 
Diagram summarising the two rounds of PCR carried out in OE-PCR. Round one amplifies the 
desired gene fragments to be spliced together. Fragment one is amplified from forward primer 
one (F1) and reverse primer one (R1) and fragment two amplified from forward primer two 
(F2) and reverse primer two (R2). During round two of OE-PCR, fragment one and two are 
merged together using primers F1 and R2. 
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2.6.4 – DNA sequencing 
DNA was sequenced by the Genomic Medicine Service at the Medical School of Sheffield 
University. 
Sequencing reaction results were checked using FinchTV software and the online application, 
EMBOSS NEEDLE Pairwise Sequence Alignment (Nucleotide): 
http://www.ebi.ac.uk/Tools/psa/emboss_needle/nucleotide 
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2.7 – Protein and Purification Methods 
2.7.1 – Protein precipitation 
Protein precipitation (ie. precipitation of supernatant proteins) was carried out by adding two 
volumes of ice-cold ethanol to the desired proteins (in solution) and incubating on ice for 1-3 
hrs. Precipitated proteins were pelleted at 3,900 x g for 30 mins at 4ᵒC. After centrifugation, 
the supernatant was discarded and the protein pellet allowed to dry in the air for 10 mins. 
Precipitated protein samples were then boiled in Laemmli buffer and analysed by SDS-PAGE 
(Section 2.7.2). In general, for Western blot analysis of bacterial supernatant samples, 10 ml 
overnight subcultures were used (unless otherwise stated). 
2.7.2 – SDS-PAGE (Sodium dodecyl sulphate polyacrylamide gel electrophoresis) 
Whole cell protein samples and pure protein samples were analysed on a 12% polyacrylamide 
gel in a geneflow (OmniPAGE Mini) SDS-PAGE gel tank. 
To produce two gels (approximately 7 mls each) the following recipe was used: 
Resolving gel: 3.3 ml dH2O, 4 ml 30% acrylamide (37.5:1 acrylamide:bisacrylamide) (Geneflow), 
2.5 ml 1.5 M Tris-HCl (pH 8.8), 50 μl 20% SDS (Melford), 200 μl 10% (w/v) Ammonium 
persulphate (APS) (Melford), 7 μl Tetramethylethylenediamine (TEMED) (Fluka). 
Stacking gel: 2.7 ml dH2O, 0.67 ml 30% Acrylamide (Geneflow), 1 ml 0.5 M Tris-HCl (pH 6.8), 40 
μl 20% (w/v) SDS (Melford), 40 μl 10% (w/v) APS, 5 μl TEMED (Fluka). 
Two sets of gel plates compatible with the geneflow (OmniPAGE Mini) SDS-PAGE gel tank were 
inserted into the gel casting apparatus. The resolving gel was produced first and levelled off 
with the addition of 0.5 ml of isopropanol. Once set, the isopropanol was removed from the 
top of each gel before the stacking gel was prepared and pipetted on top of the resolving gels. 
A comb compatible with the gel plates was inserted into the stacking gel to form the wells and 
the gel was allowed to set. The gel units were then transferred into the gel tank containing 1 X 
SDS-PAGE running buffer. Samples, boiled in laemmli buffer, were pipetted into the stacking 
gel wells and were run alongside a protein marker (geneflow 17-190 kD prestained ladder) at 
160 V via a QIAGEN power pack until the loading dye had passed through the length of the gel. 
Once run, protein gels were stained with instant blue (Gentaur) to visualise proteins present. 
2.7.3 – Western blotting 
Protein gels were run according to section 2.7.2. Once run, the gel was removed from the gel 
plates and placed in a Western blotting cassette (BIO-RAD), along with a nitrocellulose 
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membrane (Invitrogen) for proteins to be transferred onto, sandwiched between sponges and 
blotting paper. The cassette was placed into a BIO-RAD Western blotting tank containing 1 X 
transfer buffer and the transfer was carried out overnight at 10 V. 
Following transfer the nitrocellulose membrane was incubated in 20 mls of blocking buffer for 
1 hr with shaking. The blocking buffer was removed and the membrane was incubated in 20 
mls of PBS (containing 0.3% [w/v] skimmed milk powder - Marvel) and the required primary 
antibody for 1 h. The primary antibody was removed and the membrane was three times 
washed in 20 mls of PBS for 10 minutes. The membrane was then incubated in 20 mls of PBS 
(containing 0.3% [w/v] skimmed milk powder - Marvel) and the required secondary antibody 
conjugated to horseradish peroxidase (1:1000) for 1 h. The membrane was washed as before 
with PBS. Bands were visualised using ECL Western blotting detection reagents (Pierce) 
according to the manufacturer’s instructions. For detection of the signal the membrane was 
exposed to X-ray film (Thermo), adjusting the exposure time to allow for optimisation of the 
signal. 
Densitometry analysis of Western blots was carried out using ImageJ software. 
2.7.4 – Flagella Isolation 
Aeromonas flagella were isolated via a shearing and centrifugation method developed from 
Wilhelms et al. (2012). An overnight subculture of the desired strain (5 ml) was spread onto a 
large swarm plate (section 2.4.5) and incubated overnight at 37ᵒC. Subsequent bacterial 
growth was scraped off the swarm plate using 20 ml PBS and transferred to a 50 ml oakridge 
polypropylene centrifuge tube (Thermo Scientific)centrifuge tube. Cell suspensions were 
vortexed and manually shaken for 10 mins to shear the flagella from the cell bodies and three 
centrifugation steps carried out to pellet the flagella. Cell suspensions were centrifuged first at 
8,000 x g for 30 mins; the supernatant was collected in a fresh tube and centrifuged at 18,000 
x g for 20 mins. Again the supernatant was collected in a fresh tube and centrifuged at 75,000 
x g for 1.5 hrs. The supernatant was then discarded and the jelly pellet present in the 
centrifuge tube (containing the flagella) resuspended in PBS and stored at -20ᵒC. 
2.7.5 – LPS Extraction and Analysis 
LPS extractions were carried out using the LPS extraction kit from ChemBio according to the 
manufacturer’s guidelines. LPS was analysed on a 12% polyacrylamide gel (section 2.7.2) 
containing 4 M urea in both the resolving and stacking gels and visualised by silver staining 
(Guardpetter et al., 1995). Silver staining was carried out using the BioRad silver staining kit. 
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2.7.6 – Peptidoglycan (PG) Extraction and Analysis 
2.7.6.1 - PG Extraction 
To extract the PG of Gram negative bacteria, a 10 ml overnight bacterial subcultures were used 
to inoculate a 1 L flasks of BHIB (1:100). Cultures were grown to an OD600 of 0.7 and cells 
harvested at 5,000 x g for 10 mins at room temperature. Cell pellets were resuspended in 5 ml 
MiliQ water, transferred to a 50 ml falcon tubes (SLS) and frozen at -80ᵒC. A beaker of water 
was boiled on a hot-plate (SLS) and holes were made in the 50 ml falcon tube lids before they 
were plunged into the boiling water. Magnetic stirring bars (7 mm x 2 mm) were added to the 
thawed cell suspensions, allowing continuous mixing. Slowly, 5 ml of boiling 8% SDS was added 
to the cell suspensions and permitted to boil for 30 mins. Samples were then removed from 
the boiling water and allowed to cool overnight at room temperature.  
The boiled samples were centrifuged for 30 mins at 75,000 x g, the supernatant discarded and 
the jelly pellets washed with MilliQ water. This process was repeated five times, with the final 
pellets being resuspended in 2 ml of 10 mM Tris-HCl (pH 7.4) containing 2 mg/ml of pronase 
(Sigma). Samples were incubated at 60ᵒC for 3 hrs with continuous, gentle agitation to allow 
pronase digestion of PG to occur. After incubation, pronase was washed from the samples with 
MilliQ water and ultracentrifugation at 175,000 x g for 1.5 hrs; this was repeated three times. 
Final peptidoglycan samples were resuspended in 100 μl MilliQ water and stored at -20ᵒC 
before analysis. 
2.7.6.2 – PG analysis 
PG was analysed in the department of Molecular Biology and Biotechnology at the University 
of Sheffield, with the help of Dr Stephane Mesnage. In brief, PG (1mg) was digested with 50 
units of mutanolysin (Sigma) in a final volume of 150μl containing: 20 mM phosphate buffer 
(pH 6.5), 0.1 mM MgCl2 and 25μg of enzyme. The mixture was incubated for 16 hrs at 37 °C. 
After heat inactivation (5 min at 100 °C), the soluble fraction was recovered by centrifugation 
at 20,000 x g for 20 mins at 4°C. To reduce the amino sugars to their alditol derivatives, an 
equal volume of borate buffer (250 mM, pH 9.0 - Sigma) was added to the solution of 
disaccharide peptides. Two milligrams of sodium borohydride (Sigma) was added and the 
solution was incubated for 20 mins at room temperature. The solution was adjusted to pH 4.0 
with 20% orthophosphoric acid (Fisher Scientific). Reduced muropeptides were separated by 
reversed phase high performance liquid chromatography (rp-HPLC) on a Hypersil aQ 
C18 column (3 μm, 2.1 mm × 200 mm; Thermofisher) connected to an Ultimate 3000 system 
(Thermofisher) at a flow rate of 0.25 ml/min. Muropeptides were eluted for 10 mins with 
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10 mM ammonium phosphate buffer (pH 5.6; buffer A) (Fisher scientific), and then with a 65-
min methanol linear gradient (0–20%) in buffer A. 
2.7.7 – Mass spectrometry (MS) 
2.7.7.1 - In-gel trypsin digestion of flagellin 
After isolation, flagella samples were incubated at 75ᵒC for 10 minutes in Laemmli buffer (1 x 
final concentration) to cause depolymerisation of the flagella, yielding monomeric flagellins. 
Flagellin samples were run on a 12% polyacrylamide gel and directly excised from the gel using 
a clean scalpel after staining with Instant Blue (Gentaur). To minimise the protein loss due to 
protein absorption to normal microcentrifuge tube surfaces, gel slices were transferred to 
LoBind 1.5 mL microcentrifuge tubes (Eppendorf). All solutions for in-gel trypsin digestion were 
prepared with high performance liquid chromatography (HPLC) grade solvents and chemicals 
(Fischer Scientific); incubations were carried out at room temperature unless otherwise stated. 
Initially, gel slices were washed with 200 μL of HPLC water, followed by 200 μL of 100 mM 
ammonium bicarbonate (Ambic). Gel slices were then destained with a 50:50 (v/v) solution of 
100 mM Ambic and 100% acetonitrile (ACN) for 20 mins; the supernatant was removed and 
the destain process repeated until the gel slices were colourless. Once destained, 500 μL of 
100% ACN was added to dehydrate the gel slices for 10 mins. The supernatant was once again 
removed before the reduction and alkylation steps were carried out. For the reduction step, 
gel slices were incubated in 200 μL of 10 mM dithiothritol (DTT) in 100 mM Ambic for 30 
minutes at 56ᵒC. After incubation, the liquid was removed and the LoBind tubes chilled on ice 
before adding 500 μL 100% ACN to dehydrate the gel slices (10 mins). The supernatant was 
removed and alkylation was performed by addition of 200 μL of 55 mM iodoacetamide in 100 
mM Ambic to the gel slices. Reaction was performed in dark at room temperature for 30 mins. 
The excess liquid was discarded from the tubes and 500 μL of 100% ACN added to dehydrate 
the gel slices once again (10 mins). The supernatant was removed and gel slices left to air dry 
(10 mins) before trypsin (Promega) (in 100 mM Ambic) was added to the gel slices at a ratio of 
20:1 (protein:enzyme w/w) (0.5 μg). In-gel trypsin digestions were carried out at 37ᵒC for 18 
hours. 
After digestion, tryptic peptides were extracted from the gel slices. Tubes were vortexed and 
the peptide solution pipetted into clean LoBind microcentrifuge tubes before 60 μL of 100 mM 
Ambic was added to the gel slices (incubated at 37ᵒC for 15 mins). Again, tubes were vortexed 
before the supernatant was collected and combined into the tubes. Peptides were extracted a 
further three times, with each step incubating the gel slices at 37ᵒC for 15 mins before 
collecting the excess liquid. Gel slices were first incubated with 50μL of 100% ACN, then with 
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50 μL of a 5% (v/v) formic acid solution (in HPLC water) and finally in 50% (v/v) ACN containing 
5% (v/v) formic acid. Extracted peptides were dried in a vacuum concentrator (Eppendorf) at 
room temperature and stored at -20ᵒC before mass spectrometric analysis.  
2.7.7.2 - High Performance Liquid Chromatography (HPLC) Mass Spectrometry (MS) Analysis 
Tryptic peptides were separated via reverse phase liquid chromatography (LC) on a U3000 
HPLC system (ThermoFisher) and MS analysed on both a maXisTM (Bruker) Quadrupole Time of 
Flight (Q-TOF) system (for collision induced dissociation [CID] tandem mass spectrometry 
[MS/MS] analysis) and an amaZonTM (Bruker) ion trap system (for electron transfer dissociation 
[ETD] MS/MS analysis). Both mass spectrometers were interfaced with an electrospray ion 
source.  
For analysis on both mass spectrometers, the HPLC system was equipped with a 75 μm x 15 cm 
C18 analytical column (LC Packings) and a 300 μm x 5 cm micro precolumn packed with C18 
material (LC Packings). Peptides were separated at a flow rate of 300 nL/min and 30 μL/min 
respectively at 30ᵒC.  
Reverse phase separation of peptides was achieved, in both cases, using the following buffers: 
buffer A (3% (v/v) HPLC ACN and 97% (v/v) HPLC water, incorporating 0.1% (v/v) formic acid) 
and buffer B (97% (v/v) HPLC ACN and 3% (v/v) HPLC water, incorporating 0.1% (v/v) formic 
acid). A gradient from 5% (v/v) buffer B to 40% (v/v) buffer B was set up over the course of 90 
mins to elute the peptides.  
Both mass spectrometers were set up for positive ion detection at an m/z range of 50 – 2200 
(Q-TOF) and 200 – 2000 (ion trap). To generate the spray, the Q-TOF parameters were set at: 
endplate offset of -500 V, capillary voltage of 1,700 V, nebuliser gas at 0.4 bar, dry gas at 6 
L/min and a dry temperature of 180ᵒC. The ion trap parameters were set at: endplate offset of 
-500 V, capillary voltage of 2,700 V, dry gas of 6 L/min and a dry temperature of 180ᵒC. Ion 
transmission was optimised for detection of glycopeptide diagnostic ions in the MS/MS 
analysis. 
Peptide information was generated by CID (on the Q-TOF) and ETD (on the ion trap) MS/MS 
using an auto Ms(n) setting where the top three most intense peaks were selected for 
dissociation with the total ion count above the threshold of 5,000 (Q-TOF) and 25,000 (ion 
trap). The Q-TOF included a lock mass for internal calibration using hexakis ion at an m/z of 
1221 to obtain exact mass measurements. The following software was used in both MS: for 
operating the LC system, Chromeleon was used (LC Packings) and MS operating parameters 
were integrated via Hystar software. 
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2.7.7.3 - MS/MS Data Analysis 
Using DataAnalysisTM software (Version 4.1) (Bruker) raw mass spectrometric data was 
converted into mascot generic files (.mgf) for examination via the graphical platform, EasyProt 
(Gluck et al., 2013). On EasyProt, the proteins of interest (FlaA and FlaB from Aeormonas 
caviae Sch3, Shaw Unpublished) were uploaded as a database and pseudaminic acid (able to 
modify serine and threonine residues) was added to the modifications list. For EasyProt 
analysis of data, trypsin was selected as the protease, with up to two miscleavages considered. 
A fixed modification of carbamidomethyl on cysteine was set and the following variable 
modifications were considered: methionine oxidation, glycosylation of serine/threonine 
residues with pseudaminic acid and methylation of lysine residues 
(methyl/dimethyl/trimethyl). Protein Prospector (http://prospector.ucsf.edu/) was used to aid 
manual analysis of spectra. 
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2.8 – Microscopy 
2.8.1 – Fluorescence Microscopy 
Fluorescence microscopy samples were prepared from overnight bacterial cultures in LB broth. 
Samples were allowed to dry on L-lysine-coated coverslips (Neuvitro) and were then fixed with 
4% paraformaldehyde for 30 mins. After fixing, paraformaldehyde was washed off the 
coverslips with phosphate buffered saline (PBS). The samples were then post-stained with 
Alexafluor 594 (Life Technologies) by submerging the coverslips in 200 μl PBS and adding 20 μl 
of a 5mg/ml Alexa Fluor solution in DMSO to the PBS. Residual fluorescent dye was removed 
by washing cells with PBS. Samples were mounted onto glass microscope slides (Fisher 
Scientific) with ProLong Antifade Gold with DAPI (Life Technologies) and incubated in the dark 
for 24 hrs. Samples were analysed on Zeiss Axiovert fluorescence microscope at 1000 x 
magnification. 
2.8.2 – Scanning Electron Microscopy (SEM) 
Bacterial subcultures (10 mls) were grown overnight in LB and samples, normalised to an OD600 
of one, were pelleted at 16,000 X g and submitted to Mr Chris Hill at the Sheffield University 
Electron Microscopy Unit (Dept. Biomedical Sciences) for SEM sample preparation in a gold 
sputter coater (Edwards S150b). Samples were analysed on a Philips XL-20 SEM and cell 
lengths measured manually. 
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Chapter 3: Investigation into the Function of AHA0618 – 
a Flagellin Deglycosylase or Cell Wall Remodelling 
Enzyme? 
 
3.1 - Introduction 
The Maf proteins have been described in a number of bacteria as the putative 
glycosyltransferases thought to be responsible for the O-glycosylation of the bacterial 
flagellum. Some Campylobacter species possess seven maf genes and it has been suggested 
that the expression of the genes can be phase variable, which may allow different Maf proteins 
to decorate the Campylobacter flagellum with different nonulosonate sugars (ie. Pseudaminic 
or legionaminic acid) at different stages of infection and has been shown to alter 
autoagglutination ability of cells (van Alphen et al., 2008; Karlyshev et al., 2002).  This suggests 
that tailoring the amount of flagellin glycosylation may modulate bacterial behaviour. In 
addition, mutational studies carried out by Howard et al. (2009) demonstrated that the 
behaviour of Campylobacter could be altered (such as ability to form biofilm and 
autoagglutinate) by modifying glycosylation and changing the overall surface charge of the 
flagellum. 
Helicobacter pylori glycosylates its flagellins solely with pseudaminic acid, similarly to 
Aeromonas caviae Sch3 (Josenhans et al., 2002; Schirm et al., 2003). In recent years, a possible 
flagellin deglycosylation pathway has been highlighted by Asakura et al. (2010) in H. pylori 
which may be allowing modulation of flagellin glycosylation and therefore bacterial behaviour. 
The putative deglycosylation enzyme, HP0518, was identified and a mutant of which was 
hypermotile on semisolid agar. H. pylori flagellins (FlaA) displayed increased glycosylation 
levels which could be detected clearly by western blot analysis and was confirmed by mass 
spectrometry. In addition, the mutant exhibited ‘superior colonisation capabilities’, whereby it 
was able to interact more efficiently with host cells (work carried out on a human gastric 
carcinoma cell line), leading to enhanced CagA (cytotoxin-associated gene A) phosphorylation 
and the subsequent host cell responses caused by this toxin (Asakura et al., 2010). 
Sycuro et al., 2012 called into question the true function of HP0518, renamed Cds6 in this 
study, as they demonstrated the protein to have LD-carboxypeptidase activity, a hydrolytic 
enzyme which was found to be responsible for cleaving uncross-linked tetrapeptides in the 
peptidoglycan structure to yield tripeptides (Sycuro et al., 2013). This study identified a 
number of genes important for H. pylori cell morphology and demonstrated that by mutating 
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cds6 (ie. HP0518), H. pylori exhibited a straight-rod cell morphology compared to its usual 
characteristic helical shape (Sycuro et al., 2013). 
In light of these studies this chapter focuses on the characterisation of a HP0518 homologue, 
AHA0618, and looks into the potential existence of a flagellin deglycosylation pathway in A. 
caviae Sch3. This work resulted in Lowry et al. (2014b). 
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3.2 – Results 
3.2.1 – Bioinformatic analysis of AHA0618  
AHA0618, was identified from analysis of the A. caviae Sch3 genome sequence (Shaw 
unpublished) by probing the genome with the gene sequence of a putative deglycosylation 
enzyme, HP0518, from H. pylori (ncbi BLAST) (Askura et al., 2010). The predicted amino acid 
sequence was found to have 37% homology to the central region of the putative 
deglycosylation enzyme, HP0518 (Asakura et al., 2010), at the primary level (Fig. 3.1 A/B). 
Furthermore, the identified AHA0618 gene sequence was also used to re-probe the H. pylori 
genome for homologues (ncbi BLAST); HP0518 was the top match suggesting that AHA0618 
and HP0518 are true orthologues.  
Cellular localisation of AHA0618 could not be accurately determined from further analysis of 
the amino acid sequence using the Cello server (http://cello.life.nctu.edu.tw/) which suggested 
this protein to be either cytoplasmic or periplasmic, and no signal peptide could be detected 
when the protein sequence was run through the SignalP server 
(http://www.cbs.dtu.dk/services/SignalP/) for export to the periplasm. Conserved domain 
searches through the Pfam (http://pfam.xfam.org/) and ncbi conserved domain servers 
revealed this protein to be in the YkuD-superfamily of proteins. YkuD was originally 
characterised in Bacillus subtilis and contains a his/cys motif invariant amongst members of 
this superfamily (Bielnicki et al., 2006). E. coli possess five YkuD protein homologues: ErfK, 
YbiS, YcfS, YnhG and YcbB, and studies have indicated that these are a family of L,D-
transpeptidases that allow the formation 3-3 type peptidoglycan cross linkages at the cell wall 
(Magnet et al., 2007; Magnet et al., 2008). In addition these proteins are also thought to be 
associated with anchoring of the Lpp lipoproteins (or Braun’s lipoprotein) to peptidoglycan, 
with three out of the five E. coli homologues (ErfK/YbiS/YcfS) being shown to have this function 
(Magnet et al., 2007). Mutational studies by Sanders and Pavelka (2013) demonstrated that E. 
coli lacking the three L,D-transpeptidases responsible for Lpp anchoring to peptidoglycan 
resulted in loss of outer-membrane stability and cells showed altered stress resistance. In 
addition, deletion of all YkuD homologues was detrimental to E. coli growth under stressful 
conditions (Sanders and Pavelka, 2013).  
When aligned with characterised and predicted YkuD-superfamily proteins, both AHA0618 and 
HP0518 were found to contain the histidine and cysteine residues thought to be characteristic 
of the YkuD family catalytic domain (Fig. 3.2). However, HP0518 is significantly larger than 
AHA0618, similarly to YkuD domain containing proteins (such as the E. coli homologues 
YbiS/ErfK/YcfS) which may indicate the presence of multiple domains in HP0518, perhaps 
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giving this protein an additional role in the cell, compared to AHA0618. Analysis of the primary 
amino acid sequence of HP0518 suggests this to be the case as when submitted to both ncbi 
conserved domain and Pfam prediction servers, results suggested that as well as belonging to 
the YkuD superfamily of proteins, an additional, uncharacterised ‘SnoaL’ domain of unknown 
function is also present. 
The position of AHA0618 in the A. caviae genome is interesting as it is not associated with 
either of the two known loci associated with flagellin glycosylation, where the putative 
glycosyltransferase, Maf1, and pseudaminic biosynthetic genes are located (Fig. 3.3) (Rabaan 
et al., 2001; Parker et al., 2012; Tabei et al., 2009). Instead, AHA0618 is close to homologues of 
the cellulose synthase operon from Yersinia enterocolitica (Fuchs et al., 2011) and genes 
encoding nutrient uptake apparatus (eg. ABC transport systems)(Fig. 3.3). It is flanked by an 
M3 family oligoendopeptidase and an AzlC family protein which is predicted to be involved in 
amino acid transport/metabolism; these being drastically different from genes involved in 
bacterial motility and flagellin post-translational modification (Fig. 3.3).  
Bioinformatic analysis therefore suggests that AHA0618 is unlikely to be involved in flagellin 
modification and motility, but that it instead may have a role in cell wall maintenance. 
In order to explore further the function of AHA0618, phenotypic analysis of an insertional 
mutant previously created in the Shaw group, was carried out. This mutant was created by 
inserting a kanamycin resistance cassette into the AHA0618 gene in the same transcriptional 
orientation, with an outward reading promoter to decrease the chance of polar effects 
downstream of the mutation. PCR was used to confirm the location and orientation of the 
resistance cassette. 
3.2.2 - Analysis of A. caviae AHA0618 mutant motility 
In order to assess whether the AHA0618 mutation had an effect on the motility of A. caviae, 
swimming motility assays were carried out on semi-solid agar alongside the wild type strain 
(Chapter 2, section 2.4.4). Motility assays were carried out on large plates, allowing eight 
technical repeats for each strain to be carried out per plate; in addition, three biological 
replicates were carried out. Figure 3.4 A displays a close up of motility halos from each strain, 
taken from one of the motility plates analysed, however is representative of each of the 
biological repeats. The radius of each halo was measured and an average measurement 
calculated. The AHA0618 mutant was found to swim significantly more than the wild type 
strain (p < 0.0001), having a mean radius, in this case, of 20.8 mm compared to the wild type 
mean measurement of 13.6 mm, therefore showing a 1.5 fold increase in motility (Fig. 3.4 
A/B).  
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Figure 3.1: (A) Alignment of Aeromonas caviae Sch3 AHA0618 (Accession HG934767) (AcAHA0618) primary amino acid sequence with the central region of the 
homologue HP0518 form Helicobacter pylori 26695 (HpHP0518) (amino acids 51 – 200) (Asakura et al., 2010). The alignment was executed using CLUSTALW 
(Thompson et al., 1994) and displayed with box-shade. (B) Diagrammatic representation of A. caviae Sch3 AHA0618 (AcAHA0618) compared to H. pylori 26695 
HP0518 (HpHP0518) in their unfolded state. 
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Figure 3.2: Alignment of Aeromonas caviae Sch3 AHA0618 (AcAHA0618) and Helicobacter pylori 26695 HP0518 (HpHP0518) with other YkuD superfamily proteins: 
Bacillus subtilis (Bs) (accession NP_389287), Aeromonas hydrophila (Ah) (accession AHE48181), Aeromonas salmonicida (As) (accession WP_021138855), 
Shewanella oneidensis (So) (accession NP_717783), Pleisiomonas shigelloides (Ps) (accession WP_010864114), Vibrio cholerae (Vc) (accession NP_232564). The 
conserved histidine and cysteine residues from the his/cys motif in the YkuD predicted catalytic domain are highlighted in orange. 
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Figure 3.3 - The genetic context of AHA0618 in the A. caviae Sch3 genome and surrounding genes, showing their predicted functions (Shaw, unpublished). The 
arrows depict the open reading frames present. 
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Figure 3.4: (A) Swimming motility analysis of Aeromonas caviae Sch3 (WT) compared to the A. 
caviae AHA0618 mutant (AHA0618). Assays were carried out on 0.25% (w/v) agar. (B) The 
radius of each motility halo was measured and average measurements for A. caviae Sch3 (WT) 
and AHA0618 mutant (AHA0618) motility are presented here (n=8) ± the standard error of the 
mean.  A p-value of < 0.0001 was generated when a paired T-test was carried out on the data 
sets. (C) Swarming motility analysis of A. caviae Sch3 (WT) compared to the A. caviae AHA0618 
mutant (AHA0618). Assays were carried out on 0.6% (w/v) swarming agar.  
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Swarming motility assays were also carried out (0.5% ‘Eiken’ Agar) (Chapter 2, section 2.4.5) 
and the AHA0618 displayed increased motility when compared to the wild type (Fig. 3.4 C). 
However, swarming motility could not be quantified like swimming motility due to irregular 
colony formation and was therefore only visually analysed. The lateral flagellar system of A. 
caviae is induced when grown on solid media (Shimada et al., 1985) and there is some 
evidence to suggest that this system also glycosylates its flagellins (Gavin et al., 2002; Wilhelms 
et al., 2012; Wilhelms et al., 2013); however, nothing is known about the A. caviae lateral 
flagellar glycan or mechanism. The hypermotility observed on swarming agar suggests that 
AHA0618 may have a wider role than solely effecting polar flagella mediated motility.  
A growth curve was carried out of wild type and AHA0618 mutant A. caviae to assess whether 
the strains were growing at different rates and that being the reason why the mutant was 
displaying increased swimming and swarming motility (Chapter 2, section 2.4.3). Growth 
curves were carried out in triplicate for each strain, results of which are displayed in figure 3.5 
and demonstrate that both strains grow similarly.  
 
3.2.3 – Analysis of AHA0618 mutant and wild type A. caviae containing 
pSRK_AHA0618 
In order to explore whether the observed hypermotility phenotype of the A. caviae AHA0618 
mutant was due to the AHA0618 mutation itself, or due to any downstream effects of this 
mutation, complementation analysis was carried out whereby AHA0618 was cloned into the 
IPTG inducible vector pSRK(Gm), expressed in the mutant strain and the effect on both motility 
and flagellin glycosylation status investigated. Furthermore, this construct was also analysed in 
the wild type strain to examine the effects of AHA0618 overexpression; overexpression 
analysis can give an indication of protein roles due to producing mutant or exaggerated 
phenotypes.  
3.2.3.1 – Generation of pSRK_AHA0618 
Initially AHA0618 was amplified using the primers JLP_28 and JLP_29 (Chapter2, Table 2.6) 
using the Expand high fidelity PCR system (Roche) (Chapter 2, section 2.6.2.1) with A. caviae 
Sch3 genomic DNA as the template. The expected size of the PCR product was around 410 bp 
(gene size of 408 bp) which was checked via agarose gel electrophoresis (Fig. 3.6). The Expand 
High Fidelity DNA polymerase system allows TA-cloning due to the addition of non-templated 
adenines to the PCR product; the correct size PCR product was therefore ligated into the TA-
cloning vector pGEM-T EASY (Promega) (Fig. 3.7 A) and subsequently transformed into 
chemically competent E. coli DH5 . An EcoRI digest was carried out on the plasmid DNA  
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Fig. 3.5 – Growth Curves comparing the growth of Aeromonas caviae Sch3 (WT) and the 
AHA0618 mutant (AHA0618) over 7 hours. Growth curves were carried out in triplicate, at 
37ᵒC, in BHIB (Table 2.3) and average measurements plotted here ± the standard error of the 
mean. 
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Figure 3.6 – 1% agarose gels displaying (A) the AHA0618 PCR product  and (B) EcoRI digested 
pGEM_AHA0618 (with empty pGEM-T EASY as a negative control. 
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Figure 3.7 – Diagrammatic representation of the cloning method of: (A) AHA0618 from Aeromonas caviae Sch3 into pGEM-T EASY, and (B) AHA0618 from 
Aeromonas caviae Sch3 into pSRK(Gm) (Khan et al., 2008) (pSRK_AHA0618) using SnapGene software. 
A B 
79 
 
isolated from the resulting transformants (present at each side of the pGEM-T EASY multiple 
cloning site) to check for the presence of the AHA0618 gene which was excised from the vector 
(agarose gel electrophoresis) (Fig. 3.6 & 3.7 A). The presence of AHA0618 was confirmed by 
sequencing using sequencing primers T7 forward and SP6 reverse. This construct was then 
digested with a combination of NdeI and BamHI restriction enzymes to excise AHA0618 from 
the vector and ligated into NdeI/BamHI cut pSRK(Gm) (Khan et al,. 2008) (Fig. 3.7 B).  Ligations 
were transformed into E. coli DH5  (selected for on Gm plates) and overnight subcultures 
made from resulting transformants. Plasmids were isolated from the subcultures and digested 
with BamHI to linearise. Digested vector was finally run on an agarose gel alongside empty, 
BamHI cut pSRK(Gm); a size shift of the correct size between the empty vector and the one 
potentially carrying the desired gene indicated the presence of AHA0618.  
3.2.3.2 – Motility analysis of A. caviae strains containing pSRK_AHA0618 
The pSRK_AHA0618 and empty pSRK(Gm) vectors were transformed into E. coli S17-1 λ pir, a 
strain containing conjugal transfer genes, allowing conjugation of plasmid DNA into A. caviae 
strains. The gene, AHA0618, was reintroduced into the A. caviae AHA0618 mutant to test 
whether the hypermotility phenotype observed could be complemented (Chapter 2, section 
2.4.13). Three transconjugants from each conjugation were selected to phenotypically analyse. 
Swimming motility assays were carried out with each conjugant on large motility plates (0.25 
% w/v) containing 1 mM IPTG to induce the expression of AHA0618 from pSRK(Gm), alongside 
wild type A. caviae, the AHA0618 mutant and the AHA0618 mutant containing empty 
pSRK(Gm). Conjugants were analysed on separate plates, therefore allowing five technical 
repeats to be carried out per strain on each plate (in addition three biological repeats were 
carried out) (Fig. 3.8). The measurements from one motility plate (from one transconjugant) 
are displayed in figure 3.8 but are representative of all transconjugants and plates measured. 
Reintroduction of AHA0618 was able to partially complement the mutant strain, significantly 
reducing its motility, therefore discounting polar effects on genes downstream of the 
mutation. The pSRK_AHA0618 construct was also introduced into the wild type A. caviae strain 
by bacterial conjugation (method as above) and the effect of AHA0618 overexpression was 
investigated. Again, three transconjugants were selected for phenotypic analysis via swimming 
motility assays (as above). Motility of the overexpression strain (wild type A. caviae containing 
pSRK_AHA618) was compared solely to wild type containing the empty vector as the empty 
vector was found to have a great negative effect on motility (Fig 3.9 A). The measurements 
from one motility plate (from one conjugant) are displayed in figure 3.9 (B/C) and 
demonstrates there are no discernible differences in motility between the overexpression 
strain and wild type containing the empty vector on swimming motility agar containing 1 mM  
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Figure 3.8 – Analysis of pSRK_AHA0618 expression in an Aeromonas caviae AHA0618 mutant 
(A) Swimming motility assays were carried out on 0.25% (w/v) agar containing 1 mM IPTG for: 
A. caviae Sch3 (WT) , the AHA0618 mutant (AHA0618-), the mutant containing empty 
pSRK(Gm) [AHA0618- (pSRK)] and the mutant containing pSRK_AHA0618 [AHA0618-
(pAHA0618)]. (B) The radius of each motility halo was measured and average measurements 
are presented here (n=5) ± the standard error of the mean.  A one-way ANOVA, with a Tukey’s 
multiple comparisons test, was carried out on the data sets. *p = 0.01-0.05, **p = 0.001-0.009, 
***p = 0.0001-0.0009, ns = not significant.  
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Figure 3.9 – Analysis of pSRK_AHA0618 overexpression in Aeromonas caviae Sch3. Swimming 
motility assays (A/B) were carried out on 0.25% (w/v) agar containing 1 mM IPTG. (A) Motility 
assay to demonstrate the difference in A. caviae Sch3 motility (WT) compared to that of A. 
caviae containing empty pSRK(Gm) [WT(pSRK)] or pSRK_AHA0618 [WT(pAHA0618)]. (B) 
Swimming motility analysis of A. caviae Sch3 containing empty pSRK(Gm) compared to A. 
caviae Sch3 containing pSRK_AHA0618. (C) The radius of each motility halo (from B) was 
measured and average measurements for A. caviae Sch3 motility when containing either 
empty pSRK(Gm) or pSRK_AHA0618 are presented here (n=10) ± the standard error of the 
mean.  No statistical significance between the motility of each strain was seen when a paired 
T-test was carried out on the data sets. 
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IPTG. The results of one large motility plate are displayed in figure 3.9 and are representative 
of the motility of all transconjugants analysed. 
3.2.3.3 – Analysis of flagellin glycosylation levels via western blot analysis in the AHA0618 mutant 
and strains containing pSRK_AHA0618 
As AHA0618 shows 37% homology to HP0518 of H. pylori and mutating the gene gives a 
hypermotility phenotype in each case (Asakura et al., 2010), it was hypothesised that AHA0618 
from A. caviae may therefore be having a similar role to HP0518 and elevated glycosylation 
levels on the AHA0618 mutant polar flagellins (FlaA/B) may be the reason for the increased 
motility compared to the wild type. In order to assess whether AHA0618 has an effect on 
flagellin glycosylation, whole cell Western blots (Chapter 2, section 2.7.3) were carried out 
with wild type and the A. caviae AHA0618 mutant (Fig. 3.10 A). Samples were probed with an 
anti-FlaA/B(+Pse) antibody that recognises only glycosylated flagellin and an anti-FlaA/B 
antibody that recognises both unglycosylated and glycosylated flagellins (Fig. 3.10 A). An A. 
caviae maf1 mutant (overexpressing flaA) was used as a negative control when samples were 
probed with the antibody that recognises only glycosylated flagellin, anti-FlaA/B(+Pse). Maf1 is 
the putative polar flagellin glycosyltransferase, a mutant of which is non-motile and lacks the 
ability to glycosylate its flagellins (Parker et al., 2012). Unglycosylated flagellin in a maf1 
mutant strain cannot be detected via whole cell western blot analysis due to very low levels, 
however when flaA is overexpressed in the multicopy vector pSRK(Gm) in this strain, 
unglycosylated flagellin can then be detected by the anti-FlaA/B antibody. A size shift can be 
clearly seen when unglycosylated flagellin is compared to the glycosylated version; however, 
there is no size shift between the wild type and AHA0618 mutant flagellins (Fig. 3.10 A). This 
therefore suggests that both wild type and AHA0618 mutant polar flagellins are glycosylated 
similarly and it is unlikely that AHA0618 is affecting flagellin glycosylation levels.  
Whole cell western blots were also carried out to investigate the glycosylation status of wild 
type and AHA0618 mutant strains containing pSRK_AHA0618 (Fig. 3.10 B/C). Again, samples 
were probed with both antibodies and flagellins appeared to be identical in size. Western blots 
in figure 3.10 B and C display the results of a whole cell sample taken from one of the 
transconjugants previously phenotypically analysed in section 3.2.3.2, but is representative of 
all the transconjugants analysed. 
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Figure 3.10 – Western blot analysis of Aeromonas caviae whole-cell samples probed with a rabbit, anti-polar flagellin antibody that recognises only glycosylated 
polar flagellin [ -FlaA/B(+Pse)]  (1:10,000) and a rat, anti-polar flagellin antibody that recognises both glycosylated and unglycosylated polar flagellin [ -FlaA/B] 
(1:1,000) . (A) Lane 1, A. caviae Sch3 (WT); lane 2, maf1 mutant containing pSRK_flaA [maf1- (pflaA)]; lane 3, AHA0618 mutant (AHA0618-). (B)  Lane 1, AHA0618 
mutant (AHA0618-); lane 2, AHA0618 mutant containing pSRK(Gm) [AHA0618- (pSRK)]; lane 3,  AHA0618 mutant containing pSRK_AHA0618 [AHA0618- 
(pAHA0618)]. (C) Lane 1, A. caviae Sch3 (WT); lane 2, Sch3 containing pSRK(Gm) [WT (pSRK)]; lane 3,  Sch3 containing pSRK_AHA0618 [WT (pAHA0618)]. 
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3.2.4 – Analysis of AHA0618 mutant and wild type A. caviae containing 
pSRK_HP0518 
HP0518 of H. pylori was shown by Asakura et al. (2010) to be a putative flagellin 
deglycosylation enzyme and mutant flagellin had elevated levels of flagellin glycosylation. The 
effect of HP0518 expression was therefore assessed in wild type and AHA0618 mutant A. 
caviae to see if the resultant protein had an effect on A. caviae motility or flagellin 
glycosylation. HP0518 was cloned into the IPTG inducible vector, pSRK(Gm), similarly to 
AHA0618. 
3.2.4.1 – Generation of pSRK_HPO518 
The same cloning method previously described for creating pSRK_AHA0618 (section3.2.3.1) 
was adopted for creating pSRK_HP0518. However, HP0518 was amplified via PCR by the 
primers JLP_108 and JLP_109 (Chapter 2, Table 2.6) using H. pylori 26695 genomic DNA as the 
template. The expected PCR product size of HP0518 was around 1 kb (gene size of 993 bp) and 
was again cloned with NdeI and BamHI restriction sites either side of the gene for insertion 
into pSRK(Gm). Once the sequence of HP0518 was confirmed by sequencing, pSRK_HP0518 
was transformed into E. coli S17-1 λ pir for conjugation into the A. caviae AHA0618 mutant and 
the wild type strain. Please refer to section 3.2.3.1 for the specific method of cloning used. 
3.2.4.2 - Motility and flagellin glycosylation analysis of A. caviae strains containing pSRK_HP0518 
Following conjugal transfer of pSRK_HP0518 into wild type A. caviae and the AHA0618 mutant, 
three transconjugants were selected for analysis of motility on motility agar plates and flagellin 
glycosylation status via western blotting.  
Motility assays were carried out as previously stated in section 3.2.3.2 and revealed that 
HP0518 is able to complement the increased motility phenotype of the AHA0618 mutant 
strain, significantly reducing motility to slightly below wild type levels (Fig. 3.11 A/B).  
However, whole cell western blot analysis of polar flagellins revealed no size difference 
between flagellins from the AHA0618 mutant and the mutant expressing HP0518, when 
samples were probed with both anti-FlaA/B(+Pse) and anti-FlaA/B, suggesting that 
glycosylation levels are not affected by the expression of this gene (Fig. 3.12).  
In contrast to AHA0618 overexpression in wild type A. caviae, overexpression of HP0518 in the 
wild type strain significantly reduced motility when compared to the motility of the wild type 
containing empty pSRK(Gm) (Fig. 3.13 A/B). In this case motility was reduced by 26.5% (p = 
0.0001) in comparison to motility of wild type containing the empty vector.  
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Figure 3.11 - Analysis of pSRK_HP0518 overexpression in AHA0618 mutant Aeromonas caviae. 
(A) Swimming motility assays were carried out on 0.25% (w/v) agar containing 1 mM IPTG for 
A. caviae Sch3 (WT), the AHA06108 mutant (AHA0618-), the mutant containing pSRK(Gm) 
[AHA0618- (pSRK)] and the mutant containing pSRK_HP058 [AHA0618- (pHP0518)]. (C) The 
radius of each motility halo was measured and average measurements are presented here 
(n=5) ± the standard error of the mean.  A one-way ANOVA, with a Tukey’s multiple 
comparisons test, was carried out on the data sets. **p = 0.001-0.009, ***p = 0.0001-0.0009, 
****p < 0.0001, ns = not significant.  
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Figure 3.12 – Whole-cell western blot analysis of the A. caviae AHA0618 mutant (AHA0618-), 
the mutant containing pSRK(Gm) [AHA0618- (pSRK)] and the mutant containing pSRK_HP0518 
[AHA0618- (pHP0518)] probed with a rabbit, anti-polar flagellin antibody that recognises only 
glycosylated polar flagellin [ -FlaA/B(+Pse)]  (1:10,000) and a rat, anti-polar flagellin antibody 
that recognises both glycosylated and unglycosylated polar flagellin [ -FlaA/B] (1:1,000).  
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Figure 3.13 - Analysis of pSRK_HP0518 overexpression in Aeromonas caviae Sch3. (A) 
Swimming motility assays were carried out on 0.25% (w/v) agar containing 1 mM IPTG for A. 
caviae Sch3 containing pSRK(Gm) [WT (pSRK)] and pSRK_HP0518 ) [WT (pHP0518)]. (B) The 
radius of each motility halo was measured and average measurements are presented here 
(n=10) ± the standard error of the mean.  A p-value of < 0.0001 was generated when a paired 
T-test was carried out on the data sets. 
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Additionally, western blot analysis of whole cell samples revealed flagellins from each strain to 
be of an identical size when probed with both anti-FlaA/B(+Pse) and anti-FlaA/B, suggesting 
flagellin glycosylation levels to be similar in each strain (Fig. 3.14). 
Figures 3.11, 3.12, 3.13 and 3.14 display the findings from one transconjugant containing 
pSRK_HP0518 (AHA0618 mutant and wild type respectively) but are representative of all three 
transconjugants analysed. 
3.2.5 – Analysis of AHA0618 mutant A. caviae cellular envelope 
In addition to modifying its polar flagellins, FlaA/B, A. caviae also modifies the LPS O-antigen 
with pseudaminic acid (Tabei et al., 2009). Once pseudaminic acid is activated with the 
addition of CMP, it travels down a pathway independent of flagellin glycosylation, for transfer 
onto the LPS O-antigen. Mutations in genes of the pseudaminic acid biosynthetic pathway 
(flmA, flmB, neuA, flmD, neuB) lead to the loss of the sugar on the LPS O-antigen and therefore 
the LPS profiles of these mutants differ significantly to the wild type (Tabei et al., 2009). 
If AHA0618 is altering LPS O-antigen glycosylation levels, this could lead to a change in 
bacterial cell surface charge and effect how A. caviae interacts with its environment (which 
may help to explain why we see increased motility in the AHA0618 mutant). LPS was extracted 
from overnight subcultures of wild type and AHA0618 mutant A. caviae using an LPS extraction 
kit from ChemBio (Chapter 2, section 2.7.5). Once obtained, samples were run on a 12% 
polyacrylamide gel containing 4 M urea to solubilise the highly hydrophobic LPS and visualised 
by silver staining (section 2.7.5). The LPS profiles were found to be identical indicating that 
AHA0618 does not affect the levels of LPS O-antigen glycosylation (Fig. 3.15). LPS extractions 
and gels were carried out in triplicate, with each repeat showing identical profiles for each 
strain. 
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Figure 3.14 - Whole-cell western blot analysis of Aeromonas caviae Sch3 (WT), Sch3 containing 
pSRK(Gm) [WT (pSRK)] and Sch3 containing pSRK_HP0518 [WT (pHP0518)], probed with a 
rabbit, anti-polar flagellin antibody that recognises only glycosylated polar flagellin [ -
FlaA/B(+Pse)]  (1:10,000) and a rat, anti-polar flagellin antibody that recognises both 
glycosylated and unglycosylated polar flagellin [ -FlaA/B] (1:1,000). 
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Figure 3.15 – Lipopolysaccharide (LPS) profile analysis of A.caviae Sch3 (WT) and an AHA0618 
mutant (AHA0618-). LPS was extracted from each strain grown in BHIB at 37⁰C, was analysed 
by SDS-PAGE (12%, containing 4 M urea) and visualised via silver staining. LPS extractions and 
analyses were repeated three times. One extraction is displayed here but is representative of 
all the repeats.  
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3.2.6 – Analysis of A. caviae cellular morphology 
Recent cell morphology studies by Sycuro et al. (2013) identified a number of peptidoglycan 
modification enzymes important for maintaining the characteristic helical shape of H. pylori. 
HP0518 (known as Csd6 in this study) was shown to have L,D-carboxypeptidase activity and a 
mutant of which exhibited straight rod cellular morphology compared to the helical wild type 
Sycuro et al. (2013). The cell morphology of AHA0618 mutant A. caviae was therefore 
investigated due to the homology between AHA0618 and HP0518 and the behavioural 
similarities between the corresponding mutants in each case. Initially, scanning electron 
microscopy (SEM) was implemented to analyse the gross cell morphology of the AHA0618 
mutant compared to the straight-rod wild type. Mutant and wild type A. caviae cell samples 
were submitted to the University of Sheffield Electron Microscopy Unit for SEM sample 
preparation and analysis on a Philips XL-20 SEM (Chapter 2, section 2.8). Both wild type and 
mutant samples were analysed in five fields of view on the SEM grids at 8000 x magnification. 
No drastic changes in cell shape were detected, however, a small but significant difference in 
cell length between strains was observed when cells were measured manually from pole to 
pole (n = 100; p < 0.0001) (Fig. 3.16 A/B). 
The higher throughput method of fluorescence microscopy was then used to further 
investigate this initial difference in cell length between A. caviae strains (Chapter 2, section 
2.8). Strains analysed included: wild type and AHA0618 mutant alone, wild type and mutant 
containing empty pSRK(Gm), the mutant containing pSRK_AHA0618 and the mutant containing 
pSRK_HP0518. A. caviae samples were grown in LB containing 1 mM IPTG and were labelled 
with the thiol-reactive dye, Alexa Fluor 594, to fluorescently label the cell surfaces; a DAPI 
mount was also used which additionally labelled the chromosomal DNA. Samples were each 
analysed in four fields of view on a Zeiss Axiovert fluorescence microscope at 1000 x 
magnification. Again, a subtle but significant difference was observed between mutant and 
wild type A. caviae cell lengths, with the mutant displaying a 14% decrease in mean cell length 
compared to that of the wild type (n = 80; p < 0.0001) (Fig. 3.17). Furthermore, when the cell 
lengths of AHA0618 mutant strains complemented with either AHA0618 or HP0518 genes (in 
pSRK) was investigated, these strains displayed a significant increase in cell length compared to 
the AHA0618 mutant containing empty pSRK(Gm) (p = 0.0026 and p < 0.0001 respectively) (Fig. 
3.17).  
Due to such subtle differences in cell lengths being observed between strains, the frequency 
distribution of cell length measurements was analysed to ensure the mean measurements 
acquired were not concealing important details of the spread of cell lengths across strains (Fig. 
3.18). The AHA0618 mutant (containing empty pSRK) displayed the smallest minimum cell  
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Figure 3.16 – (A) Scanning electron microscopy (SEM) carried out on a Philips XL-20 SEM at 
8000 x magnification of samples: (i) Aeromonas caviae Sch3 (WT) and (ii) A. caviae AHA0618 
mutant (AHA0618-). (B) Bacterial cell lengths from the electron micrographs were manually 
measured from five fields of view and average cell lengths are presented here (n=100) ± the 
standard error of the mean.  A p-value of < 0.0001 was generated when a paired T-test was 
carried out on the data sets. 
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Figure 3.17 – Investigation into differences in cell lengths of Aeromonas caviae strains using 
fluorescence microscopy. Bacterial cell lengths were manually measured from micrographs of 
fluorescently labelled A. caviae samples (Chapter 2, section 2.8): A. caviae Sch3 (WT), the 
AHA0618 mutant (AHA0618-), Sch3 containing pSRK(Gm) [WT (pSRK)], the AHA0618 mutant 
containing pSRK(Gm) [AHA0618- (pSRK)], the AHA0618 mutant containing pSRK_AHA0618 
[AHA0618- (pAHA0618)] and the AHA0618 mutant containing pSRK_HP0518 [AHA0618- 
(pHP0518)]. Cell lengths were measured from four fields of view at 1000 x magnification and 
average cell lengths are presented here (n=80) ± the standard error of the mean. A one-way 
ANOVA, with a Tukey’s multiple comparisons test, was carried out on the data sets. **p = 
0.001-0.009, ****p < 0.0001.  
S t r a in
L
e
n
g
th
 (

m
)
W
T
A
H
A
0 6
1 8
-
W
T  
(p
S R
K
)
A
H
A
0 6
1 8
-  
(p
SR
K
)
A
H
A
0 6
1 8
-  
(p
A
H
A
0 6
1 8
)
A
H
A
0 6
1 8
-  
(p
H
P 0
1 5
1 8
)
0 .0
0 .5
1 .0
1 .5
2 .0
**** **** **
****
94 
 
 
 
 
Figure 3.18 – Frequency distribution of cell lengths of Aeromonas caviae strains measured 
fluorescence micrographs previously discussed in figure 3.17. The frequency distributions of 
cell length measurements from A. caviae Sch3 containing pSRK(Gm) [WT (pSRK)], the AHA0618 
mutant containing pSRK(Gm) [AHA0618- (pSRK)], the AHA0618 mutant containing 
pSRK_AHA0618 [AHA0618- (pAHA0618)] and the AHA0618 mutant containing pSRK_HP0518 
[AHA0618- (pHP0518)], are displayed here (n=80). 
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length of 0.77 μm, compared to the other strains analysed, and was more frequently measured 
at the lower end of the frequency distribution scale, showing a shift to the left (with a mode 
cell length of 1.2 μm) when compared to the wild type (mode length of 1.5 μm) (Fig. 3.18). 
Both AHA0618 mutant strains containing either pSRK_AHA0618 or pSRK_HP0518 displayed 
similar patterns of spread of cell length, showing a shift to the right when compared to the 
AHA0618 mutant (containing empty pSRK) and both strains having a mode measurement of 
1.5 μm (Fig. 3.18). 
3.2.7 – A. caviae muropeptide analysis 
Muropeptide analysis was carried out in conjunction with Stephane Mesnage’s group in the 
Department of Molecular Biology and Biotechnology at the University of Sheffield. 
If AHA0618 from A. caviae is involved in peptidoglycan processing at the cell wall, then the 
muropeptide profiles of the wild type and mutant strains may be different. Therefore, 
peptidoglycan from A. caviae Sch3 and the AHA0618 mutant was extracted in triplicate and 
digested with mutanolysin to cleave the N-acetylmuramyl-β(1-4)-N-acetylglucosamine linkages 
in peptidoglycan, before being analysed via high performance liquid chromatography (HPLC) 
(Chapter 2, section 2.7.6). These initial studies did not show any differences between the 
peptidoglycan of these strains as determined by the similarity of the HPLC traces obtained (Fig. 
3.19). However, very subtle differences could take much experimental optimisation and time 
to discover.  
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Figure 3.19 – HPLC analysis of peptidoglycan (PG) extracted from A. caviae Sch3 (WT) and the 
AHA0618 mutant (AHA0618-). A quantity of 1 mg of PG was digested with murolysin and 
loaded onto the HPLC for analysis. This trace was created with the help of Stephane Mesnage 
and displays the results from only one of the PG samples obtained from each strain, but is 
representative of all the samples analysed. 
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3.3 – Discussion 
This chapter focused on examining the function of the protein, AHA0618, from Aeromonas 
caviae, which was identified due to its homology with a putative flagellin deglycosylation 
enzyme, HP0518, from Helicobacter pylori (Asakura et al., 2010). The AHA0618 gene is not 
associated with the polar flagellar locus in A. caviae, although a disruption mutant was shown 
here to display a similar hypermotile phenotype to a H. pylori HP0518 mutant (Asakura et al., 
2010). These results suggested that AHA0618 may also be affecting flagellin glycosylation 
levels and perhaps adding a new level of complexity to this post-translational modification 
pathway. Although the role of flagellin glycosylation is unknown, it is tempting to speculate 
that this modification could be involved in mediating interactions with the bacterial 
environment, perhaps assisting with adherence to host cells, as the bacterial flagellum has 
previously been identified as a key adherence factor as well as a propeller for motility (Pratt 
and Kolter, 1998; Rabaan et al., 2001; Giron et al., 2002). If this is the case then bacteria being 
able to maintain or modulate their levels of flagellin glycosylation may be beneficial, perhaps 
in response to the environment, allowing bacterial behaviour to be altered. Modulation of 
flagellin glycosylation and consequently bacterial behaviour has been previously observed in 
Campylobacter jejuni, where studies by van Alphen et al. (2008) suggested the presence of a 
phase-variable glycosyltransferase (Maf4). During Maf4 expression, flagellins were modified 
with a new pseudaminic acid derivative and the autoagglutination ability of the bacterial 
population increased (van Alphen et al., 2008). Furthermore, the presence of legionaminic acid 
on the C. jejuni flagellum, which is not required for flagellar assembly (as pseudaminic acid is), 
has been found to aid chicken colonisation (Howard et al., 2009). These studies therefore 
demonstrate how the differential glycosylation of the C. jejuni flagellum with a variety of 
sugars can modify bacterial behaviour and aid survival in their specific niche. A. caviae and H. 
plyori only glycosylate their flagellins with pseudaminic acid compared to the wide variety of 
sugars found decorating the Campylobacter flagellum. Therefore, where C. jejuni can 
potentially use Maf protein expression to change flagellin glycosylation and in doing so, 
bacterial behaviour, an alternative pathway may be in place in other bacteria that do not 
possess such vast glycosylation islands, such as in A. caviae and H. pylori, enabling them to 
control how their flagellins are glycosylated.  
Although an AHA0618 A. caviae mutant displays a similar hypermotile phenotype to the 
HP0518 H. pylori mutant, examination of polar flagellin glycosylation via western blot analysis 
suggested the glycosylation status of mutant A. caviae flagellins is comparable to the wild type.  
Furthermore, analysis of the LPS profiles from both wild type and mutant A. caviae strains 
suggested that AHA0618 is not affecting glycosylation of the LPS O-antigen, therefore the 
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hypermotility phenotype of the mutant is not likely due to an altered cell surface charge from 
elevated LPS glycosylation levels. 
To further examine the role of these genes, HP0518 was introduced into A. caviae and was 
found to reduce the motility of the AHA0618 mutant strain similarly to when the mutant is 
complemented with AHA0618. In addition, heterologous expression of HP0518 in the wild type 
strain reduced motility, in contrast to AHA0618 overexpression which had no effect on wild 
type A. caviae motility.  This suggests that AHA0618 and HP0518 are functioning similarly in A. 
caviae and there is perhaps a control mechanism in place that is not functioning with the 
heterologously expressed HP0518 from H. pylori, where possibly enzyme activity is being 
controlled, or AHA0618 is being targeted for degradation when present in excess amounts. 
Western blot analysis of the flagellins from these A. caviae strains containing vectors encoding 
AHA0618 and HP0518 showed there to be no discernible effect on overall levels flagellin 
glycosylation. A. caviae FlaA and FlaB are glycosylated with six-eight pseudaminic acid residues 
(out of a possible 19 sites on FlaA and 18 on FlaB) in the central D2/3domain of the flagellin 
(Tabei et al., 2009), and Pse5Ac7Ac has a predicted mass of 316 Da, therefore the mass 
difference caused by subtle changes in glycosylation (for example, corresponding to 1 or 2 
Pse5Ac7Ac residues) between wild type and mutant flagellins may be too subtle to visualise 
using our methodology. These data suggest that the hypermotility phenotype observed from 
AHA0618 mutation is therefore unlikely to be the result of altered polar flagellin glycosylation 
levels in A. caviae.  
It is also possible that AHA0618 and HP0518 are involved in pathways unrelated to flagellar 
assembly and glycosylation in A. caviae. Recently, work by Sycuro et al. (2013) suggested an 
alternative role for HP0518 (named csd6 in this study) as an L,D-carboxypeptidase involved in 
peptidoglycan modification at the cell wall, a mutant of which displayed straight-rod cell 
morphology compared to the helical wild type. AHA0618 may be working in a related fashion, 
in peptidoglycan synthesis. To strengthen this notion, this work revealed AHA0618 to have 
homology with proteins shown to be involved in peptidoglycan cross linking at the bacterial 
cell wall (YkuD superfamily) (Bielnicki et al., 2006) and both AHA0618 and HP0518 were also 
found to possess the conserved cysteine and histidine residues found in L,D-transpeptidases of 
the YkuD superfamily of proteins (along with the original YkuD characterised from B. subtilis), 
reinforcing that these proteins likely play a role in peptidoglycan modification. Furthermore, 
SEM analysis of the A. caviae AHA0618 mutant suggested a subtle but significant decrease in 
cell length compared the wild type and AHA0618 mutant strains expressing either HP0518 or 
AHA0618 displayed overall larger cell lengths. However, when initial studies were carried out 
to explore the muropeptide profiles of the wild type and mutant strains, no differences were 
99 
 
observed. Nonetheless, these were very preliminary studies and very subtle differences in 
muropeptide profiles would take further work, with much experimental optimisation, to 
uncover. 
However, H. pylori HP0518 is around twice the size of AHA0618 which may indicate that this 
protein contains a number of other domains, allowing multiple protein functions or an 
alternative mechanism of action to AHA0618. Penicillin binding proteins containing multiple 
functioning domains, such as glycosyltransferase and transpeptidase domains, have been 
described in a number of bacteria (Sauvage et al., 2008); HP0518 is therefore potentially 
bifunctional, containing separate domains with carboxypeptidase and deglycosylase activities. 
Analysis of the HP0518 amino acid sequence through the Pfam server suggests this may be the 
case as it predicts there to be an uncharacterised ‘SnoaL’ domain of unknown function in 
addition to the YkuD superfamily region.   
The concept that bacterial cell morphology can affect bacterial behaviour has been described 
by a number of studies. In addition to a H. pylori csd6 mutant displaying a straight-rod cell 
shape, studies prior to this by Sycuro et al. (2012) on a csd4 H. pylori mutant (csd4 encoding a 
zinc metalloprotease with carboxypeptidase activity) demonstrated that this straight-rod 
mutant actually has diminished directional motility through gel-like media and displayed 
colonisation defects in a mouse model. Therefore the helical shape of H. pylori appears to be 
beneficial for its specific niche, allowing penetration of the mucous lining of the stomach, with 
morphological mutants showing altered behaviour. CwpFM of Bacillus cereus was also 
identified as a putative cell wall peptidase by Tran et al. (2010) and deletion of the gene 
encoding this protein resulted in larger, ‘peanut shaped’ cells that appeared to be less able to 
divide compared to the rod-shaped wild type. Because of this, the mutant was less motile and 
exhibited a number of other behavioural changes, such as a reduced ability to adhere to 
epithelial cells and diminished biofilm formation, compared to the wild type. Additionally, 
virulence of this strain in an insect model was found to be compromised (Tran et al., 2010). 
Moreover, recent work by Frirdich et al. (2014) demonstrated the importance of a specific L,D-
carboxypeptidase (Pgp2) on helical cell morphology, motility and biofilm formation as a 
mutant in the gene encoding this protein resulted in a straight-rod mutant. 
Another function of some peptidoglycan remodelling enzymes is to create gaps in the bacterial 
cell wall for structures, such as the flagellar complex, to assemble and function efficiently 
(Scheurwater and Burrows, 2011). Although there is no evidence for the tampering of flagellar 
rotation efficiency in this case and a difference in cell length has been observed between 
mutant and wild type strains, we cannot rule out the possibility that an AHA0618 mutation in 
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A. caviae may actually improve efficiency of polar flagellar formation or rotation, hence the 
reason for enhanced motility. For example, H. pylori lacking the lytic transglycosylase, MltD, 
form flagella that cannot rotate, resulting in non-motility due to the mutants being unable to 
cleave the peptidoglycan backbone correctly (Roure et al., 2012). The authors of this study 
hypothesised that the mutation may be affecting how the stator of the flagellar complex, 
MotB, and peptidoglycan interact, in doing so affecting torque generation (Roure et al., 2012; 
Roujeinikova, 2008). Mutational studies on peptidoglycan remodelling enzymes that enhance 
bacterial motility, however, have not yet been reported and therefore the difference in 
bacterial cell length discussed here is likely to be the reason for the increased bacterial motility 
of the AHA0618 A. caviae mutant.  
In the case of Aeromonas caviae, so far no flagellin deglycosylation pathway has been 
identified, and if polar flagellin glycosylation is modulated then this is not achieved by 
AHA0618. However, this Chapter, and a number of other studies, have highlighted the link 
between bacterial cell morphology/size and bacterial behaviour. In the case of bacterial 
velocity, this may be explained by the physics of bacterial motility, where differences in cell 
shapes result in changes in resistance when cells are moving through aqueous environments, 
altering speed of motility. With the condition that the efficiency of flagellar formation and 
rotation is not altered, then it is tempting to speculate that larger cells will produce more drag 
when moving through solution, resulting in slower motility, compared to smaller cells. 
Therefore this study supports the role of peptidoglycan remodelling/processing enzymes in 
bacterial cell shape development, where even the subtlest changes in cell morphology can 
have an effect on bacterial motility and behaviour. 
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Chapter 4: Investigating the sites of Aeromonas caviae 
Sch3 Polar Flagellin Glycosylation 
 
4.1 – Introduction 
Many bacteria are able to O-glycosylate their flagellins, a number of which use nonulosonic 
acids. The precise role of this post-translational modification, however, remains unknown. It 
has been determined that Aeromonas caviae Sch3 glycosylates its flagellins with pseudaminic 
acid on six to eight serine or threonine residues within the central D2/D3 domains of the 
protein (Tabei et al., 2009); a region which is thought to form the surface of the flagellar 
filament (Yonekura et al., 2003).  The exact sites of flagellin glycosylation have not been 
identified in A. caviae; however, how this bacterium modifies its flagellins may give an 
indication towards the function of this sugar at the cell surface. For example, if glycosylation is 
homologous, by always being present on the same serine or threonine residues, it may have a 
structural role, as flagellin glycosylation is essential for flagellar assembly in a variety of 
bacteria (Goon et al., 2003; Schirm et al., 2003; Twine et al., 2009; Wu et al., 2011; Tabei et al., 
2009). It is possible that the presence of sugars may also disguise surface-exposed loop-regions 
of the flagellins from environmental protease cleavage, as N-glycans at the Campylobacter 
jejuni cell surface have been shown to potentially protect proteins from gut proteases (Alemka 
et al., 2013). It could also be required for favourable interactions with host-cell surfaces, as 
flagella are essential for bacterial adherence to host cells and therefore the first stages of 
colonisation (Haiko and Westerlund-Wikstrom, 2013). However, if flagellin glycosylation is 
heterologous, the movement of pseudaminic acid around the flagellum may disguise this 
appendage from the host’s immune system during infection or it is also possible that flagellin 
glycosylation may vary depending on the bacterium’s situation. As previously discussed in 
chapter 3, studies in Campylobacter have demonstrated that flagellar glycosylation may vary 
due to phase-variation of the glycosyltransferase proteins (Maf proteins) (van Alphen et al., 
2008), of which it has several and is capable of glycosylating its flagella with a plethora of 
nonulosonate sugars (Karlyshev et al., 2002). Furthermore, work by Howard et al. (2009) 
demonstrated that altered glycosylation levels in C. jejuni affects the overall surface charge of 
the Campylobacter flagellum and in doing so, alters the behaviour of a population (Howard et 
al., 2009). The mutational studies concluded that when C. jejuni (11168H) can no longer 
glycosylate its flagellum with legionaminic acid (and derivatives), strains are still motile (due to 
the presence of pseudaminic acid), but show altered behaviour, likely due to the decreased 
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hydrophobicity of the polar flagellum (Howard et al., 2009). Mutants were less able to: 
autoagglutinate, form biofilms and colonise chickens (Howard et al., 2009). 
The previous findings that A. caviae Sch3 glycosylates its flagellins with six-eight pseudaminic 
acid residues suggests there to be some heterogeneity in the glycosylation process (Tabei et 
al., 2009). 
O-linked flagellin glycosylation has previously been characterised, either partially or fully, in a 
number of other bacteria. Campylobacter species possess vast and complex glycosylation 
islands due to being able to glycosylate their flagellins with a variety of nonulosonate sugars. 
Studies exploring C. jejuni 81-176 sites of flagellin glycosylation have revealed 19 serine and 
threonine residues to be modified, with all but one of these sites being present within the 
central region of the protein (Thibault et al., 2001). Flagellin was found to be predominantly 
modified with pseudaminic acid, but other derivatives were also present (such as acetamidino, 
O-acetyl and dihydroxyproprionyl derivatives). Furthermore, intact mass spectrometry analysis 
of flagellins revealed different flagellin components to exist at one time, suggesting 
heterogeneity (Thibault et al., 2001). However, although 81-176 glycosylates its flagella with a 
number of sugars and different flagellin components were identified, it was established that 
the identified sites are ‘usually’ occupied, therefore proposing only a small amount of 
heterogeneity with regards to the site of modification (Thibault et al., 2001). Furthermore, 
many of the corresponding sites on other Campylobacter flagellins were also found to be 
modified (Thibault et al., 2001). Glycosylation in C. coli VC167 has also been characterised and 
was found to modify 16 residues with pseudaminic acid and derivatives of legionaminic acid 
(acetamidino and N-methylacetamidoyl versions); this was the first demonstration of 
legionaminic acid decorating a bacterial flagellum (Logan et al., 2002; McNally et al., 2007). In 
addition, the sugars decorating the C. jejuni 11168 flagellum have been explored, which 
possesses a more complex glycosylation locus to that of other Campylobacter strains analysed 
to date (Logan et al., 2009; Zampronio et al., 2011). This strain was found to synthesise novel 
pseudaminic acid derivatives (acetamidino and di-O-methylglyceric derivatives), and four 
possible sites of flagellin modification have been so far recognised (Logan et al., 2009; 
Zampronio et al., 2011). 
In contrast to the variety of sugars decorating the polar flagella of Campylobacter species, 
Helicobacter pylori glycosylates its polar flagellum solely with pseudaminic acid, similarly to A. 
caviae (Schirm et al., 2003). Little heterogeneity was discovered, with FlaA containing six-seven 
sugars and FlaB, nine-ten (Schirm et al., 2003). 
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More recently, glycosylation in the organism, Shewanella oneidensis, has been investigated. 
Two agreeing publications discovered flagellins to be modified with a sugar related to 
pseudaminic acid, with five sites of modification being confirmed on the dominant flagellin, 
FlaB, and four sites on FlaA (Bubendorfer et al., 2013; Sun et al., 2013). Heterogeneity between 
the sites of glycosylation occupied was not reported in these studies (Bubendorfer et al., 2013; 
Sun et al., 2013). As well as glycosylation, these studies also identified methylation on both S. 
oneidensis flagellins, however, sites of methylation did not appear to be essential for either 
flagellin glycosylation, or the production of a functional filament (Bubendorfer et al., 2013; Sun 
et al., 2013). 
Moreover, there have also been reports of Gram-positive bacteria containing genes to 
synthesise nonulosonic acids (Twine et al., 2008; Li et al., 2015), with group I Clostridium 
botulinum flagellins being modified with pseudaminic/legionaminic acid, and a currently 
undetermined derivative, on up to seven sites per monomer (as well as hexuronic acid 
derivatives) (Twine et al., 2008). 
Although the biological role of flagellin glycosylation is not well understood, it is clear that 
bacteria modify their flagella in different ways, and therefore the role of glycosylation may 
vary in each case. 
The aims of this chapter were to develop a method of flagellin purification to obtain pure, 
glycosylated A. caviae Sch3 flagellins, and identify sites of glycosylation using mass 
spectrometry and in doing so, delve deeper into the role of this modification at the A. caviae 
cell surface. Two tandem mass spectrometry (MS/MS) fragmentation methods were tested to 
establish an appropriate method for analysing A. caviae Sch3 flagellin glycosylation sites. Once 
identified, specific sites of glycosylation were then subjected to site-directed mutagenesis 
studies to assess their effect on motility. 
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4.2 – Results 
4.2.1 – Method of flagellin purification 
To purify Aeromonas caviae Sch3 flagellins, a shearing and centrifugation method, developed 
from Wilhelms et al. (2012) was carried out (Chapter 2, section 2.7.4). In short, bacterial cells 
isolated from large swarming plates were vortexed to knock the fragile flagella from the cell 
surfaces, and three centrifugation steps implemented to pellet the flagella. The polyacrylamide 
gel in Figure 4.1 (A) displays the results of the flagella isolation procedure versus precipitating 
the supernatant of an A. caviae overnight culture with ice-cold ethanol to obtain flagellins. The 
flagella shearing method provides a clear band of flagellins that can be excised from the 
polyacrylamide gel for mass spectrometric analysis, with minimal background protein 
contamination. The presence of glycosylated flagellins was confirmed via a western blot using 
an antibody that only recognises glycosylated FlaA/B (Fig. 4.1 B). 
To further confirm the presence of A. caviae Sch3 flagellins, an in-gel trypsin digestion was 
carried out on an A. caviae Sch3 flagellin sample (Chapter 2, section 2.7.7.1), which was then 
run on a maXisTM (Bruker) Quadrupole Time of Flight mass spectrometer (Q-TOF) for the 
identification of FlaA and FlaB (Chapter 2, section 2.7.7.2). Mass spectrometric data obtained 
was submitted to EasyProt (Gluck et al., 2013) and percentage coverages of 59.5% for FlaA and 
67.2% for FlaB, were obtained (Fig. 4.2A) (when A. caviae Sch3 flagellins were submitted as a 
database to EasyProt). As this was to confirm the presence of the flagellins, no modifications 
were considered on EasyProt except those which could result from the in-gel trypsin digestion 
or mass spectrometry process. Therefore only the variable oxidation of methionine residues 
(maximum 3) was considered. Trypsin was set as the specific protease used, allowing for two 
miscleavages. The central region of the proteins (the D2/D3 domains) was not detected, which 
is likely due to being modified with pseudaminic acid. The actual mass of the central tryptic 
peptides would not have matched the predicted, unglycosylated masses.  
As flagella are not formed in an A. caviae glycosyltransferase mutant (maf1 mutant), but 
flagellins are still exported (albeit less efficiently) (Parker et al., 2014), these flagellins were 
obtained for mass spectrometry analysis via ethanol precipitation of supernatant samples. 
Flagellins from a maf1 mutant can only be detected by our means when overexpressing FlaA in 
an inducible vector (please refer to Chapter 3, figure 3.12). A maf1 mutant containing flaA on 
the IPTG inducible vector pSRK(Gm) was therefore utilised and flagellins cut from a 12% 
polyacrylamide gel after the ethanol precipitation of the supernatant of a 50 ml overnight 
culture. These flagellins are thought to be unglycosylated (Parker et al., 2012; Parker et al., 
2014)  
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Figure 4.1 – (A) A 12 % polyacrylamide gel displaying: Lane 1, an A. caviae Sch3 precipitated supernatant sample (WT Sn), and lane 2, A. caviae Sch3 flagella sample 
obtained from the flagella shearing method (WT flagella). (B) Western blot analysis of: lane 1, an A. caviae Sch3 precipitated supernatant sample (WT Sn); lane 2, 
an A. caviae maf1 mutant precipitated supernatant sample (maf1- Sn), and lane 3, an A. caviae Sch3 flagella sample (WT flagella), probed with an anti-polar 
flagellin antibody that only recognises glycosylated flagellin [anti-FlaA/B(+Pse)] (1:10,000).  
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Figure 4.2 – Percentage coverage of A. caviae Sch3 (A) and maf1 mutant flagellins (B) when run analysed via CID-MS/MS. Underlined regions of the flagellins 
represents the peptides detected by EasyProt (Gluck et al., 2009), the highlighted regions show the D2/D3 domains and the red letters demonstrate where trypsin 
is able to cleave the proteins.  
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and are extremely insoluble, so very little protein was yielded. An in-gel digest was also carried 
out of these flagellins samples and their presence confirmed by CID-MS/MS (via EasyProt 
analysis of the data); however, very few peptides were detected, likely due to the insoluble 
and less efficient export of these flagellins (Fig 4.2 B) (Parker et al., 2014). 
 
4.2.2 – Mass spectrometry analysis of Aeromonas caviae polar flagellins 
This work was carried out in conjunction with Prof Philip Wright’s group in the department of 
Chemical and Biological Engineering at the University of Sheffield. Samples were digested and 
run on the mass spectrometers with the help of a postdoctoral researcher, Dr Narciso Couto. 
4.2.2.1 – Mass Spectrometry Methods for Glycoprotein Analysis 
In gel trypsin digestions of A. caviae flagellin samples were carried out to yield manageable 
FlaA/B peptides for mass spectrometry analysis. Trypsin was found to be the best protease by 
cutting flagellins frequently, after arginine and lysine residues in the flagellin protein sequence 
(Fig. 4.2). Other enzymes were also investigated alone and in combinations, as trypsin 
digestion of flagellins yields extremely large peptides from the glycosylated region of interest, 
the central D2/D3 domain (due to the lack of lysine and arginine residues in this region) (Fig. 
4.2); larger peptides are usually are too heavy to run effectively on the mass spectrometer, as 
they take a lot more energy to fragment (Domon and Aebersold, 2006). However, the best 
spectra were obtained when the tryptic peptides were subjected to the methods of mass 
spectrometry discussed here (section 4.2.2). Other enzymes such as LysC, GluC and 
Chymotrypsin, did not cut frequently enough on their own, but when used in combination, 
yielded peptides too small to be considered by the mass spectrometer.  
Two tandem mass spectrometry (MS/MS) fragmentation methods were investigated for 
working with flagellin glycopeptides: collision induced dissociation (CID) MS/MS and electron 
transfer dissociation (ETD) MS/MS. 
CID-MS/MS was carried out on a maXisTM Q-TOF mass spectrometer (Bruker) and mass spectra 
obtained were subjected to both manual and Easyprot analysis (Gluck et al., 2013). CID-MS/MS 
cleaves the peptide backbone in the C-N peptide bond, producing a series of b and y ions (Fig. 
4.3). CID-MS/MS was found to preferentially fragment the pseudaminic acid on glycopeptides 
present, which could be visualised in the MS/MS spectra as large, singly charged, diagnostic 
ion peaks at m/z 317.1 and 299.1, corresponding to pseudaminic acid and the sugar minus 
water respectively (Thibault et al., 2001). The presence of these oxonium ions allowed the  
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Figure 4.3 – A schematic diagram to show how the peptide backbone is fragmented during 
collision induced dissociated (CID) and electron induced dissociation (ETD) tandem mass 
spectrometry (MS/MS). CID-MS/MS produces a series of y and b ions, whereas ETD-MS/MS 
produces a series of z and c ions. 
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manual identification of glycopeptides in the CID-MS/MS spectra. In addition, the Q-TOF used 
here was found to accurately detect the fragmented tryptic peptides, the results of which 
could then be submitted to EasyProt (Gluck et al., 2013) for additional analysis of the data. 
ETD-MS/MS was carried out on an amaZonTM ion trap mass spectrometer (Bruker). This 
method of peptide fragmentation cleaves the peptide backbone at the N-C  peptide bond, 
producing a series of c and z ions (Fig. 4.3), and has previously been utilised for glycopeptide 
analysis. For example, ETD-MS/MS has allowed the successful identification of: S. onedensis, C. 
jejuni and C. botulinum, sites of flagellin glycosylation (Bubendorfer et al., 2013; Sun et al., 
2013; Twine et al., 2008; Zampronio et al., 2011).  However, despite these findings, minimal 
glycopeptides could be detected using ETD for A. caviae flagellins. As the sugar on the 
glycopeptides is not fragmented so fervently during this fragmentation method, fewer to no 
diagnostic ions are present in the mass spectra, making manual analysis of the spectra more 
difficult. In theory, CID-MS/MS data could be used to identify the glycopeptides present, and 
then ETD-MS/MS be used for more detailed analysis of the peptide (ie. identification of sites of 
modification). However, no glycopeptides could be identified in this way. In addition, the ions 
produced from peptide fragmentation were detected at less accurate m/z values compared to 
CID-MS/MS on the Q-TOF, making EasyProt analysis of the data challenging (due to requiring 
extremely accurate m/z value information). In light of these findings, analysis of A. caviae 
flagellin glycosylation was carried out using CID-MS/MS. 
4.2.2.2 - Manual analysis of CID-MS/MS spectra 
Protein Prospector was utilised to support the manual analysis of CID MS/MS spectra (Chapter 
2, section 2.7.7.3). The Protein Prospector ‘digest tool’ was used to perform a theoretical 
trypsin digest of both FlaA and FlaB (with two miscleavages considered) to yield hypothetical 
m/z values of the tryptic peptides (up to a charge state of +6, due to high charge states of 
glycopeptides being visualised in the spectra). As Protein Prospector does not take into 
account any post-translational modifications in the digests, the predicted m/z values for 
glycosylated, tryptic peptides was manually calculated using Microsoft Excel, with up to eight 
pseudaminic acids being considered on appropriate peptides containing serine or threonine 
residues. The Protein Prospector ‘MS product’ tool was also used to help annotate the MS/MS 
spectra of peptides of interest. 
Spectra obtained from trypsin digestion of A. caviae Sch3 flagellins was manually examined for 
the characteristic oxonium ions of pseudaminic acid, m/z 317.1[1+] and m/z 299.1[1+]. These ions 
were present throughout the CID-MS/MS spectra of wild type flagellins, however were absent 
from A. caviae maf1 mutant flagellin samples (Fig 4.4). Figure 4.4 displays the glycosylated 
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Figure 4.4 – CID-MS/MS spectra of the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, 
which contributed towards Parker et al. (2014). This peptide eluted multiple times between 
60-100 min retention times. (A) MS/MS of the triply charged ion, m/z 1135.2, of which this 
particular peptide eluted at 96.22 min an A. caviae Sch3 sample. The ion corresponds to the 
peptide glycosylated with two pseudaminic acid residues. (B) MS/MS of the quadruply charged 
ion, m/z 851.7, of which this particular peptide eluted at 96.25 min an A. caviae Sch3 sample. 
The ion corresponds to the peptide glycosylated with two pseudaminic acid residues. (C) 
MS/MS spectra from an A. caviae maf1 mutant flagellin sample. The quadruply charged ion, 
m/z 692.85, elutes here at 74.43 min and corresponds to the unglycosylated peptide. S refers 
to a potentially modified serine residue. 
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tryptic peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, from wild type A. caviae FlaB (Fig 4.4 
A&B). This peptide is only ever found in its glycosylated form in this strain. However, figure 4.4 
C shows the corresponding, unglycosylated peptide from a maf1 mutant strain (Fig4.4 C). Maf1 
has been identified as the putative polar flagellin glycosyltransferase and these data therefore 
further support this notion (Parker et al., 2012; Parker et al., 2014). 
Although many glycopeptides could be manually visualised within the spectra (recorded 
between 60-100 minute retention times), many difficulties were faced when trying to identify 
them. As previously found, FlaA/B are glycosylated with 6-8 pseudaminic acid residues in their 
D2/D3 domains (Tabei et al., 2009) out of a possible 19 sites on each flagellin within this 
region. Due to the lack of lysine and arginine residues, tryptic peptides within this D2/D3 
region are large; therefore there are many possible sites of glycosylation on each tryptic 
peptide. The FlaB peptide [146-173] was the most frequent glycopeptide observed when 
analysing the spectra manually; this was present at m/z 1135.2[3+] and 851.7[4+] corresponding 
to this peptide containing two pseudaminic acids, and at m/z 1029.8[3+], equivalent to the 
peptide containing one pseudaminic acid (Table 4.1). The exact sites of glycosylation could not 
be determined without the aid of EasyProt (Chapter 2, section 2.7.7.3) due to the preferential 
fragmentation of pseudaminic acid via CID-MS/MS; the peaks corresponding to the rest of the 
peptide fragmentation were therefore extremely small and largely lost in the spectra’s 
background noise. This peptide was also found to be triply charged with two protons and one 
sodium ion, at m/z 1142.5, corresponding to the peptide containing two pseudaminic acids. 
This was determined to be the same peptide, as the MS/MS spectrum was similar to that of 
the triply and quadruply charged ions, m/z 1135.2 and 851.7, respectively. Furthermore, if the 
mass of this tryptic peptide containing two sugars is 3402.6 Da, the predicted m/z value of the 
ion, [M+2H+Na]3+, can be estimated, which would give a value of m/z 1142.5 due to the 
following calculation: (3402.6+2+23)/3. Protein prospector MS-product confirmed that the 
triply charged ion of the FlaB tryptic peptide, [146-173] (with a sodium ion present), modified 
with two pseudaminic acid residues, is likely to have an m/z value of 1142.5. Table 4.1 displays 
the other glycopeptides that were recorded multiple times during CID-MS/MS. The table 
presents predicted glycopeptides which have been identified due to the observed m/z values 
matching predicted values obtained from the theoretical trypsin digest of FlaA/B carried out by 
Protein Prospector. However, manual analysis of MS/MS spectra could not confirm these to be 
the actual glycopeptides present in most cases (shown as x or ✓) (Table 4.1).  
There were also peptides present that displayed the diagnostic ions of pseudaminic acid in 
their MS/MS spectra, but could not be assigned a protein sequence such as: 1154.2[3+] (which 
was as common as 1135.2[3+]), 1212.6[6+] , 1217.1[2+] , 1250.58[3+] , 1272.4[3+] , 1274.3[3+] ,  
113 
 
Table 4.1 – The potential sequence of predicted glycopeptides identified during CID-MS/MS analysis of Aeromonas caviae Sch3 flagellins (FlaA/B).  ✓ and X denote 
whether the  predicted peptide is likely to  be actually present depending on the presence of y and b ions in the MS/MS spectra.
m/z present Potential Glycopeptide Flagellin? Peptide Information Expected m/z Matched peaks 
(y/b/internal) 
1029.8
[3+]
 
Present throughout 
spectra
 
146
FQVGADANQTIGFSLSQAGGFSISGIAK
173
 FlaB 1 Pse5Ac7Ac – unknown position 
[M+3H+Pse5Ac7Ac]
3+
 
1029.8
[3+]
 ✓ - section 4.2.2.3, 
figures: 4.5, 4.6 & 4.7. 
1135.2
[3+]
/851.7
[4+] 
Present throughout 
spectra 
146
FQVGADANQTIGFSLSQAGGFSISGIAK
173 
FlaB 2 Pse5Ac7Ac – unknown position 
[M+3H+Pse5Ac7Ac]
3+
 
1135.2
[3+]
/851.7
[4+]
 ✓ - section 4.2.2.3. 
figures: 4.8 & 4.9 
1142.5
[3+]
 
146
FQVGADANQTIGFSLSQAGGFSISGIAK
173
 FlaB 2 Pse5Ac7Ac – unknown position 
[M+2H+Na+2Pse5Ac7Ac]
3
 
1142.5
[3+]
 ✓ 
1140.8
[3+]
 
Present throughout 
spectra 
Many peaks in spectra matching fragmentation pattern of 
146
FQVGADANQTIGFSLSQAGGFSISGIAK
173
 
FlaB Unknown N/A N/A 
1129.2
[3+]
 
 
38
INSAKDDAAGLQISNRLTSQINGLDQGNR
66 
 
OR 
 
146
FQVGADANQTIGFSLSQAGGFSISGIAK
173
 
FlaA/B 
 
 
 
FlaB 
 
1 Pse5Ac7Ac 
[M+3H+Pse5Ac7Ac]
3+
 
2 miscleavages 
 
2 Pse5Ac7Ac – unknown position 
[M+2H+Na+2Pse5Ac7Ac-H2O]
3+
 
1129.2
[3+]
 
 
 
 
1129.2
[3+]
 
 
X - unlikely  
 
 
 
✓- Loss of water before 
fragmentation 
1048.99
[2+]
 
16
NLMNTSKSMDTSYTR
31
 FlaB 1 Pse5Ac7Ac, 2 oxidation methionine 
[M+2H+Pse5Ac7Ac]
2+
 
1 miscleavage 
1048.96
[2+]
 X - unlikely 
1288.06
[2+]
 
24
SRIRDADFATETANMTK
42
 FlaB 2 Pse5Ac7Ac. 1 oxidation methionine 
[M+2H+2Pse5Ac7Ac]
2+
 
2 Miscleavages 
1288.09
[2+]
 X - unlikely 
1292.5
[2+]
 MRTLAQQSANGSNSAKDR FlaA 2 Pse5Ac7Ac, 1 oxidation methionine 
[M+2H+2Pse5Ac7Ac]
2+
 
2 Miscleavages 
1292.1
[2+]
 X - unlikely 
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1296.5[2+], 1317.28[3+] , 1341.3[3+] , 1383.99[3+]. All of these ions were observed multiple times 
during manual analysis. Furthermore, there were also many glycopeptides present that only 
appeared once in the spectra and could not be assigned to a single peptide. This may 
demonstrate that A. caviae flagellin glycosylation is extremely variable, with many different 
glycopeptides, or versions of the same peptide, being present in a wild type flagellin sample.  
4.2.2.3 – EasyProt analysis of CID-MS/MS spectra 
EasyProt (Gluck et al., 2013) was utilised to complement manual analysis of CID-MS/MS data. 
This was carried out with the help of Andrew Landells in Chemical and Biological engineering at 
Sheffield University (Chapter 2, section 2.7.7.3). EasyProt parameters were updated to also 
consider the variable modification of serine and threonine residues with pseudaminic acid 
(maximum 3). Peptides with a z-score above six were considered (statistical score assigned to 
the peptides by EasyProt depending on the peaks present in the spectra and therefore judging 
the likelihood that the said peptide is actually present). 
EasyProt confirmed that the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, is 
glycosylated either once or twice, and is never found in its unglycosylated form. In addition, it 
suggested the exact sites of glycosylation appear to vary on this peptide. When glycosylated 
once, the FlaB peptide was found to be glycosylated either on: threonine 155, serine 159 or 
serine 161 (Fig. 4.5, 4.6 & 4.7). When glycosylated twice (which was more common), the 
modification of both central serine residues (serine 159 and 161) was observed most 
frequently (Fig. 4.8); however, the peptide was also present with modifications on both, 
threonine 155 and serine 159 (Fig. 4.9). 
As Sun et al. (2013) demonstrated that Shewanella oneidensis FlaB is also methylated, 
methylation of lysine residues was also investigated in A. caviae. When methylation of lysine 
residues (methyl/dimethyl/trimethyl) was introduced into the EasyProt search parameters as 
an optional, variable modification, a variety of methylated peptides were discovered. The FlaA 
peptide, 108DREALQKEVDQLGAEINR125, was suggested to be present in numerous forms in a 
wild type A. caviae flagellin sample, as evidence for dimethylation and trimethylation on the 
central lysine 114 was discovered, along with the unmodified peptide (Fig. 4.10, 4.11 & 4.12). 
Furthermore, EasyProt analysis of flagellin also suggested the FlaB peptide, 126ISKDTTFAGTK136, 
to be dimethylated on lysine 128 and the peptide, 38INSAKDDAAGLQISNR53, present in both 
FlaA and FlaB, to be di- and trimethylated on lysine 42. Both peptides were discovered in their 
unmodified forms also. Please refer to figures 4.13 and 4.14 for FlaB peptide [26-136], and 
figures 4.15, 4.16 and 4.17 for FlaA/B peptide [38-53]. 
EasyProt did not identify any other modified peptides in wild type A. caviae flagellin samples. 
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Figure 4.5 – CID-MS/MS spectra of the triply charged ion, m/z 1029.8, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, containing 
one pseudaminic acid residue at threonine 155. T denotes the likely position of the sugar and the red text refers to the y and b ions present in the spectra. This 
particular peptide eluted at 100.42 min.  
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Figure 4.6 – CID-MS/MS spectra of the triply charged ion, m/z 1029.8, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, containing 
one pseudaminic acid residue at serine 159. S denotes the likely position of the sugar and the red text refers to the y and b ions present in the spectra. This 
particular peptide eluted at 79.6 min. 
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Figure 4.7 – CID-MS/MS spectra of the triply charged ion, m/z 1029.8, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, containing 
one pseudaminic acid residue at serine 161. S denotes the likely positions of the sugar and the red text refers to the y and b ions present in the spectra. This 
particular peptide eluted at 80.82 min. 
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Figure 4.8 – CID-MS/MS spectra of the triply charged ion, m/z 1135.2, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, containing 
two pseudaminic acid residues at serine 159 and serine 161. S denotes the likely positions of the sugar and the red text refers to the y and b ions present in the 
spectra. This particular peptide eluted at 86.24 min.  
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Figure 4.9: Part A - CID-MS/MS spectra of the triply charged ion, m/z 1135.2, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, 
containing two pseudaminic acid residues at threonine 155 and serine 159. S and T denote the likely positions of the sugar and the red text shows the combination 
of y and b ions present in both (A) and (B). Part (B) to this figure can be found on the following page.  This particular peptide eluted at 73.53 min. Part (B) displays 
the central region of the MS/MS spectra amplified (m/z values between 300 and 1400). 
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Figure 4.9: Part B - CID-MS/MS spectra of the triply charged ion, m/z 1135.2, which corresponds to the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, 
containing two pseudaminic acid residues at threonine 155 and serine 159. This figure shows the amplified central region (m/z values between 300 and 1400) from 
the MS/MS spectra shown in figure 4.9, part (A). For the combination of y and b ions present please refer to part (A).  
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Figure 4.10 – CID-MS/MS spectra of the triply charged ion, m/z 695.35, which corresponds to the unmodified FlaA peptide, 108DREALQKEVDQLGAEINR125. The red 
text refers to the y and b ions present in the spectra. This particular peptide eluted at 39.19 min. 
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Figure 4.11 – CID-MS/MS spectra of the triply charged ion, m/z 704.69, which corresponds to the dimethylated FlaA peptide, 108DREALQKEVDQLGAEINR125. K 
denotes the likely modified residue and the red text refers to the y and b ions present in the spectra. This particular peptide eluted at 44.29 min.  
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Figure 4.12 – CID-MS/MS spectra of the quadruply charged ion, m/z 532.3, which corresponds to the trimethylated FlaA peptide, 108DREALQKEVDQLGAEINR125. K 
denotes the likely modified residue and the red text refers to the y and b ions present in the spectra. This particular peptide eluted at 38.07 min. 
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Figure 4.13 – CID-MS/MS spectra of the doubly charged ion, m/z 584.8, which corresponds to the unmodified FlaB peptide, 126ISKDTTFAGTK136. The red text refers 
to the y and b ions present in the spectra. This particular peptide eluted at 19.59 min. 
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Figure 4.14 – CID-MS/MS spectra of the doubly charged ion, m/z 598.8, which corresponds to the dimethylated FlaB peptide, 126ISKDTTFAGTK136. K denotes the 
likely modified residue and the red text refers to the y and b ions present in the spectra. This particular peptide eluted at 28.87 min. 
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Figure 4.15 – CID-MS/MS spectra of the doubly charged ion, m/z 836.9, which corresponds to the unmodified FlaA/B peptide, 38INSAKDDAAGLQISNR53. The red 
text refers to the y and b ions present in the spectra. This particular peptide eluted at 23.18 min. 
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Figure 4.16 – CID-MS/MS spectra of the doubly charged ion, m/z 850.9, which corresponds to the dimethylated FlaA/B peptide, 38INSAKDDAAGLQISNR53. K denotes 
the likely modified residue and the red text refers to the y and b ions present in the spectra. This particular peptide eluted at 32.47 min. 
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Figure 4.17 – CID-MS/MS spectra of the triply charged ion, m/z 572.3, which corresponds to the trimethylated FlaA/B peptide, 38INSAKDDAAGLQISNR53. K denotes 
the likely modified residue and the red text refers to the y and b ions present in the spectra. This particular peptide eluted at 26.99 min. 
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4.2.3 – Flagellin Mutational Studies 
As the FlaB peptide, 146FQVGADANQTIGFSLSQAGGFSISGIAK173, was identified to be 
glycosylated (potentially with either one or two pseudaminic acid residues), and the site of 
glycosylation appears to vary, FlaB was selected for site-directed mutagenesis studies to 
investigate whether any specific glycoforms of this peptide are particularly required for the 
motility of A. caviae. These studies were carried out in an A. caviae flaA flaB double mutant 
background (which will be referred to as flaAB mutant), created from the insertion of a 
chloramphenicol cassette into flaA and a kanamycin cassette into flaB (Rabaan et al., 2001). 
Site-directed flaB mutants were cloned into the broad host range vector pBBR1MCS-5 and 
strains created were compared to the flaAB mutant containing wild type flaB (from Sch3 A. 
caviae) in pBBR1MCS-5, as although flaB can complement the non-motile phenotype of a flaAB 
mutant, motility is slightly impaired compared to the wild type (Fig. 4.18).  
4.2.3.1 – Generation of pBBR1MCS-5_flaB 
The flaB gene (918 base pairs), encoding the A. caviae Sch3 polar flagellin (FlaB), was cloned 
into pBBR1MCS-5 along with a region upstream of the transcription start site to allow 
expression of flaB from its native promoter (99 base pairs). Q5 high fidelity DNA polymerase 
(NEB) was used to amplify flaB from Sch3 A. caviae genomic DNA with the primers RCL_55 and 
RCL_56 (Fig. 4.19 A). The PCR product was directly cut with a combination of HindIII and BamHI 
restriction enzymes before being ligated into HindIII/BamHI cut pBBR1MCS-5 (Fig. 4.19 A). The 
ligation was transformed into chemically competent DH5  and minipreps carried out with 
resulting transformants to isolate the vector DNA. The presence of flaB was investigated with a 
BamHI restriction digest and agarose gel electrophoresis (compare with linearised empty 
pBBR1MCS-5). Likely pBBR1MCS-5_flaB constructs were sent for sequencing using M13 
forward and reverse primers to confirm the presence of flaB. 
4.2.3.2 – Site-directed Mutagenesis of FlaB Glycosylation Sites Identified via Mass Spectrometry 
In order to determine whether particular glycosylation sites were important for the motility of 
A. caviae, FlaB site-directed mutants were created via overlap extension PCR (OE-PCR) 
(Chapter 2, section 2.6.2.3); where serine and threonine residues on the peptide, 
146FQVGADANQTIGFSLSQAGGFSISGIAK173, were mutated to alanine residues, due to the 
structural simplicity and non-polar properties of this amino acid. Site directed mutants 
created, and the primers used to generate each fragment for OE-PCR, are summarised in table 
4.2 (mutants 1-4). 
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Figure 4.18 – Swimming motility assays were carried out on 0.25% (w/v) agar of A. caviae Sch3 
(WT), a flaAB mutant (AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB) and a 
flaAB mutant containing empty pBBR1MCS-5 (AB- pBBR). 
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Figure 4.19 – Diagrammatic representation of cloning methods, using SnapGene software: (A) the cloning method of flaB from A. caviae Sch3 into pBBR1MCS-5 
(Kovach et al., 1995) and (B) how flaB site-directed mutants were cloned into pBBR1MCS-5 using overlap extension PCR [using pBBR_flaB(S159/161A) as an 
example]. 
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 Site-directed mutant PCR fragment 1 PCR fragment 2 
1 FlaB(T155A) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) &  
B-T155A (R) 
B-T155A (F) & 
RCL_56 (R) 
2 FlaB(S159/161A) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) & 
B-S159/161A (R) 
B-S159/161A (F) & 
RCL_56 (R) 
3 FlaB(S167/169A) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) &  
B-S167/169A (R) 
B-S167/169A (F) & 
RCL_56 (R) 
4 FlaB(S159/161/167/169A) or FlaB(4) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) &  
B-S159/161A (R)  
When pBBR1MCS-
5_flaB(S167/169A) 
used as the template 
B-S159/161A (F) & 
RCL_56 (R) 
When pBBR1MCS-
5_flaB(S167/169A) 
used as the template 
5 FlaB(L160A) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) &  
B-L160A (R) 
B-L160A (F) & 
RCL_56 (R) 
6 FlaB(I168A) 
146FQVGADANQTIGFSLSQAGGFSISGIAK173 
RCL_55 (F) &  
B-I168A (R) 
B-I168A (F) &  
RCL_56 (R) 
7 FlaB(S208/210A) 
…195ISLIFVSGSAGGISISTQSKAQAVLA220… 
RCL_55 (F) &  
B-S208/210A (R) 
B9S208/210A (F)  
& RCL_56 (R) 
 
Table 4.2 - All serine and threonine residues highlighted in the FlaB peptide above (S/T) were 
mutated to alanine residues. The site-directed mutants were coded for in the flaB internal 
primers used to generate the two fragments for overlap extension PCR. For all SDMs, overlap 
extension PCR was carried out with fragments 1 and 2 with the primers RCL_55 and RCL_56 to 
create flaB containing the desired mutations.  
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Once each mutated flaB PCR product was generated (Fig. 4.19 B), cloning into pBBR1MCS-5 
proceeded as previously described in section 4.2.3.1 for pBBR1MCS-5_flaB. 
4.2.3.3 – Analysis of Site-Directed Mutant pBBR1MCS-5_flaB constructs in Aeromonas caviae 
The plasmid, pBBR1MCS-5_flaB, and the vectors containing desired site-directed mutations 
(T155A; S159/161A; S167/169A; S159/161/167/169A), were transformed into the conjugal 
transfer strain, E. coli S17 1-λ pir, and conjugated into an A. caviae flaAB mutant (Rabaan et al., 
2001) (Chapter 2, section 2.4.13), along with the wild type flaB construct and the empty 
pBBR1MCS-5 vector, to analyse the effect of each mutation on A. caviae swimming motility. 
Three transconjugants were analysed for each strain expressing FlaB site-directed mutants. 
Swimming motility assays were carried out on large swimming motility plates (Chapter 2, 
section 2.4.4), allowing an A. caviae flaAB mutant expressing a desired FlaB site-directed 
mutant to be analysed alongside: the flaAB mutant alone, the mutant containing the empty 
vector and the mutant containing wild type flaB. The large plates allowed for six biological 
repeats per strain to be analysed; three technical repeats were also carried out. 
The flaB(T155A) construct was able to complement the non-motile phenotype of the A. caviae 
flaAB mutant and was found to swim significantly more (18% more) than the mutant 
expressing wild type FlaB (Fig. 4.20 A/B). Expression of the pBBR1MCS-5 constructs containing 
the double mutations, flaB(S159/161A) and flaB(S167/169A), were both found to restore 
motility in the flaAB mutant, however, the motility was significantly impaired (Fig. 4.21 A/B 
and Fig. 4.22 A/B). These strains displayed a reduction in motility of 26% (S159/161) and 39% 
(167/169) compared to the motility levels of the flaAB mutant containing the wild type FlaB 
(Fig. 4.21 A/B and Fig. 4.22 A/B). 
When the motility of the quadruple mutant construct, flaB(S159/161/167/169A), in the flaAB 
mutant was analysed, severely impaired motility was visualised after 24 hours; this strain was 
therefore classed as non-motile (Fig. 4.23 A). Fig. 4.23 B shows a close up of the impaired 
motility of this strain compared to the flaAB mutant containing the empty pBBR1MCS-5 vector. 
The presence of an uneven colony demonstrates that there are possibly problems with 
flagellin export, or folding, in order to form a functional filament. Any filaments that are 
formed here may be weak, or not form as favourable interactions with aqueous environments 
due to the lack of glycosylation. 
Western blot analysis was carried out on whole-cell and supernatant site-directed mutant 
flagellin samples, to compare the mutant flagellins to wild type FlaB. Each sample was probed 
with an antibody that recognises glycosylated flagellin only [anti-FlaA/B(+Pse)], and an  
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Figure 4.20 – Analysis of a FlaB T155A site-directed mutant in an A. caviae flaAB mutant. (A) 
Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae flaAB mutant 
(AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant containing 
pBBR1MCS-5_flaB(T155A) [AB- pflaB(T155A)] and a flaAB mutant containing empty 
pBBR1MCS-5 (AB- pBBR). (B) The radius of each motility halo was measured after 24 hours and 
average measurements are presented here (n=6) ± the standard error of the mean. A p value < 
0.0001 was generated when a paired t-test was carried out on the data sets. Here, the flaAB 
mutant containing pBBR1MCS-5_flaB(T155A) swims 18% more than when the wild type 
flagellin is present. 
 
p < 0.0001 
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Figure 4.21 - Analysis of a FlaB S159/161A site-directed double mutant in an A. caviae flaAB 
mutant. (A) Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae 
flaAB mutant (AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant 
containing pBBR1MCS-5_flaB(S159/161A) [AB- pflaB(S159/161A)] and a flaAB mutant 
containing empty pBBR1MCS-5 (AB- pBBR). (B) The radius of each motility halo was measured 
after 24 hours and average measurements are presented here (n=6) ± the standard error of 
the mean. A p value of 0.002 was generated when a paired t-test was carried out on the data 
sets. Here, the flaAB mutant containing pBBR1MCS-5_flaB(S159/161A) displays a 26% 
reduction in motility levels compared to the flaAB mutant containing pBBR1MCS-5_flaB. 
 
p = 0.002 
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Figure 4.22 - Analysis of a FlaB S167/169A site-directed double mutant in an A. caviae flaAB 
mutant. (A) Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae 
flaAB mutant (AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant 
containing pBBR1MCS-5_flaB(S167/169A) [AB- pflaB(S167/169A)] and a flaAB mutant 
containing empty pBBR1MCS-5 (AB- pBBR). (B) The radius of each motility halo was measured 
after 24 hours and average measurements are presented here (n=6) ± the standard error of 
the mean. A p value of < 0.0001 was generated when a paired t-test was carried out on the 
data sets. Here, the flaAB mutant containing pBBR1MCS-5_flaB(S159/161A) displays a 39% 
reduction in motility levels compared to the flaAB mutant containing pBBR1MCS-5_flaB. 
p < 0.0001 
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Figure 4.23 - Analysis of a FlaB S159/161/167/169A site-directed quadruple mutant in an A. 
caviae flaAB mutant. (A) Swimming motility assays were carried out on 0.25% (w/v) agar of an 
A. caviae flaAB mutant (AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB 
mutant containing pBBR1MCS-5_flaB(S159/161/167/169A) [AB- pflaB(4)] and a flaAB mutant 
containing empty pBBR1MCS-5 (AB- pBBR). Motility plates were incubated for 24 hours. (B) A 
close up of the impaired motility of the A. caviae flaAB mutant containing pBBR1MCS-
5_flaB(S159/161/167/169A) [AB- pflaB(4)] compared to the non-motile flaAB mutant 
containing empty pBBR1MCS-5 (AB- pBBR). 
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antibody that recognises both glycosylated and unglycosylated flagellin forms (anti-FlaA/B) 
(Fig. 4.24). 
When FlaB is analysed via Western blot analysis, a thick band results; most likely due to the 
flagellins being present in different glycoforms, with some possessing only six pseudaminic 
acid residues and others seven or eight sugars (Fig. 4.24) (Tabei et al., 2009). When the site-
directed mutant flagellins are analysed via Western blot analysis, FlaB(T155A) displays a band 
thickness comparable to the wild type flagellin when normalised whole cell samples and the 
supernatant samples are analysed with both anti-FlaA/B and anti-FlaA/B(+Pse). Therefore it is 
likely that FlaB(T155A) is glycosylated similarly to the wild type flagellin and the point mutation 
has no effect on the flagellins ability to polymerise and form a filament (which was expected 
due to the motility observed). However, although both FlaB(S159/161A) and FlaB(S167/169A) 
are able to produce a functioning flagella, they are observed as thinner bands on the Western 
blots compared to wild type FlaB; this is potentially due to only possessing the lower levels of 
flagellin glycosylation (ie. restricted to possessing only six-seven pseudaminic acid residues 
where as wild type flagellin is free to occupy more sites). Additionally, in the normalised 
whole-cell samples, the levels of both FlaB(S159/161A) and FlaB(S167/169A) visually appear to 
be lower than the levels of wild type FlaB or FlaB(T155A) (fig. 4.24 A); a notion which is further 
supported by densitometry data collected from whole-cell Western blots probed with anti-
FlaA/B(+Pse) (Fig. 4.25). 
Furthermore, a noticeable size shift can be observed when wild type FlaB, FlaB(T155A), 
FlaB(S159/161A) and FlaB(167/169A) samples are compared to the quadruple FlaB mutant 
flagellin sample (Fig. 4.24 A&B). This is apparent both in the whole cell and supernatant 
western blots (Fig. 4.24 A&B) and demonstrates that although the quadruple mutant flagellin 
is still glycosylated and exported, it is either not incorporated into a functional flagellar 
filament, or any filament formed has an impaired function. It may be that the glycosylation of 
this peptide is essential for the motility of A. caviae when FlaB is the only flagellin present. 
These mutations, however, may also result in the improper folding of flagellin and be the 
reason for the non-motile phenotype observed in the flaAB mutant expressing this FlaB 
containing quadruple serine point mutations. Densitometry analysis of whole-cell western 
blots also confirmed that the quadruple FlaB mutant is present at much lower levels in the cell 
than the other flagellins analysed (Fig. 4.25). 
4.2.3.4 – Mass spectrometry analysis of the site-directed mutant flagellin, FlaB(S159/161A) 
The mutated FlaB(S159/161A) flagellin was selected for analysis via CID-MS/MS, due to these 
serine residues being the most regularly occupied sites on the wild type flagellin (observed by   
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Figure 4.24 – Western blot analysis of Aeromonas caviae whole cell samples (A), and supernatant samples (B). Both samples from A and B were probed with a 
rabbit, anti-polar flagellin antibody that recognises only glycosylated flagellin [anti-FlaA/B(+Pse)] and a mouse, anti-polar flagellin antibody that recognises both 
glycosylated and unglycosylated forms of flagellin (anti-FlaA/B). In each case: lane 1, the A.caviae flaAB mutant (AB-); lane 2, the flaAB mutant containing 
pBBR1MCS-5_flaB (AB- pflaB); lane 3, the flaAB mutant containing empty pBBR1MCS-5 (AB- pBBR); lane 4, the flaAB mutant containing pBBR1MCS-5_flaB(T155A) 
[AB- pflaB(T155A)]; lane 5, the flaAB mutant containing pBBR1MCS-5_flaB(S159/161A) [AB- pflaB(S159/161A)]; lane 6, the flaAB mutant containing pBBR1MCS-
5_flaB(S167/169A) [AB- pflaB(S167/169A)]; lane 7, the flaAB mutant containing pBBR1MCS-5_flaB(S159/161/167/169A) [AB- pflaB(4)]. 
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Figure 4.25 – Densitometry analysis of whole-cell Western blots to show the level of FlaB and 
site-directed mutant FlaB [FlaB(T155A); FlaB(S159/161A); FlaB(S1567/169A); 
FlaB(S159/161/167/169A)] present in normalised A. caviae flaAB mutant samples when 
expressed from the native flaB promoter in pBBR1MCS-5. The relative intensity of each site-
directed mutant flagellin is shown compared to wild type FlaB (n=4) ± the standard error of the 
mean. A one-way ANOVA, with a Tukey’s multiple comparisons test, was carried out on the 
data sets to compare the level of site-directed mutant FlaB in whole-cell samples to levels of 
wild type FlaB. **p = 0.001-0.009. ****p < 0.0001, ns = not significant. 
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EasyProt). Flagella were purified from an A. caviae flaAB mutant containing pBBR1MCS-
5_flaB(S159/161A), using the shearing method previously described and tryptically digested 
before being run on the maXisTM Q-TOF. The mutated FlaB amino acid sequence was uploaded 
as a database to EasyProt in order to analyse the MS/MS data. EasyProt analysis of the data 
suggested that when serine 159 and serine 161 are co-mutated to alanine residues, the new 
peptide,   146FQVGADANQTIGFALAQAGGFSISGIAK173, is still glycosylated, but only ever with one 
sugar. EasyProt detected the triply charged ion, m/z 1019.18, corresponding to this peptide 
modified with one sugar. This sugar can occupy any of the remaining serine or threonine sites 
(T155, S167 or S169), with a pseudaminic acid at serine 167 being the predominant glycoform. 
Although EasyProt estimated the most probable site of glycosylation due to the ions present in 
the MS/MS spectra, when these glycopeptides were manually analysed, specific sites of 
glycosylation could not be determined due to the preferential fragmentation of the sugar and 
the presence of too similar fragment ions in the MS/MS spectra. Serine 167 and 169 were not 
found to be modified at the same time in the mutant peptide, even to replace the preferred 
co-modification of serine 159 and 161 observed on the wild type peptide, which may indicate 
that this region is required for Maf1 docking to the flagellins. 
 When CID-MS/MS data was manually analysed, glycopeptides were recorded between 60-100 
minute retention times. The triply charged ion, m/z 1019.18, was recorded throughout 
(similarly to m/z 1135.3[3+] in the wild type flagellin spectra), with MS/MS spectra 
corresponding to the mutated FlaB peptide, [146-173], decorated with one pseudaminic acid 
residue. The doubly charged ion of this peptide containing one sugar, m/z 1528.27, was also 
observed. Furthermore, the triply charged ion, m/z 1026.51, was also frequently detected and 
found to be related to the glycosylated FlaB peptide, [146-173], due to the presence of similar 
peaks in the MS/MS spectra. Previously, it was observed that when wild type flagellin is 
analysed via CID-MS/MS, 146FQVGADANQTIGFSLSQAGGFSISGIAK173 can also be ionised by the 
addition of a sodium cation (section 4.2.2.2), and this is also likely to be occurring with the 
mutated peptide. If the mass of the mutated tryptic peptide containing one pseudaminic acid 
is 3054.5 Da, then the m/z value of the triply charged ion, ionised with two protons and a 
sodium cation, [M+2H+Na]3+, can be calculated: (3054.5+2+23)/3 = 1026.5. This m/z value was 
also predicted by Protein Prospector, showing that different ionised versions of the same 
glycopeptide can be present during CID-MS/MS, making analysis difficult. Moreover, another 
version of this peptide was also identified, with a triply charged ion of m/z 1025.5 being 
present. This was found to be related to the FlaB tryptic peptide, [146-173], due to common 
peaks from peptide fragmentation being present in the MS/MS spectra. As previously stated, 
the mass of this peptide containing one sugar is estimated at 3054.5 Da, and the mass of the 
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newly observed version of this peptide is 3073.5 Da [(1025.5 x 3)-3]. Therefore, a mass 
discrepancy of 28 Da is observed between these two related peptides, which is common with 
dimethylation. EasyProt identified this peptide as the dimethylated version of the FlaB [146-
173] peptide (modified with one pseudaminic acid), with the dimethyl being located at the 
terminal lysine (K 173). This is questionable however, as trypsin would be unlikely to cleave at 
a modified lysine residue. Therefore the cause of this mass discrepancy cannot be confirmed 
currently.  
The triply charged ion, m/z 1124.56, which would result from the ionisation of the FlaB tryptic 
peptide, [146-173], containing two pseudaminic acid residues, was never observed when CID-
MS/MS data was analysed manually. This therefore confirms the observation from EasyProt, 
that the mutated tryptic FlaB peptide, [146-173], is only ever decorated with one sugar.  
As with CID-MS/MS analysis of wild type flagellins, many unidentified glycopeptides were also 
present when mass spectrometric analysis of FlaB(S159/161A) was carried out, which 
possessed the diagnostic oxonium ions of pseudaminic acid (m/z 299.13 and 317.13) in their 
MS/MS spectra. This may therefore demonstrate the heterologous nature of A. caviae flagellin 
glycosylation.  
As expected, ions at m/z values: 851.7[4+], 1135.2[3+], 1029.7[3+], corresponding to the 
glycosylated wild type FlaB tryptic peptide, [146-173], (previously observed in section 4.2.2) 
did not elute from the mutant sample. However, more unexpectedly, the unidentified 
glycopeptide, observed throughout the wild type spectra at m/z 1154.2 [3+], was also not 
present in the mutant sample. This may show that this peptide is related to FlaB [146-173]. 
4.2.3.5 – Further Site-Directed mutagenesis of FlaB 
Although there is no consensus sequence for O-linked flagellin glycosylation to occur, unlike N-
linked glycosylation (Nothaft and Szymanski, 2013), a number of studies have recognised that 
the specific sites of glycosylation appear to occur in highly hydrophobic regions of the protein, 
suggesting there to be some selectivity to the glycosylation process (Schirm et al., 2003; 
Thibault et al., 2001). Thibault et al. (2001) observed that the sites of C. jejuni flagellin 
glycosylation were directly preceded by hydrophobic amino acids and Schirm et al. (2003) 
suggested glycosylation of certain serine/threonine residues in H. pylori may occur due to the 
local hydrophobicity surrounding the sites. These observations, and the lack of heterogeneity 
in the site of flagellin modification in a number of bacteria, therefore suggest partial selectivity 
in the glycosylation process. 
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The Kyte and Doolittle hydrophobicity plot in figure 4.26 (A) shows that the hydrophobic 
amino acids in FlaB are clustered in the D2/D3 domain. Values above zero on the kyte-doolittle 
scale indicates hydrophobicity, which can be visualised on this plot as peaks above zero and 
predominantly arises within the D2/D3 domain of the flagellin (Fig. 4.26 A). Furthermore, these 
regions of hydrophobicity are most commonly separated by serine or threonine residues, 
unlike the rest of the protein (Fig. 4.26 B). The sites of glycosylation identified here, on the FlaB 
tryptic peptide [146-173],  are surrounded by hydrophobicity, with the commonly, co-modified 
serine 159 and serine 161, being separated by a leucine residue. Furthermore, these serine 
residues are also flanked by hydrophobic residues (Fig. 4.26 B). Although serine 167 and 169 
are not found co-modified, they are individually targeted for glycosylation (from EasyProt 
analysis) and are separated by an isoleucine residue, as well as being flanked by hydrophobic 
regions (although not quite as hydrophobic as serine 159/161). The less commonly modified 
threonine 155 precedes a hydrophobic amino acid sequence; however, it is itself, preceded by 
acidic and polar amino acids (Fig. 4.26 B). This may indicate why the mutation of this residue is 
not detrimental to A. caviae motility and why the modification of this residue is not as 
common as the central serine residues.  
The hydrophobic amino acids, L160 and I168, separating the serine residues on the FlaB 
peptide [146-173], were targeted for site-directed mutational studies. The residues were 
individually mutated to the less hydrophobic and similarly sized amino acid, alanine. 
Furthermore, although the rest of the FlaB D2/D3 domain was not identified during mass 
spectrometric analysis (due to the size of the tryptic peptide), it was observed that there are 
two serine residues present here, also separated by a hydrophobic isoleucine residue and 
preceded by a region of hydrophobicity: serine 208 and serine 210. Due to speculation that 
these serine residues may be co-modified, with the glycosyltransferase recognising the local 
hydrophobicity and the hydrophobic iseoleucine separating these serine residues, they were 
co-mutated to alanine residues to analyse the effect of these mutations on A. caviae motility.
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Figure 4.26 – The presence of hydrophobic amino acids in the Aeromonas caviae Sch3 polar flagellin, FlaB. A. A kyte and Doolittle hydrophobicity plot displaying 
the hydrophobicity of the FlaB N-terminal domain (NTD), D2/D3 domain and the chaperone binding domain (CBD) (scored by the kyte-doolittle scale) B. The amino 
acid sequence of FlaB highlighting the location of the hydrophobic amino acids: F, I, L, M, P and V and the slightly hydrophobic amino acids, A and G.
A. 
B. 
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 FlaB site-directed mutants were created by overlap-extension PCR and cloned into 
pBBR1MCS-5 as previously described in section 4.2.3.2 (Table 4.2, mutants 5-7). Once created, 
the vectors were analysed in an A. caviae flaAB mutant, as described in section 4.2.3.3. Both 
the leucine 160 and isoleucine 168 point mutations individually had a detrimental effect on A. 
caviae motility. The mutant FlaB containing the leucine mutation (L160A), could not restore 
the motility of a flaAB mutant after 24 hours (Fig. 4.27 A), however, after 40 hours, impaired, 
speckled motility was observed, but could not be quantified due to the irregular halo 
formation (Fig. 4.27 B). This was observed with all three A. caviae transconjugants analysed. 
When the isoleucine FlaB mutant (I168A) was introduced into the A. caviae flaAB mutant, all 
three transconjugants analysed displayed inconsistent motility. Fig. 4.28 displays the motility 
of the same transconjugant during different technical repeats, after 24 hours. Motility was 
extremely inconsistent, and when it was observed, only minimal amounts of motility were 
present, showing the I168A mutation to have a serious, detrimental effect on the motility of A. 
caviae (Fig. 4.28). 
Furthermore, as observed with the previous double serine mutations (S159/161A & 
S167/169A), the co-mutation of serine 208 and 210 to alanine residues still complements the 
motility of a flaAB mutant; however, motility is drastically reduced when compared to the 
mutant containing the wild type flagellin (FlaB) (Fig. 4.29). A 50% reduction in motility was 
observed (Fig. 4.29). It is possible that glycosylation is targeted to serine/threonine residues 
that are surrounded by hydrophobicity, and in doing so counteracts this hydrophobicity 
allowing the formation of a fully functional flagellum. The reduced motility of the double 
mutant here, however, may be due to increasing the local hydrophobicity of this area of the 
D2/D3 domain (due to mutating two serine residues to alanine residues), and may not be due 
to reduced glycosylation of the area, as we currently do not have proof of which amino acids in 
this region are glycosylated. 
The FlaB site-directed mutant flagellins were also subjected to Western blot analysis. 
Normalised whole-cell Western blots were carried out (Chapter 2, section 2.7.3) of the flaAB 
mutant strains containing the site-directed mutant FlaB, were probed with both anti-
FlaA/B(+Pse) (recognises only glycosylated flagellin) and anti-FlaA/B (recognises both flagellin 
forms) (Fig. 4.30 A). All mutated flagellins were shown to be present in their glycosylated form 
[when probed with anti-FlaA/B(+Pse)], but only very low levels of FlaB(L160A) and FlaB(I168A) 
were detected, and these levels could not be detected in the whole-cell samples using anti-
FlaA/B that recognises both forms of the flagellins (Fig. 4.30 A). FlaB(S208/210A) was present   
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Figure 4.27 - Analysis of a FlaB L160A site-directed mutant in an A. caviae flaAB mutant. (A) 
Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae flaAB mutant 
(AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant containing 
pBBR1MCS-5_flaB(L160A) [AB- pflaB(L160A)] and a flaAB mutant containing empty 
pBBR1MCS-5 (AB- pBBR). Motility plates were incubated for 24 hours. (B) A close up of the 
impaired, speckled motility of the A. caviae flaAB mutant containing pBBR1MCS-5_flaB(L160A) 
[AB- pflaB(L160A)] compared to the non-motile flaAB mutant containing empty pBBR1MCS-5 
(AB- pBBR) after 40 hours incubation. 
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Figure 4.28 - Analysis of a FlaB I168A site-directed mutant in an A. caviae flaAB mutant. 
Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae flaAB mutant 
(AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant containing 
pBBR1MCS-5_flaB(I168A) [AB- pflaB(I168A)] and a flaAB mutant containing empty pBBR1MCS-
5 (AB- pBBR). Motility plates were incubated for 24 hours. Both (A) and (B) display the variable 
motility of the sample AB- pflaB(I168A) transconjugant during different biological replicates. 
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Figure 4.29 - Analysis of a FlaB S208/210A site-directed double mutant in an A. caviae flaAB 
mutant. (A) Swimming motility assays were carried out on 0.25% (w/v) agar of an A. caviae 
flaAB mutant (AB-), a flaAB mutant containing pBBR1MCS-5_flaB (AB- pflaB), a flaAB mutant 
containing pBBR1MCS-5_flaB(S208/210A) [AB- pflaB(S208/210A)] and a flaAB mutant 
containing empty pBBR1MCS-5 (AB- pBBR). (B) The radius of each motility halo was measured 
after 24 hours and average measurements are presented here (n=6) ± the standard error of 
the mean. A p value of < 0.0001 was generated when a paired t-test was carried out on the 
data sets. Here, the flaAB mutant containing pBBR1MCS-5_flaB(S208/210A) displays a 50% 
reduction in motility compared to the flaAB mutant containing pBBR1MCS-5_flaB.
p < 0.0001 
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Figure 4.30 – Western blot analysis of Aeromonas caviae whole cell samples (A), and supernatant samples (B). Both samples from A and B were probed with a 
rabbit, anti-polar flagellin antibody that recognises only glycosylated flagellin [anti-FlaA/B(+Pse)] and a mouse, anti-polar flagellin antibody that recognises both 
glycosylated and unglycosylated forms of flagellin (anti-FlaA/B). In each case: lane 1, the A.caviae flaAB mutant (AB-); lane 2, the flaAB mutant containing 
pBBR1MCS-5_flaB (AB- pflaB); lane 3, the flaAB mutant containing empty pBBR1MCS-5 (AB- pBBR); lane 4, the flaAB mutant containing pBBR1MCS-5_flaB(L160A) 
[AB- pflaB(L160A)]; lane 5, the flaAB mutant containing pBBR1MCS-5_flaB(I168A) [AB- pflaB(I168A)]; lane 6, the flaAB mutant containing pBBR1MCS-
5_flaB(S208/210A) [AB- pflaB(S208/210A)]. 
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in whole-cell samples in comparable amounts to the wild type (Fig. 4.30 A). In addition, 
Western blots of supernatant samples were carried out to analyse the export of these mutated 
flagellins (Fig. 4.30 B). As expected, FlaB(S208/210A) was found to be present in supernatant 
smaples (Fig. 4.30 B). Furthermore, even though FlaB(L160A) and FlaB(I168A) caused impaired, 
inconsistent motility in A. caviae, glycosylated flagellins were still found to be exported  but 
only in small amounts (Fig. 4.30 B). Although these samples could not be normalised due to the 
inconsistent precipitation of proteins, it is likely that these proteins are present in smaller 
amounts due to the levels observed in whole-cell samples (Fig. 4.30). Additionally, the 
detection of these mutated flagellins in supernatant samples with the anti-FlaA/B antibody, 
shows that these mutations do not affect antibody recognition of these proteins and that 
extremely low protein levels are why this antibody could not detect these mutated proteins in 
whole-cell samples (Fig. 4.30). 
The flagella shearing method was carried out in an attempt to purify glycosylated FlaB(L160A) 
and FlaB(I168A) for mass spectrometry analysis. Only very small amounts of flagella could be 
pelleted in each case by this method. Samples were tryptically digested and run on the 
maXisTM Q-TOF for CID-MS/MS analysis of the samples, however, no glycopeptides could be 
detected via manual analysis and EasyProt detected limited peptides for each mutant. 
Therefore, analysis of the glycosylation of these flagellins could not be carried out due to being 
unable to obtain sufficient amount of protein. This, however, could indicate that although 
these mutated flagellins are still glycosylated and exported, these mutations may have a 
severe effect of flagellar assembly, or export, and may be the reason for the lack of flagella 
pelleted during the shearing method of flagellin purification. 
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4.3 – Discussion 
Here, CID-MS/MS was chosen to analyse A. caviae Sch3 flagellin glycosylation, as the manual 
analysis of the data acquired could be complemented with EasyProt analysis (Gluck et al., 
2013). However, many difficulties were faced when working with the flagellins, as trypsin 
digestion of the D2/D3 domain (the glycosylated region of interest) resulted in large, heavy, 
tryptic peptides, making analysis of this region problematic. This is likely to be why only the 
smallest tryptic peptide, FlaB [146-173], could be identified from this region. Furthermore, 
there are also many limitations of using CID as the fragmentation method when working with 
glycopeptides. Although the diagnostic ions of the sugar can be seen in the MS/MS spectra 
allowing identification of glycopeptides, the sugar is preferentially fragmented, resulting in 
large peaks in the MS/MS spectra corresponding to pseudaminic acid and very small peaks 
corresponding to the rest of the peptide (such as y and b ions). This therefore makes analysis 
of the specific site of glycosylation challenging. Despite these difficulties, manual analysis of 
CID-MS/MS spectra concluded that flagellins from an A. caviae maf1 mutant are not 
glycosylated, due to the lack of pseudaminic acid oxonium ions in the MS/MS spectra (Parker 
et al., 2014), providing further support to the findings in Parker et al. (2012), that Maf1 is the 
flagellin-specific glycosyltransferase. 
Further manual analysis of wild type A. caviae flagellins by CID-MS/MS demonstrated that 
many glycopeptides are present in a sample, although the majority could not be designated a 
peptide sequence due to the limitations of CID-MS/MS. Some eluted multiple times, whereas 
others were only detected once; which may show the heterogeneity of A. caviae flagellin 
glycosylation. One glycopeptide was confidently identified from FlaB: 
146FQVGADANQTIGFSLSQAGGFSISGIAK173; however, analysis of this single glycopeptide was 
extremely complex due to several glycoforms being present and the ionisation of the peptide 
with sodium cations also being a possibility. It was observed that this peptide can be 
glycosylated with either one or two pseudaminic acid residues; with EasyProt data analysis 
suggesting that the site of modification can vary on the peptide. This was confirmed with 
manual annotation of the MS/MS spectra, however glycosylation of the two central serine 
residues (Serine 159 and 161) was detected most frequently. This peptide was never found in 
its unmodified form in wild type flagellin samples, suggesting that the glycosylation of this 
D2/D3 domain peptide in particular, is essential for the formation of a functional flagellar 
filament. This was also hinted at with site-directed mutagenesis studies, where serine and 
threonine residues on this FlaB peptide were mutated to alanine residues.  
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A FlaB T155A mutation had no detrimental effect on A. caviae motility and was found to be 
present in comparable amounts to wild type FlaB in the whole-cell. However, the double 
mutations at: S159/161A and S167/169A, caused a significant decrease in A. caviae motility, 
and a lower level of flagellin was found to be present in the whole-cell. This may show that 
these mutant flagellins are more readily degraded, maybe due to their less efficient 
polymerisation, or they are perhaps less stable compared to the wild type flagellins. 
Alternatively, this region of FlaB, at the beginning of the D2/D3 domain, may be important for 
Maf1 docking to the flagellin, and when mutated may lead to the less efficient glycosylation of 
flagellins by Maf1, which may be having an effect on flagellation, and therefore, motility. 
Mass spectrometric analysis of the mutated flagellin, FlaB(S159/161A) uncovered that the 
mutated FlaB [146-173, S159/161A] peptide is still glycosylated, but only ever with a single 
sugar. Here, pseudaminic acid had the ability to occupy any of the remaining serine and 
threonine sites, with serine 167 being identified as the most frequently glycosylated site on 
this peptide by EasyProt. It is therefore possible that the decreased A. caviae motility observed 
when only this mutated flagellin is present, may be due to the flagella formed having a 
decreased hydrophilicity, and therefore impaired ability to move through an aqueous 
environment. In addition, it has previously been noted that unglycosylated flagellin is 
recognised less by the chaperone, FlaJ (Parker et al., 2014). Therefore, reduced flagellin 
glycosylation may lead to reduced recognition of the flagellins by FlaJ, leading to decreased 
flagellin export and therefore filament polymerisation. However, there is also less protein 
present within the bacterial whole-cells which may be affecting flagellar assembly and filament 
length. On the other hand, a slight decrease in glycosylation levels may cause the formation of 
more delicate flagella that are readily broken, causing impaired motility compared to when 
wild type FlaB is present. Site-directed mutagenesis studies of the 19 sites of glycosylation in C. 
jejuni have also shown specific glycosylation sites to have an impact on motility, where the 
individual mutation of three serine residues in particular (in C. jejuni 81-176) caused the 
formation of truncated flagellar filaments and therefore reducing bacterial motility (Ewing et 
al., 2009). Furthermore, the modification of other sites were also shown to be crucial for the 
autoagglutination behaviour of C. jejuni which demonstrates that different glycosylation sites 
may play a different role in bacterial behaviour (Ewing et al., 2009).   
Impaired motility is also observed when the mutated flagellin, FlaB(S167/169A), is the only 
flagellin present. The two mutated residues here were never found to be co-modified in wild 
type flagellin samples, and therefore it is likely that the serine residues, 159 and 161, are still 
the predominantly modified residues on the FlaB peptide [146-173, S167/169A]. As impaired 
motility is also seen with the co-mutation of these residues, it is possible that this 
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phenomenon is not related to flagellin glycosylation, but occurs due to the increased 
hydrophobicity of the peptide (from mutating serine to alanine) resulting in an overall increase 
in the hydrophobicity of the polar flagellum. This may lead to less favourable interactions with 
the aqueous environment. Alanine is only slightly hydrophobic and can exist in all 
environments, so is unlikely to have drastic effects on flagellar function, which may be why 
these mutant flagellins still produce functional flagella, and only display slightly impaired 
motility. However, again, the point mutations here may also have an effect on the stability or 
the overall form of the flagella, compared to flagella polymerised from wild type flagellin. 
When all four serine residues on this peptide (159, 161, 167, 169) were mutated to alanine 
residues, although glycosylated flagellin was still detected both in whole-cell and supernatant 
samples, motility of an A. caviae flaAB mutant could not be restored. This quadruple mutant 
flagellin was found to be smaller than the wild type and other site-directed mutant flagellins, 
due to a clear size-shift being detected via Western blot analysis. This suggests that the 
glycosylation status of this flagellin differs to that of the wild type and that these sites are 
unequivocally the target of Maf1 glycosylation. Furthermore, the size of this flagellin also 
demonstrates that when this region of the protein cannot be glycosylated and that the 
glycosylation status is not made up for with the modification of other serine/threonine 
residues. This further indicates, for unknown reasons, that the glycosylation of this peptide is 
essential for motility. The D2/D3 domain is situated in the centre of the primary amino acid 
sequence of the flagellin, but folds in order to form the flagellar surface once polymerised into 
a filament (Fig. 4.31). Figure 4.31 displays the predicted folding of FlaB and the location of the 
serine and threonine residues on FlaB peptide [146-173]. It is possible that the mutation of 
these residues may result in the improper folding of the flagellin, or these flagellins may 
polymerise differently to the wild type flagellins, and be the reason for the impaired and non-
motile phenotypes visualised here (although a FlaB T155A mutation appear to increase A. 
caviae motility, not have a detrimental effect on motility). 
As serine residues, 159 and 161, were found to be the most frequently modified sites on FlaB 
peptide [146-173], and the site-directed mutagenesis of these residues (S159/161A) did not 
result in the co-modification of the neighbouring serine 167 and 169 residues, it is likely S159 
and S161 are the preferred sites of modification. A consensus sequence for O-linked flagellin 
glycosylation has never been identified, but it is intriguing as to why these two sites are 
predominantly glycosylated over the other three sites of glycosylation available on this 
peptide, suggesting there to be some selectivity to the glycosylation process.   
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Figure 4.31 – Predicted Aeromonas caviae Sch3 FlaB folding, generated using the Phyre2 server and analysed using Jmol software. The structure is based on the 
phase 1 flagellin from Salmonella enterica (Accession: 1UCU_A) (Mimori et al., 1995). The predicted locations of the serine and threonine residues on the FlaB 
peptide [146-173] (T155, S159, S161, S167, S169), are also shown. 
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Previous studies into bacterial O-linked flagellin glycosylation have suggested that local regions 
of hydrophobicity may play a role in glycosyltransferase selection of these residues (Schirm et 
al., 2003; Thibault et al., 2001). In particular, Thibault et al. (2001) identified hydrophobic 
amino acid sequences preceding their identified sites of flagellin modification in C. jejuni. 
Hydrophobic amino acids are also focused in the D2/D3 domain of A. caviae flagellins, 
preceding the serine residues 159 and 161, and the serine 167 and 169 residues. However, 
hydrophobic amino acids are not preceding threonine 155, which may show that this residue is 
not the desired target for the glycosyltransferase and be why mutation of this residue does not 
impair motility. Furthermore, the double serine residues on this peptide are both separated by 
hydrophobic amino acids, which led to the selection of leucine 160 and isoleucine 168 for 
further site-directed mutagenesis studies (L160A and I168A). Both mutations resulted in 
severely reduced A. caviae motility compared to when wild type FlaB was present, and only 
very low levels of these proteins were detected in whole-cell and supernatant samples. It is 
therefore possible that these mutated proteins are readily degraded, or less stable than their 
wild type counterparts. The substitutions, L160A and I168A, may also result in decreased 
hydrophobicity on the FlaB [146-173] peptide of the D2/D3 domain, which may result in an 
impaired ability for Maf1 to bind this region of the flagellin, resulting in the reduced motility 
seen. However, these flagellins were still found to be glycosylated, the glycosylation status of 
which did not appear to differ drastically from that of the wild type flagellin when analysed via 
Western blot analysis, showing that Maf1 is still able to identify and modify these flagellins.  It 
is also possible that the mutations present may affect the ability of these flagellins to be 
secreted, or affect the folding of FlaB, having an effect on flagellar assembly. When purification 
of these mutant flagellins was attempted for mass spectrometry analysis, only small amounts 
of flagella could be isolated by the methods used here, further indicating that these mutations 
affect flagellar assembly.  
As the serine residues identified on the FlaB peptide [146-173] (S159/161 and S167/169) are 
separated by a hydrophobic isoleucine or leucine residue, it was speculated that similar sites 
may be targeted by Maf1 for modification within the rest of the FlaB D2/D3 domain. 
Therefore, S208 and S210, separated by an isoleucine residue, were co-mutated to alanine 
residues which resulted in significantly reduced motility in an A. caviae flaAB mutant. 
However, the level of flagellins present, and their glycosylation status, appeared to be 
comparable to the wild type when investigated by Western blot analysis. If these residues are 
modified in wild type FlaB, it is possible that their co-mutation cause the site of modification to 
move to another residue, as serine 201 and 203 are located close upstream. This could not be 
explored, however, as the tryptic peptide on which these residues are located, was not 
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observed during CID-MS/MS.  With regards to the local hydrophobicity of this region of the 
D2/D3 domain, it is possible that not only serine 208 and 210 are modified, but also the double 
serine residues upstream (S201/203). There residues are surrounded by more local 
hydrophobicity and may suggest that these are the preferred glycosylation sites of Maf1.  
Although there is no consensus sequence for O-linked glycosylation, it is tempting to speculate 
that these local regions of hydrophobicity within the D2/D3 domains of the flagellins, may 
guide the glycosyltransferase, Maf1, to the preferred residues for modification, allowing more 
frequent glycosylation of these residues and the production of a polar flagellum functioning at 
its optimum. As this is not a fixed consensus sequence, it indicates the modification process to 
be flexible, permitting other residues to also be modified, although less commonly. 
To continue on from these studies, future work could concentrate on exploring the flagella 
structures formed by these mutant flagellins (if any are formed at all), as motility can be 
affected by a number of factors such as the amino acid sequence, pH and temperature, which 
can alter the flagellar wave formation (Turner et al., 2000). In addition the regions of flagellins 
important for Maf1 docking could be explored, by carrying out Maf1 binding affinity studies to 
different flagellin regions, as the mutations carried out here may be altering how Maf1 
recognises and modifies the flagellins (please see the short-term perspectives in Chapter 6, the 
general discussion). 
Another post-traslational modification, methylation, was also detected on lysine residues on 
both A. caviae flagellins (FlaA/B). Methylation is important in biological systems for a number 
of processes, such as regulation of gene expression or protein activity. This modification did 
not appear to be essential for flagellar formation and motility, however, as the methylated 
peptides were also identified in their unmodified forms. This is not the first time that 
methylation has been identified on bacterial flagellins, as S. oneidensis flagellins have also 
been found to be methylated on at least five lysine residues on the dominant flagellin, FlaB 
(Bubendorfer et al., 2013; Sun et al., 2013). The role of flagellin methylation in S. onedensis is 
unclear, however, mutation of the putative methyltransferase had no effect on bacterial 
motility (Sun et al., 2013). Although not associated with the genetic loci for polar flagellum 
biogenesis, a putative methyltransferase has been identified in the lateral flagellar operon in A. 
caviae Sch3; however mutation of this gene had no effect on swimming motility (Shaw, 
unpublished). It is possible that if this putative methyltransferase is associated with modifying 
the lateral flagellar system, there may be some cross-talk between the polar and lateral 
systems, resulting in the methylation of the polar flagellins also. Although methylation may not 
have a role in A. caviae motility, its presence does highlight the future difficulties that could be 
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faced when further characterising A. caviae flagellin glycosylation by mass spectrometric 
methods. Not only may different peptide glycoforms be present (as observed with the FlaB 
peptide [146-173]), but also other modifications such as methyl groups. This may be why such 
a large number of glycopeptides identified during CID-MS/MS could not be assigned a peptide 
sequence here. 
The biological role of flagellin glycosylation is still to be determined, however, the function 
may be unique to the individual bacterium itself. For example, the ability of Camplylobacter 
species to modify their flagellins with a variety of nonulosonate sugars, may aid the bacterium 
in different circumstances. The presence of pseudaminic acid is essential for Campylobacter 
flagellation; however, the presence of other sugars, such as legionaminic acid in C. jejuni on 
the hypermotile strain 11168H (Howard et al., 2009), is not required for motility, but is 
required for certain behaviours of this bacterium. C. jejuni (11168H) unable to produce 
legionaminic acid to decorate their flagella showed reduced ability to form biofilms and 
colonise chickens, demonstrating this sugar is important for the colonisation and persistence 
of this species (Howard et al., 2009). 
Furthermore, H. pylori has a sheathed polar flagellum (Geis et al., 1993) and so the 
modification of the filament surface is unlikely to aid interactions with the environment. 
Furthermore, H. pylori flagellins have been shown to evade TLR-5 recognition by the host’s 
innate immune system, due to changes in the conserved sequences of the D0 region of the 
flagellin (Gewirtz et al., 2004), and so glycosylation is not required for host immune evasion. 
Therefore, glycosylation may have a different role here, although explanations for why this 
modification is involved in flagellation, and consequently virulence, have not yet been 
explored. 
It is now becoming clear that flagellin glycosylation is more widespread than originally 
believed, with reports of Gram- positive bacteria also modifying their flagella. Some are able to 
glycosylate their flagellins with nonulosonic acids, such as C. botulinum, where it is clear that 
the presence of these sugars play a role in pathogenicity, as strains isolated from infant 
botulism patients were more frequently found to modify their flagella with nonulosonic acids 
compared to strains that did not cause disease (Twine et al., 2008). Furthermore, although C. 
difficile flagellins are not modified with nonulosonic acids, their modification with N-
acetylglucosamine has been found to be essential for flagellation (Twine et al., 2009). Recent 
work by Faulds-Pain et al. (2014), whereby the glycan at the C. difficile flagellar surface was 
altered, has demonstrated that motility is not essential for colonisation, but the specific 
structure of the sugar is. C. difficile glycan-structural mutants displayed a reduced ability to 
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colonise a mouse model of infection compared to the wild type strain (Faulds-Pain et al., 
2014). Furthermore, some mutants exhibited altered behaviours, such as motility defects and 
increased cellular aggregation (Faulds-Pain et al., 2014). 
Likewise, the non-pathogenic microorganism, S. onedensis, also requires glycosylation for 
flagellar assembly (Bubendorfer et al., 2013; Sun et al., 2013), and site-directed mutagenesis 
studies on the dominant flagellin FlaB have demonstrated that each glycosylation site 
contributes towards flagellar function, with the modification of one site in particular being 
critical for the motility of S. oneidensis (Sun et al., 2013). Therefore this modification is not only 
utilised by pathogenic bacteria, but contributes to the bacterial colonisation of a variety of 
environments. 
There are also a number of bacteria that are able to glycosylate their flagellins but do not 
require this modification for flagellar formation and motility; although, it is clear that this 
modification aids bacterial colonisation and virulence. For example, P. syringae, a tobacco 
plant pathogen, is able to O-glycosylate its flagellins with modified rhamnose residues 
(Takeuchi et al., 2003), and although this is not essential for swimming and swarming motility, 
glycosylation mutants have a decreased ability to adhere to surfaces and cause disease in the 
plant (Taguchi et al., 2006). Site-directed mutagenesis studies have revealed that sites of 
modification located on the surface of the flagellum are more essential for bacterial virulence, 
than sites located away from this area (Taguchi et al., 2006). However, the individual site-
directed mutagenesis of the known sites of modification were all found to impair motility, 
compared to when optimum levels of flagellin glycosylation are present (Taguchi et al., 2010). 
The role of glycosylation has been explored here and glycosylated flagellins have been found 
to polymerise into a more stable flagellum, being more heat resistant that the unglycosylated 
equivalent (Taguchi et al., 2009). Furthermore, it is thought this stability may aid evasion of 
host defences, as the host immune system (TLR-5) recognises an N-terminal region of the 
flagellins (Andersen-Nissen et al., 2005), so once polymerised, this N-terminal region is hidden. 
The unglycosylated monomer and polymerised flagellins, and glycosylated monomer flagellins, 
displayed increased interactions with the host immune system, leading to increase apoptosis, 
compared to the glycosylated, polymerised flagellins (Taguchi et al., 2009). This indicates that 
the increased stability of the glycosylated flagellum may aid immune evasion by preventing 
flagellum breakdown and exposure of flagellin N-terminal regions (Taguchi et al., 2009). 
Similarly to P. syringae, P. aeruginosa strains do not require glycosylation for flagellation, but 
are still capable of O-linked flagellin glycosylation, with type ‘a’ strains glycosylating with 
rhamnose-linked oligosaccharides (extremely heterologous sugars) and type ‘b’ strains 
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modifying with less heterologous hexose residues linked to an undermined 209 Da mass 
(Schirm et al., 2004; Verma et al., 2006). It has been demonstrated that glycosylation in this 
case may also be involved in virulence, as strains were found to be more virulent in a burned 
mouse model of infection compared to strains that did not glycosylate (Arora et al., 2005). 
Furthermore, instead of to evade the host defences, flagellin glycosylation here may actually 
enhance bacterial interactions with the host immune system, as unglycosylated P. aeruginosa 
flagellins were found to have a reduced ability to stimulate the release of IL-8 (in the human 
lung cancer cell line, A549) (Verma et al., 2005). This may be why hyper-inflammation is usually 
present in P. aeruginosa respiratory infections, especially in cystic fibrosis patients. 
These studies therefore show the importance of flagellin modification to a wide variety of 
bacteria and the potential different roles of glycosylation in each case.  
A number of the bacteria discussed here require flagellin modification for the assembly of 
polar flagella, and are capable of colonising the gastrointestinal tract, causing human disease 
(Aeromonas, Campylobacter and Helicobacter). It is intriguing as to why these polar flagellated 
microorganisms require this modification, whereas other gut pathogens such as, E. coli and 
Salmonella (that possess peritrichous flagella) do not. It is already well established that flagella 
contribute towards adhesion to host cell and colonisation (Haiko and Westerlund-Wikstrom, 
2013), so it may be that glycosylated flagella allow bacteria that possess only polar flagella in 
this gastrointestinal environment to compete with other pathogenic microorganisms. The 
mass spectrometry and site-directed mutagenesis work carried out in this chapter suggests 
that the A. caviae Sch3 flagellum can be created from a variety of flagellin glycoforms, with 
some sites of glycosylation being preferred and occupied more frequently, suggesting partial 
selectivity (likely due to regions of local hydrophobicity) in Maf1 selection of modification sites. 
Site-directed mutagenesis studies have suggested that optimal flagellar function may not be 
possible with the elimination of certain glycosylation sites, and therefore the removal of 
certain flagellin glycoforms. This may show that flagella are made up of a variety of flagellin 
glycoforms that allow efficient motility through aqueous environments and the production of 
favourable interactions with host cell surfaces. 
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Chapter 5: Investigations into Maf1 dependent polar 
flagellin glycosylation 
 
5.1 – Introduction 
Limited studies have been carried out on O-linked glycosylation, compared to N-linked protein 
glycosylation in bacteria. In Gram-negative bacteria, N-linked glycosylation requires the 
oligosaccharide to be synthesised on the cytoplasmic side of the inner membrane before it is 
flipped across the cytoplasmic membrane into the periplasm, via the action of a flippase 
enzyme. The glycan is then passed onto a periplasmic oligosaccharyltransferase and 
subsequently transferred onto the target protein; much of this knowledge comes from studies 
on the N-linked glycosylation process in Campylobacter jejuni (Baker et al., 2013; Nothaft and 
Szymanski, 2010; Nothaft and Szymanski, 2013). Similar events also take place with some O-
linked protein glycosylation pathways, such as pilin glycosylation in Pseudomonas and 
Neisseria species (see Chapter 1); however, the O-linked glycosylation described in this thesis, 
with the transfer of nonulosonic acids onto flagellin monomers, requires a flagellin specific 
glycosyltransferase to transfer the sugar directly onto the target protein. The Maf proteins are 
putative flagellin glycosyltransferases that have been identified in a number of bacteria (Canals 
et al., 2007; Karlyshev et al., 2002; Parker et al., 2012; Schirm et al., 2003), however, very little 
is known about their mechanism of action. Furthermore, prior to the studies carried out here 
(and by other members of the Shaw group), it was unknown as to where in the flagellar 
assembly pathway that glycosylation actually occurred. Some of the studies carried out in this 
chapter were in conjunction with Dr Jennifer Parker and contributed towards  Parker et al. 
(2014), where the location of flagellin glycosylation was assessed. 
Exploring out how specific these glycosyltransferase enzymes are (ie. the Maf proteins) and 
identifying where in the flagellar assembly pathway they actually carry out their function, 
would allow us to begin understanding these novel proteins, which could potentially be an 
antimicrobial target in the future as they play such an essential role in the virulence of a 
number of pathogens. Furthermore, these studies would also give a good indication as to 
whether these proteins would be of use for industrial or pharmaceutical applications in the 
future. For example, currently the N-linked bacterial protein glycosylation system (C. jejuni 
system reconstituted in E. coli) is being manipulated for eukaryotic protein glycosylation (for 
the production of therapeutic glycoproteins); however, these proteins first have to be targeted 
to the periplasm of the bacterium before they can be glycosylated, and then they have to be 
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isolated (Baker et al., 2013). Therefore, simpler methods for therapeutic protein glycosylation 
would be useful. 
The aim of the work carried out in this chapter was to contribute towards investigating where 
in the flagellar assembly pathway glycosylation occurs, by carrying out interaction studies with 
proteins of the flagellar assembly pathway, and analysing whether the polar flagellar cap 
protein, FlaH, is required for flagellin glycosylation. FlaH, which is known as FliD in Escherichia 
coli and Salmonella, is required for the formation of the flagellar filament, and for 
incorporating the flagellins into the growing filament (Yonekura et al., 2000). When deleted, 
flagellin monomers are exported into the supernatant, but are not incorporated into a 
functional filament, rendering bacteria non-motile (Yonekura et al., 2000). However, in A. 
caviae the glycosylation status of these exported flagellins is unknown [results have now been 
published in Parker et al. (2014)]. 
In addition, flagellin D2/D3 domain swapping studies, from other Aeromonas strains, were also 
undertaken to begin assessing the specificity of the glycosyltransferase, Maf1, from A. caviae 
(Chapter 1, figure 1.3). Furthermore, investigations were also carried out to examine whether 
A. caviae is a good model of flagellin glycosylation for the heterologous study of H. pylori 
glycosylation proteins. H. pylori possesses two Maf proteins (referred to as Maf1 and Maf2 
here), however it only glycosylates its polar flagella with pseudaminic acid, similarly to A. 
caviae Sch3 (Josenhans et al., 2002; Schirm et al., 2003). Why two Maf proteins are present in 
H. pylori is unknown, however as A. caviae is genetically amenable and possesses the simplest 
system currently known for O-linked flagellin glycosylation (Tabei et al., 2009), it may be a 
useful tool for the study of the H. pylori flagellin glycosylation pathway. 
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5.2 – Results 
5.2.1 – Interaction studies of the proteins of the Aeromonas caviae polar flagellum 
The bacterial adenylate cyclase two-hybrid (BACTH) system (EUROMEDEX) was utilised to 
explore the protein interactions between the polar flagellar proteins of A. caviae Sch3 in a non-
glycosylating system (E. coli BTH101) (Fig. 5.1). E. coli BTH101 is an adenylate cyclase mutant 
(cyaA-) and is unable to ferment lactose. Each gene of interest was cloned into the four vectors 
of the BACTH system to tag each protein with one of the two domains of adenylate cyclase 
(CyaA), T18 or T25 (Fig. 5.2). Cloning into all four BACTH vectors allowed the proteins to be 
tagged at either their N or C termini with both domains (Fig. 5.2). Protein interactions could 
then be assessed in vivo, whereby any protein interactions taking place would bring together 
the two domains of adenylate cyclase, triggering a rise in the second messenger, cyclic 
adenosine monophosphate (cAMP) (Fig. 5.1 A). The second messenger is then able to bind to 
the transcriptional activator, CAP (catabolite gene activator protein) and switch on target 
operons, such as the maltose or lactose operons (Fig. 5.1 A). Here, interaction studies were 
carried out on MacConkey agar supplemented with 1% maltose, to allow E. coli BTH101 to 
utilise maltose in the instance of a protein interaction. Bacterial colonies able to utilise maltose 
appeared purple on the agar due to a change in pH being detected on the agar from maltose 
fermentation (Fig. 5.1 B). 
5.2.1.1 – Generation of the Bacterial two-hybrid system vectors 
The A. caviae Sch3 genes of interest: flaA, flaA-CBD (flaA minus the chaperone binding 
domain), flaA-D2/D3 (flaA minus the D2/D3 domain) (Chapter 1, figure 1.3), flaB, flaJ and 
maf1, were individually cloned into all four BACTH vectors (Fig. 5.2). The genes were amplified 
using the Expand high fidelity PCR system (Roche) (Chapter 2, section 2.6.2.1) using A. caviae 
Sch3 genomic DNA as the template.  Two PCR reactions were set up for each gene to produce 
one fragment compatible for insertion into pUT18 and pKNT25, and the other fragment for 
insertion into pUT18C and pKT25. The primers used and the expected size of the PCR product 
in each case are specific in table 5.1. Once the correct sized PCR products were obtained, the 
gene fragments were ligated into pGEM-T EASY (as in Chapter 3, section 3.2.3), which were 
subsequently transformed into chemically competent E. coli DH5  and plasmids purified from 
the resulting transformants. The presence of correct sized inserts was checked with EcoRI 
restriction digests of pGEM-T EASY (as in Chapter 3, section 3.2.3), and the presence of the 
desired genes was confirmed by sequencing using T7 forward and SP6 reverse primers. 
Fragments were engineered with BamHI and EcoRI restriction sites at their 5’ and 3’ ends  
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Figure 5.1 – (A) The principle of the bacterial two-hybrid system, where proteins of interest, 
tagged with the domains of adenylate cyclase (CyaA) (T18 and T25), are expressed in a non-
lactose fermenting strain of E. coli (BTH101). The different domains of CyaA are brought 
together if an interaction occurs, causing the levels of cAMP in the cell rise and bind to the 
catabolite gene activator protein (CAP). CAP then binds to target promoters and switches on 
gene expression. (B) The appearance of E. coli BTH101 colonies on MacConkey agar once 
cotransformed with the bacterial two-hybrid vectors. Yellow colonies occur when no 
interactions take place between the proteins of interest; however, if an interaction occurs, 
purple colonies result due to the pH that occurs when E. coli is able to ferment maltose.  
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Gene Primers for insertion into pUT18 and 
pKNT25 
Primers for insertion into pUT18C and 
pKT25 
flaA JLP_39 (F) & JLP_53 (R) 
(930 bp) 
JLP_39 (F) & JLP_40 (R) 
(933 bp) 
flaA-CBD JLP_39 (F) & RCL_01 (R) 
(703 bp) 
JLP_39 (F) & RCL_02 (R) 
(701 bp) 
flaA-
D2/D3 
OE-PCR was used first to create flaA-
D2/D3 domain: 
Fragment 1 – JLP_39 (F) & RCL_17 (R) 
Fragment 2 – RCL_18 (F) & JLP_53 (R) 
 
JLP_39 (F) & JLP_53 (R) were then 
used to amplify the whole PCR 
product. 
(673 bp) 
OE-PCR was used first to create flaA-
D2/D3 domain: 
Fragment 1 – JLP_39 (F) & RCL_17 (R) 
Fragment 2 – RCL_18 (F) & JLP_40 (R) 
 
JLP_39 (F) & JLP_40 (R) were then 
used to amplify the whole PCR 
product. 
(672 bp) 
flaB JLP_47 (F) & JLP_47 (R) 
(927 bp) 
JLP_47 (F) & JLP_48 (R) 
(930 bp) 
flaJ JLP_41 (F) & RCL_20 (R) 
(432 bp) 
JLP_41 (F) & RCL_21 (R) 
(435 bp) 
maf1 JLP_79 (F) & JLP_50 (R) 
(2097 bp) 
JLP_79 & JLP_44 (R) 
(2100 bp) 
 
Table 5.1 – Summary of the primers used to amplify the genes of interest for insertion into the 
bacterial two-hybrid vectors. Spliced overlap-extension PCR (OE-PCR) was used to generate 
flaA-D2/D3. Please refer to Chapter 2 table 2.6 for the details of the primers. 
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respectively. Therefore once confirmed, the genes of interest were excised from pGEM-T EASY 
using these restriction enzymes, and then ligated into the corresponding BamHI and EcoRI 
digested BACTH vector (table 5.1). Ligations were then transformed into E. coli DH5  and 
selected for on agar plates containing appropriate antibiotics (pUT18/pUT18C on ampicillin; 
pKT25/pKNT25 on kanamycin). BACTH vectors were then purified from the resulting 
transformants, digested with BamHI to linearise, and the presence of the correct gene 
confirmed on an agarose gel (when compared to empty, linearised BACTH vectors) (as in 
Chapter 3, section 3.2.3).  
5.2.1.2 – Interaction studies 
Interaction studies were carried out with the recombinant plasmids generated (Chapter 2, 
table 2.2). Briefly, pUT18 or pUT18C (containing gene) was cotransformed into E. coli BTH101 
with pKT25 or pKNT25 (containing gene), and plated onto MacConkey agar supplemented with 
maltose. Table 5.2 displays all of the interaction studies carried out, which also included 
testing for the self-interaction of each protein. All of the necessary negative controls were 
carried out with empty BACTH vectors, and the positive controls were supplied with the 
Euromedex BACTH system kit. If the proteins of interest interacted, co-transformed E. coli 
BTH101 formed bright purple colonies on the MacConkey agar; whereas if no interaction 
occurred, yellow colonies formed (Fig. 5.1 B). At least three biological repeats were carried out 
for each interaction tested, and up to five were carried out in the case of inconsistent 
interactions (where the majority of time an interaction was observed, although sometimes 
negative results also detected or if the colonies were only marginally purple).  
No self-interactions, interactions between the flagellins (FlaA and FlaB), or interactions 
between the flagellins and the flagellin-specific chaperone (FlaJ), were detected using the 
BACTH system. However, Maf1 was found to interact, either consistently (+) or inconsistantly 
(+/-) with FlaA when tagged at the C-terminus with the T25 fragment of CyaA, or at both the N 
or C-termi with the T25 fragment (with FlaA tagged at both termini with the opposite CyaA 
fragment) (Table 5.3). Furthermore, interactions were also detected between Maf1 (+ or +/-) 
and FlaB, when Maf1 was tagged at the C-terminus with T25 (FlaB with T18 at either terminal 
region, similarly to FlaA) (Table 5.3). However, no interactions between Maf1 and FlaB were 
detected here when Maf1 was tagged at the N-terminus with either CyaA domain. The 
inconsistent results seen here between Maf1 and flagellin interactions may be due to 
unglycosylated flagellin from A. caviae Sch3 being highly insoluble [as observed in Parker et al. 
(2014)].  Interactions were also assessed when the chaperone binding domain and the D2/D3 
region of FlaA were deleted (Chapter 1, figure 1.3). Maf1 was found to strongly interact (+)  
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Plasmid 1 Plasmid 2 Expected Phenotype? 
pUT18_geneA 
pUT18_geneA 
pUT18C_geneA 
pUT18C_geneA 
pKT25_geneA 
pKT25_geneA 
pKNT25_geneA 
pKNT25_geneA 
pKT25_geneA 
pKNT25_geneA 
pKT25_geneA 
pKNT25_geneA 
pUT18_geneA 
pUT18C_geneA 
pUT18_geneA 
pUT18C_geneA 
Unknown – to be 
tested 
pUT18_geneB 
pUT18_geneB 
pUT18C_geneB 
pUT18C_geneB 
pKT25_geneB 
pKT25_geneB 
pKNT25_geneB 
pKNT25_geneB 
pKT25_geneB 
pKNT25_geneB 
pKT25_geneB 
pKNT25_geneB 
pUT18_geneB 
pUT18C_geneB 
pUT18_geneB 
pUT18C_geneB 
Unknown – to be 
tested 
pUT18_geneA 
pUT18_geneA 
pUT18C_geneA 
pUT18C_geneA 
pKT25_geneA 
pKT25_geneA 
pKNT25_geneA 
pKNT25_geneA 
pKT25_geneB 
pKNT25_geneB 
pKT25_geneB 
pKNT25_geneB 
pUT18_geneB 
pUT18C_geneB 
pUT18_geneB 
pUT18C_geneB 
Unknown – to be 
tested 
pUT18_gene? 
pUT18_gene? 
pUT18C_gene? 
pUT18C_gene? 
pKT25_gene? 
pKT25_gene? 
pKNT25_gene? 
pKNT25_gene? 
pUT18_zip 
pKT25 
pKNT25 
pKT25 
pKNT25 
pUT18 
pUT18C 
pUT18 
pUT118C 
pKT25_zip 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Positive 
 
Table 5.2 – A summary of all bacterial two-hybrid vector combinations carried out to analyse a 
pair of protein interactions. Vectors were cotransformed into Escherichia coli BTH101. A & B: 
The combinations here were used to test for protein self-interactions. C: The combinations 
here were used to test for interactions between two different proteins. D: The control plasmid 
combinations are shown here. 
 
 
A 
B 
C 
D 
167 
 
 
with FlaA-CBD when tagged at the C-terminus (with T25) and the mutant flagellin was tagged 
at either terminus (with T25) (Table 5.3). Furthermore, a strong interaction was also detected 
when Maf1 was tagged at the N-terminus (with T18) and FlaA-CBD tagged at the N-terminus 
(with T25), a consistent result of which was not observed between Maf1 and wild type FlaA/B 
(Table 5.3). This may show that the deletion of the CBD may make the D2/D3 domain more 
accessible for Maf1 binding. Interactions were also detected between Maf1 and FlaA-D2/D3, in 
the same combinations as were detected for Maf1 and FlaA (Table 5.3). Although results were 
again inconsistent, this shows that Maf1 is not only recognising the D2/D3 region of the 
flagellin.  
Although interactions were not detected between the flagellins and the chaperone here, FlaJ 
was found to interact, although inconsistently so, with Maf1 (Table 5.3). This interaction was 
only detected when Maf1 was tagged at the N-terminus (with T18) and FlaJ at the C-terminus 
(with T25) (Table 5.3). The inconsistent results here suggest that a transient interaction 
between Maf1 and FlaJ may occur, perhaps in order to allow FlaJ binding of glycosylated 
flagellin (which has not been investigated here). 
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Table 5.3 – A summary of the results obtained from the bacterial two-hybrid interaction studies, showing the position of the CyaA tag (T18/T25), at either the N- 
or C-terminus of the protein of interest. 
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5.2.2 – The polar flagellar cap protein, FlaH, is not required for flagellin 
glycosylation 
In A. caviae, FlaH is the polar flagellar cap protein, and is required for polymerising the 
flagellins into a functional flagellar filament. Studies were undertaken to analyse whether the 
polar flagellar cap protein (FlaH) is required for flagellin glycosylation, in order to give an 
indication as to: where flagellin glycosylation may be occurring in the flagellar assembly 
pathway, if FlaH is required for glycosylation, or, if a mechanism is in place to prevent the 
glycosylation of flagellin when A. caviae is unable to form a flagellar filament. Investigations 
carried out here contributed towards Parker et al. (2014). To investigate whether FlaH is 
involved in flagellin glycosylation, flagellins from an A. caviae flaH mutant, previously created 
in the Shaw group, were analysed (Rabaan et al., 2001). 
The presence of glycosylated flagellin was analysed in normalised whole-cell sample and 
ethanol precipitated supernatant samples of A. caviae Sch3 and the flaH mutant. Western blot 
analysis was carried out on the samples, whereby they were probed with an anti-polar flagellin 
antibody that only recognises the glycosylated form of flagellin [anti-FlaA/B(+Pse)] (Fig. 5.8). 
No glycosylated flagellin could be detected in the whole-cell flaH mutant sample; however it 
could be detected in the supernatant sample. This demonstrates that FlaH is not required for 
flagellin glycosylation and that even though a filament cannot be produced, glycosylated 
flagellin is still readily exported in the absence of FlaH (in monomeric form) (Fig. 5.2). 
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Figure 5.2 – Western blot analysis of Aeromonas whole-cell and supernatant samples probed 
with a rabbit, anti-polar flagellin antibody that recognises only glycosylated flagellin [anti-
FlaA/B(+Pse)] (Parker et al., 2014). The samples were as follows: A. caviae Sch3 whole-cell (WT 
Wc), A. caviae Sch3 supernatant (WT Sn), flaH mutant whole-cell (flaH- Wc) and flaH mutant 
supernatant (flaH- Sn). 
 
 
 
 
 
  
171 
 
5.2.3 – Flagellin swapping studies 
O-linked flagellin glycosylation is known to be widespread amongst Aeromonas spp., with 
many aeromonads possessing maf homologues in their genomes thought to encode the 
flagellin specific glycosyltransferase, such as the clinically relevant species: A. caviae (Parker et 
al., 2012), A. piscicola (originally classed as A. hydrophila) (Canals et al., 2007) and A. 
hydrophila (Seshadri et al., 2006). Very little is known about the Maf proteins mechanism of 
action or how specific they are, as there is no consensus sequence for O-linked flagellin 
glycosylation. Polar flagellins from these clinically relevant Aeromonas species are extremely 
similar, showing highly conserved D0 and D1 regions, with only their central D2/D3 domain 
regions being variable. Therefore, D2/D3 domain swapping investigations were carried out in 
A. caviae Sch3, whereby flagellins from different Aeromonas strains were expressed in an A. 
caviae double flagellin mutant (flaAB mutant) in order to determine if the A. caviae Sch3 
glycosyltransferase, Maf1, is able to glycosylate these foreign D2/D3 domains. Polar flagellin A 
(FlaA) from the following strains: A. caviae Ae398 (Beatson et al., 2011), A. piscicola AH-3 
(Merino et al., 1991) and A. hydrophila ATCC 7966 (Seshadri et al., 2006), were analysed. 
Alignment studies were carried out to determine how identical the flagellins from these strains 
are to FlaA from A. caviae Sch3 (Fig. 5.3). A. caviae Sch3 FlaA shares the highest identity with 
A. caviae Ae398 FlaA, at 86%, then with A. hydrophila ATCC 7966 FlaA, at 73%, and finally with 
A. piscicola AH-3 FlaA at 71%, with primarily the central regions of these proteins varying the 
most (Fig. 5.3). 
5.2.3.1 – Generation of pBBR1MCS-5 constructs containing Aeromonas flagellins 
The flaA genes from a variety of Aeromonas species: A. caviae Ae398 (891 bp), A. piscicola AH-
3 (915 bp), A. hydrophila ATCC 7966 (906 bp) and A. caviae Sch3 (921 bp) as a positive control, 
were cloned into pBBR1MCS-5 along with a region upstream of the transcription start site to 
allow expression of flagellins from their native promoters (Table 5.4). Q5 high fidelity DNA 
polymerase (NEB) was used to amplify flaA genes from the corresponding genomic DNA. The 
sets of primers used in each case are shown in table 5.4. Restriction sites encoded for in the 
primers used allowed the PCR products to be directly cut with a combination of HindIII and 
BamHI (apart from the A. hydrophila ATCC 7966 flaA PCR product which was cut with HindIII 
and XbaI) restriction enzymes before being ligated into HindIII/BamHI (or HindIII/XbaI) cut 
pBBR1MCS-5 (As in Chapter 4, section 4.2.3, figure 4.19 A). The ligations were transformed 
into chemically competent E. coli DH5  and vector DNA isolated from the resulting 
transformants. Likely pBBR1MCS-5_flaA constructs were sent for sequencing using M13 
forward and reverse primers to confirm the presence of the correct flaA gene.
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Figure 5.3 – Alignment of FlaA from: Aeromonas caviae Sch3 (accession: AAF19179), A. caviae Ae398 (Beatson et al., 2011), A. hydrophila ATCC 7966 (Seshadri et 
al., 2006) and A. piscicola AH-3 (accession ABA01569). A. caviae Sch3 FlaA shows 86% identity with FlaA from A. caviae Ae398, 73% identity with FlaA from A. 
hydrophila ATCC 7966, and 71% identifity with FlaA from A. piscicola AH-3,  The alignment was executed using CLUSTALW (Thompson et al., 1994) and displayed 
with box-shade. The location of the D2/D3 region is highlighted (amino acids 146-231 in A. caviae Sch3 FlaA). 
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Gene Information Primers for  
pBBR1MCS-5 
Primers for pSRK(Gm) 
flaA 
(Sch3) 
Gene – 921 bp 
Upstream region – 99 bp 
RCL_71 (F) & RCL_72 (R) 
 
RCL_53 (F) & RCL_54 (R) 
flaA  
(Ae398) 
Gene – 891 bp 
Upstream region – 84 bp 
RCL_28 (F) & RCL_29 (R)  
flaA  
(AH-3) 
Gene – 915 bp 
Upstream region – 72 bp 
RCL_30 (F) & RCL_31 (R) RCL_49 (F) & RCL_50 (R) 
flaA  
(ATCC 
7966) 
Gene – 906 bp 
Upstream region – 84 bp  
RCL_32 (F) & RCL_34 (R) RCL_51 (F) & RCL_52 (R) 
 
 
Table 5.4 – Flagellin swapping gene and primer information: The flaA genes described here 
were amplified for insertion into pBBR1MCS-5 and pSRK(Gm). For insertion into pBBR1MCS-5, 
a region upstream of the gene was also amplified (sizes of these regions are given here), 
however these were not included when cloned into pSRK(Gm). The primers used in each case 
are presented here. Please refer to Chapter 2 table 2.6 for the details of the primers 
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5.2.3.2 – Analysis of pBBR1MCS-5_flaA constructs in Aeromonas caviae 
The resulting pBBR1MCS-5 vectors containing the desired flagellin genes were conjugated into 
an A. caviae flaAB mutant (as previously described in Chapter 4, section 4.2.3), along with the 
empty vector and three transconjugants selected for analysis. 
Swimming motility assays were carried out with the flaAB mutant strains containing the 
various flaA genes from other Aeromonas strains. The motility assays were carried out on large 
agar plates, as described previously, to analyse the motility of the flaAB mutant, the mutant 
containing the Sch3 flagellin, the mutant containing one of the other aeromonad flagellins 
(Ae398/AH-3/ATCC 7966) and the mutant containing the empty vector, on a single plate, also 
allowing for six technical repeats per strain (Fig. 5.4). Figure 5.4 displays the results of a single 
transconjugant in each case, but represents the motility of all transconjugants analysed. 
FlaA from A. caviae Ae398 was able to complement the non-motile phenotype of an A. caviae 
(Sch3) flaAB mutant; the other flagellins expressed in pBBR1MCS-5, however, could not. 
Western blot analysis was carried out on normalised whole-cell and supernatant A. caviae 
samples to test whether the heterologous flagellins could be glycosylated by Maf1 from A. 
caviae Sch3 (Fig. 5.5 and 5.6), as it is possible that Maf1 is still able to glycosylate the AH-3 and 
ATCC 7966 flagellins, but they are just unable to form a flagellar filament. A rabbit anti-polar 
flagellin antibody, that recognises the pseudaminic acid on glycosylated flagellin (described 
previously), was used to probe the whole-cell and supernatant samples, as work in the Shaw 
group has demonstrated that this antibody is able to recognise pseudaminic acid decorating a 
variety of flagellins (such as Aeromonas, H. pylori, C. jejuni, C. coli) (Shaw, unpublished), and so 
would recognise any glycosylation on these Aeromonas flagellins (Fig. 5.5 and 5.6). 
Glycosylated FlaA (Ae398) was, as expected (due to the motility phenotype observed), found 
to be present in whole cell and supernatant samples (Fig. 5.5 A and 5.6 A). FlaA from AH-3 and 
ATCC 7966 strains, however, were not found to be glycosylated (Fig. 5.5 B/C and 5.6 B/C). 
5.2.3.3 – Generation of pSRK(Gm) constructs containing Aeromonas  flagellins 
The Aeromonas flagellins that did not complement the A. caviae (Sch3N) flaAB mutant (and 
could not be detected by western blot analysis) were cloned into the IPTG inducible vector 
pSRK(Gm), to ensure that the results obtained were not down to A. caviae (Sch3) being unable 
to express these other Aeormonas spp flagellins, as expression in pBBR1MCS-5 relies on the 
genes native promoter.  
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Figure 5.4 – Motility analysis of an Aeromonas caviae flaAB mutant expressing heterologous Aeromonas flagellins (AH-3, ATCC 7966 and Ae398). Assays were 
carried out on 0.25% agar. The motility of the A. caviae flaAB mutant containing pBBR1MCS-5_flaA from Sch3 [flaAB- pflaA(WT)], the flaAB mutant alone (flaAB-), 
the mutant containing a heterologous flaA gene [flaAB- pflaA(?)] and the mutant containing empty pBBR1MCS-5 (flaAB- pBBR), are shown. 
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Figure 5.5 – Western blot analysis of Aeromonas caviae whole-cell samples probed with a rabbit, anti-polar flagellin antibody that recognises only glycosylated 
flagellin [anti-FlaA/B(+Pse)]. (A) Lane 1, A. caviae flaAB mutant containing pBBR1MCS-5_flaA from Sch3 [flaAB- pflaA(WT)]; lane 2, the flaAB mutant alone (flaAB-); 
lane 3, the mutant containing pBBR1MCS-5_flaA from Ae398 [flaAB- pflaA(Ae398)]; and lane 4, the mutant containing the empty vector (flaAB- pBBR). (B) As 
before, but lane 3, displays the mutant containing pBBR1MCS-5_flaA from AH-3 [flaAB- pflaA(AH-3)]. (C) As before, but lane 3, displays the mutant containing 
pBBR1MCS-5_flaA from ATCC 7966 [flaAB- pflaA(ATCC 7966)]. 
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Figure 5.6 – Western blot analysis of Aeromonas caviae supernatant samples probed with a rabbit, anti-polar flagellin antibody that recognises only glycosylated 
flagellin [anti-FlaA/B(+Pse)]. (A) Lane 1, A. caviae flaAB mutant containing pBBR1MCS-5_flaA from Sch3 [flaAB- pflaA(WT)]; lane 2, the flaAB mutant alone (flaAB-); 
lane 3, the mutant containing pBBR1MCS-5_flaA from Ae398 [flaAB- pflaA(Ae398)]; and lane 4, the mutant containing the empty vector (flaAB- pBBR). (B) As 
before, but lane 3, displays the mutant containing pBBR1MCS-5_flaA from AH-3 [flaAB- pflaA(AH-3)]. (C) As before, but lane 3, displays the mutant containing 
pBBR1MCS-5_flaA from ATCC 7966 [flaAB- pflaA(ATCC 7966)]. 
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For insertion into pSRK(Gm), the A. piscicola AH-3, A. hydrophila ATCC 7966 and A. caviae Sch3 
(positive control) flaA genes were amplified using the Expand high fidelity PCR system (Roche), 
using the corresponding Aeromonas genomic DNA and the sets of primers summarised in table 
5.4. These genes were cloned into pGEM-T EASY, as in section 5.2.1.1. Once the correct flaA 
genes were present and then excised from pGEM-T EASY (using a combination of NdeI and 
HindIII restriction enzymes), they were ligated into NdeI/HindIII cut pSRK(Gm) (section 3.2.3, 
figure 3.7). The ligations were transformed into E. coli DH5  and vector DNA isolated from the 
resulting transformants. A HindIII restriction digest and agarose gel electrophoresis confirmed 
the presence of the correct genes in pSRK(Gm). 
5.2.3.4 – Analysis of pSRK_flaA constructs in Aeromonas caviae 
The resulting pSRK(Gm) vectors containing the desired flagellin genes were conjugated into an 
A. caviae flaAB mutant, along with the empty vector. Three transconjugants were selected for 
analysis. As in section 5.2.3.2, motility assays were carried out with the resulting 
transconjugants, and the glycosylation status, of the flagellins present in whole-cell and 
supernatant A. caviae samples, was analysed by immunoblotting.  
Again, both FlaA proteins from AH-3 and ATCC 7966 Aeromonas strains were unable to restore 
the motility of an A. caviae (Sch3) flaAB mutant (Fig. 5.7) and glycosylated flagellin could not 
be detected in either whole-cell or supernatant samples when they were probed with the anti-
polar flagellin antibody that only recognises glycosylated flagellin (Fig 5.8). This may indicate 
that Maf1 is an extremely specific enzyme. Although no consensus sequence for O-linked 
glycosylation has been identified, these data suggest, in addition to the results obtained in 
Chapter 4, that there is selectivity to the Maf1-dependent flagellin glycosylation process.  
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Figure 5.7 – Motility analysis of an Aeromonas caviae flaAB mutant expressing heterologous Aeromonas flagellins (AH-3 and ATCC 7966). Assays were carried out 
on 0.25% agar containing 1 mM IPTG. The motility of the A. caviae flaAB mutant containing pSRK_flaA from Sch3 [flaAB- pflaA(WT)], the flaAB mutant alone 
(flaAB-), the mutant containing a heterologous flaA gene [flaAB- pflaA(?)] and the mutant containing empty pSRK(Gm) (flaAB- pSRK), are shown. 
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Figure 5.8 – Western blot analysis of Aeromonas caviae whole-cell (A) and supernatant samples (B) probed with a rabbit, anti-polar flagellin antibody that 
recognises only glycosylated flagellin [anti-FlaA/B(+Pse)]. In each case: lane 1, the A. caviae flaAB mutant (flaAB-); lane 2, the flaAB mutant containing pSRK_flaA 
from Sch3 [flaAB- pflaA(WT)]; lane 3, the flaAB mutant containing the empty vector (flaAB- pSRK); lane 4, the mutant containing pSRK_flaA from AH-3 [flaAB- 
pflaA(AH-3)] and pSRK_flaA from ATCC 7966 [flaAB- pflaA(ATCC 7966)]. 
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5.2.4 – Helicobacter pylori Maf studies 
These studies were carried in conjunction with Corrie Porter, a second year undergraduate 
student from the department of Molecular Biology and Biotechnology, who carried out a 
summer research project in the Shaw group (SURE scheme, 2014). 
 H. pylori glycosylates its polar flagella solely with pseudaminic acid (Josenhans et al., 2002; 
Schirm et al., 2003), similarly to A. caviae (Tabei et al., 2009); however, for unclear reasons, H. 
pylori possesses two maf homologues in its genome (Fig. 5.9) (Tomb et al., 1997) (described as 
maf1 and maf2 here). In H. pylori 26695, maf1 is located directly next to the gene for flagellin 
B (flaB), whereas maf2 is located entirely in a separate region of the genome (Fig. 5.9) (Tomb 
et al., 1997).  The initial studies carried out here were to determine whether A. caviae Sch3 is a 
good model of O-linked glycosylation for the heterologous expression of H. pylori glycosylation 
proteins, to see if the function of these proteins can be explored. Additionally these studies 
also allow the further exploration of whether the Maf proteins have broader specificity for 
other flagellins, or whether they are specific for their own cognate flagellins.  
5.2.4.1 – Generation of pSRK_maf (H. pylori) constructs 
The H. pylori 26695 maf genes, maf1 and maf2, thought to each encode a 72 kDa protein (628 
and 631 amino acids respectively), were cloned into the IPTG inducible vector pSRK(Gm). The 
maf genes were cloned into pSRK(Gm) using the same cloning method as previously described 
in section 5.2.3.3, using the primers, RCL_61 (F) and RCL_62 (R) for the amplification of maf1, 
and RCL_63 (F) and RCL_64 (R) for maf2, from H. pylori 26695 genomic DNA (Chapter 2, Table 
2.6). 
5.2.4.2 - Analysis of pSRK_maf (H. pylori) constructs in Aeromonas caviae 
The pSRK_maf constructs were individually conjugated into the A. caviae maf1 mutant 
previously created in the Shaw group (Parker et al., 2012), along with empty pSRK(Gm), and 
three transconjugants were selected for analysis in each case.  
Swimming motility assays were carried out on the strains created, again on the large motility 
plates discussed previously, allowing for the analysis of multiple strains, and six technical 
repeats per strain, per plate. A. caviae was used as a positive motility control during these 
motility assays.  
When the motility of the maf1 mutant containing maf1 from H. pylori was analysed, 
inconsistent motility phenotypes were observed (Fig. 5.10). Out of the three transconjugants  
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Figure 5.9 – The genetic organisation of the polar flagellar and pseudaminic acid biosynthetic 
genes in Helicobacter pylori 26695 (Tomb et al., 1997). 
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Figure 5.10 - Motility analysis of an Aeromonas caviae maf1 mutant containing maf1 from Helicobacter pylori 26695 [maf1- pmaf1(Hp)]. (A) and (B) show the 
motility of two different transconjugants [maf1- pmaf1(Hp)-1 and maf1- pmaf1(Hp)-2]. Assays were carried out alongside: A. caviae Sch3 (WT), the maf1 mutant 
(maf1-) and the mutant containing empty pSRK(Gm) (maf1- pSRK), on 0.25% agar containing 1 mM IPTG.  
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analysed, two displayed a non-motile phenotype, whereas one showed faint, highly impaired, 
motility (not the characteristic motility halos produced by wild type A. caviae) (Fig. 5.10). 
Figure 5.10 displays the motile transconjugant (A), and one of the non-motile transconjugants 
(B). Three biological repeats of these motility assays were also carried out, but the plates 
shown here are representative of them all. Furthermore, when normalised whole-cell and 
precipitated supernatant samples from these transconjugants were probed with the anti-polar 
flagellin antibody that only recognises glycosylated flagellin, the motile transconjugant was 
shown to be producing glycosylated flagellin, whereas the non-motile strains were not (Fig. 
5.11). The conjugations of these pSRK_maf1 vectors into the A. caviae maf1 mutant were 
repeated twice more, with one repeat showing three fully motile transconjugants, and the 
other resulting in non-motile transconjugants (data not shown). Extremely variable results 
were observed here. 
However, when the motility of the maf1 mutant containing maf2 from H. pylori was analysed, 
all transconjugants displayed non-motile phenotypes (Fig. 5.12) and no glycosylated flagellins 
could be detected by Western blot analysis (Fig. 5.13). 
Therefore, some promiscuity was detected with Maf1 from H. pylori, which suggests that this 
protein in H. pylori is a flagellin-specific glycosyltransferase. Although as inconsistent results 
were observed here, it is possible that both Maf proteins are required for efficient H. pylori 
flagellin glycosylation to take place. However, it is possible that Maf2 from H. plyori has an 
alternative target in the cell. 
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Figure 5.11 - Western blot analysis of the glycosylation status of flagellin present in Aeromonas caviae whole-cell (A) and supernatant (B) samples, when Maf1 
from Helicobacter pylori 26695 is heterologously expressed in an A. caviae maf1 mutant.  In each case: lane 1, A. caviae Sch3 (WT); lane 2, the maf1 mutant (maf1-
); lane 3, the maf1 mutant empty pSRK(Gm) (maf1- pSRK); and lanes 4-6, show the three transconjugants which are the A. caviae maf1 mutant containing 
pSRK_maf1 from H. pylori [maf1- pmaf1(Hp)-1/2/3]. 
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Figure 5.12 - Motility analysis of an Aeromonas caviae maf1 mutant containing maf2 from Helicobacter pylori 26695 [maf1- pmaf2(Hp)]. The motility of one 
transconjugant is shown but is representative of all analysed. Assays were carried out alongside: A. caviae Sch3 (WT), the maf1 mutant (maf1-) and the mutant 
containing empty pSRK(Gm) (maf1- pSRK), on 0.25% agar containing 1 mM IPTG. 
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Figure 5.13 - Western blot analysis of the glycosylation status of flagellin present in Aeromonas caviae whole-cell (A) and supernatant (B) samples, when Maf2 
from Helicobacter pylori 26695 is heterologously expressed in an A. caviae maf1 mutant.  In each case: lane 1, A. caviae Sch3 (WT); lane 2, the maf1 mutant (maf1-
); lane 3, the maf1 mutant empty pSRK(Gm) (maf1- pSRK); and lanes 4-6, show the three transconjugants which are the A. caviae maf1 mutant containing 
pSRK_maf2 from H. pylori [maf1- pmaf2(Hp)-1/2/3]. 
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5.3 – Discussion 
Continuing on from section 5.2.1, the bacterial adenylate cyclase two-hybrid system was 
utilised to explore the interactions between proteins associated with A. caviae Sch3 flagellin 
glycosylation and polar flagellar assembly. This system allowed in vivo interactions between 
these proteins, in a non-glycosylating system (E.coli BTH101), to be explored. No self-
interactions, interactions between the unglycosylated flagellins (FlaA and FlaB), or interactions 
between the flagellins and the flagellin-specific chaperone (FlaJ) were observed. This further 
demonstrates that glycosylation is likely to be required for the correct folding of flagellin and 
for polymerisation, as it has previously been determined that glycosylation is essential for the 
formation of A. caviae polar flagellum ((Tabei et al., 2009). However, when flagellins fold, the 
N and C termini come together to form conserved D0 and D1 domains, which are required for 
polymerisation (Auvray et al., 2001). Therefore the presence of the adenylate cyclase tags at 
the N or C termini of these proteins may have had an effect on their ability to interact with 
other proteins (such as each other) here. These results also suggest that chaperone binding of 
the flagellins may occur after glycosylation, as no interactions were detected between the 
unglycosylated flagellins and FlaJ (Table 5.3). This agrees with the work from Parker et al. 
(2014), where interactions between glycosylated and unglycosylated A. caviae flagellins were 
explored by Far Western blot analysis. Only very minor interactions could be detected 
between FlaJ and the unglycosylated form of flagellin, compared to the strong interactions 
observed when the glycosylated flagellin was present (Parker et al., 2014). Therefore, the 
likelihood of detecting interactions between these proteins in an in vivo, non-glycosylating 
system is extremely slim. 
It was concluded, however, that Maf1 is able to interact with the unglycosylated flagellins, 
FlaA and FlaB, and in the absence of pseudaminic acid; although a number of the results 
obtained were inconsistent. Maf1 interacted with both flagellins when tagged at either the N 
or C termini with either domains of CyaA, but particularly strong interactions were observed 
between Maf1 tagged at the C-terminus (with T25) and both the flagellins tagged at their C-
termini (with T18). This suggests that the N-terminal region of Maf1 may be important for 
flagellin recognition, and when the N-terminal region of the flagellin is free, this may allow 
Maf1 access to the D2/D3 domain for glycosylation to occur. It has been previously 
determined that the chaperone binding domain of glycosylated flagellin is essential for FlaJ 
binding and export of the flagellin (Parker et al., 2014), therefore another region of the 
flagellin, such as the N-terminal domain, may be important for Maf1 docking. It is also known 
that the flagellin N-terminus is important for secretion, and in addition, the D0 regions of the 
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flagellins are essential for the newly proposed chain mechanism of flagellar assembly (Evans et 
al., 2013). Therefore if Maf1 docks to thisregion, it may the block signals for flagellin export, 
resulting in the decreased export of unglycosylated flagellin that cannot be incorporated into a 
filament. Other interactions observed were very inconsistent, likely due to the insoluble nature 
of unglycosylated A. caviae flagellins (Parker et al., 2014). Additionally, the large tags of CyaA 
may also affect correct protein folding, leading to inconsistent results.  
Strong positive interactions were, however, detected between Maf1 tagged at the C-terminus 
(with T25) and FlaA-CBD (FlaA minus the chaperone binding domain) when tagged at either 
the N or C-termini (with T18). Furthermore interactions were also detected when Maf1 was 
tagged at the N-terminus (with T18) and FlaA-CBD tagged at the N-terminal region (with T25). 
A strong positive interaction had previously not been detected between Maf1 and either 
flagellin tagged at their N-termini (inconsistent results); however, the removal of the 
chaperone binding domain may make the glycosylated region of flagellin, the D2/D3 domain 
(Tabei et al., 2009), more accessible for Maf1 to bind and allow access even when the flagellin 
is tagged at the N-terminus. In addition, the combination of the removal of the CBD and being 
tagged by a domain of adenylate cyclase may also make the flagellin more soluble, allowing for 
more interactions to be observed in vivo between the mutant flagellin and Maf1 here.  
More unexpectedly, however, was that when interactions between Maf1 and FlaA-D2/D3 
(FlaA minus the D2/D3 domain) were assessed, interactions were observed (either strong or 
inconsistent) in all the combinations previously witnessed between FlaA and Maf1. This was 
surprising as although the central region that Maf1 glycosylates has been removed, Maf1 is 
still able to recognise and bind to the mutant flagellin (though interactions were again 
extremely inconsistent). However, as it was previously discussed in chapter 4, hydrophobic 
residues appear to be clustered in the central (D2/D3) region of flagellins and glycosylation 
may mask these hydrophobic regions. So when removed, a mutant flagellin made up of only 
D0 and D1 domains may allow the production of a soluble flagellin (compared to the usual, 
highly insoluble, wild type version). This mutant flagellin may therefore exist more freely in E. 
coli and be available to interact with Maf1. These results also suggest that Maf1 can interact 
with other regions of the flagellins and is not solely recognising the D2/D3 region. It is 
therefore possible that the N-terminal region of flagellin is required for Maf1 docking, before 
glycosylation occurs, as interactions are observed between Maf1 and both the mutant 
flagellins investigated here (FlaA-CBD and FlaA-D2/D3). In addition, these observations also 
indicate that glycosylation occurs before chaperone binding of flagellin, and therefore, likely to 
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occur in the cytoplasm of the bacterium (Fig. 5.14). The ‘handover’ experiment carried out in 
Parker et al. (2014) further supports these observations, as it was concluded that Maf1 and 
glycosylated flagellin co-purify from A. caviae, and the in vitro experiments demonstrated that 
FlaJ is able to take this glycosylated flagellin directly from the glycosyltransferase. This is 
thought to mimic the events that are occurring inside the cell. Moreover, as FlaJ also appears 
to have a higher affinity for glycosylated flagellin, it is likely to only interact with these proteins 
inside the cell once glycosylated, to allow the efficient export of only the modified version of 
the flagellins for incorporation into the flagellar filament (Fig. 5.14) (Parker et al., 2014). This 
also agrees with studies in C. jejuni whereby mutant strains incapable of producing basal body 
and hook proteins, and therefore deficient in a flagellar export system, were still able to 
produce glycosylated flagellins, suggesting glycosylation occurs in the cytoplasm (Ewing et al., 
2009). 
An inconsistent interaction was also detected between Maf1 and FlaJ, which would be 
expected if this ‘handover’ event takes place within the cell (Parker et al., 2014). However, 
again, the bulky CyaA tags may be affecting protein folding, leading to the inconsistent 
interactions observed. Interactions were only detected here when Maf1 had a free C-terminal 
region, which suggests that this region may be more important for the recognition of FlaJ, and 
the N-terminus for the recognition of flagellins. 
Continuing on from section 5.2.2, FlaH is the polar flagellar cap protein in A. caviae and carries 
out the same job as FliD from E. coli and Salmonella (Yonekura et al., 2000). Although it is 
known that the filament cap is required for incorporation of the flagellins into a functional 
filament, and that flagellar cap mutants are non-motile (Yonekura et al., 2000); it was not 
known if FlaH in A. caviae had a role in the flagellin glycosylation process. Here, the flagellins 
of an A. caviae flaH mutant were analysed and it was confirmed by Western blot analysis that 
the flagellins present in this strain are still glycosylated and are readily exported into the 
culture supernatant. These data therefore demonstrate that FlaH is not involved in the 
glycosylation process and together with the results from the interaction studies, suggest that 
flagellin modification occurs in the cytoplasm before protein targeting to the type III export 
apparatus and incorporation into the flagellar filament (Parker et al., 2014). Furthermore, 
these data also show that there is no mechanism to prevent flagellin glycosylation in the 
occurrence that the bacterium is unable to form a functional filament (Parker et al., 2014).  
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Figure 5.14 – A theoretical model of the pathway of flagellin glycosylation. Pseudaminic acid 
(Pse5Ac7Ac) is activated via the addition of cytidine monophosphate (CMP) before it is 
transferred onto the D2/D3 domain of the flagellin by Maf1 in the cytoplasm. FlaJ binding is 
likely to occur after glycosylation, which depends on the presence of the chaperone binding 
domain (CBD) of the flagellin (Parker et al., 2014), resulting in the export of glycosylated 
flagellins [FlaA/B(+Pse)] that can be incorporated into a flagellar filament. This model of 
flagellin glycosylation agrees with that from Parker et al. (2014). 
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In section 5.2.3, flagellin swapping studies were carried out to assess whether Maf1 from A. 
caviae is a promiscuous enzyme capable of glycosylating alternative Aeromonas flagellin 
D2/D3 domains. The ability of Maf1 from A. caviae to glycosylate flagellins from: A. piscicola 
AH-3 (Merino et al., 1991), A. hydrophila ATCC 7966 (Seshadri et al., 2006) and A. caviae Ae398 
(Beatson et al., 2011), was explored. Of the flagellins analysed, FlaA from A. caviae Sch3 
displays the highest sequence identity (of 86%) with FlaA from A. caviae Ae398; however, their 
D2/D3 regions only display 58% identity. It was found that A. caviae Ae398 flagellins could 
restore the motility of an A. caviae flaAB mutant, with Western blot analysis confirming that 
the flagellins were glycosylated. In contrast, A. piscicola AH-3 and A. hydrophila ATCC 7966 
flagellins (FlaA) could not complement the motility of a flaAB mutant, and glycosylated 
flagellin could not be detected in the whole-cell or supernatant samples analysed here. The 
flagellins show 71% (A. piscicola AH-3) and 73% (A. hydrophila ATCC 7966) identity to A. caviae 
Sch3 FlaA, with the most variation being located in the D2/D3 regions of the proteins. A. caviae 
displays less identity with the D2/D3 domains of these proteins compared to with A. caviae 
Ae398 FlaA, at 40% identity with the D2/D3 region of A. piscicola AH-3 flagellin, and 51% with 
A. hydrophila ATCC 7966 flagellin. This therefore suggests that although some promiscuity is 
detected with Maf1, this enzyme does show some specificity. Interaction studies carried out 
here and by Parker et al. (2014) also suggest that Maf1 does not only recognise the D2/D3 
region of the flagellins, but may recognise the N-terminus also. Therefore, Maf1 may not 
actually be binding to and glycosylating flagellins due to their D2/D3 domain sequences, but 
due to another site perhaps located in the N-terminal region of the protein. A. caviae Sch3 and 
Ae398 FlaA show the highest level of identity in their N-terminal regions, at 98%. However, the 
FlaA N-terminal regions from A. piscicola AH-3 and A. hydrophila ATCC 7966 only show 80% 
and 82% identity respectively with A. caviae Sch3 FlaA. This therefore suggests that the N-
terminal regions of the flagellins could be responsible for Maf1 docking and glycosylation.  
However, flagellin glycosylation from A. piscicola AH-3 and A. hydrophila ATCC 7966 is thought 
to be more complex than A. caviae Sch3. A. piscicola AH-3 possess more complex glycosylation 
loci than A. caviae, due to the presence of two maf genes (Chapter 1, figure 1.7) (Canals et al., 
2007), and recent work from Wilhelms et al. (2012) also suggests that flagellins are modified 
with a heterogenous heptasaccharide (376 Da) which includes pseudaminic acid. Furthermore, 
the flagellin glycosylation loci in A. hydrophila ATCC7966 (Seshadri et al., 2006) is also far more 
complex than that of A. caviae Sch3, as it possesses two maf homologues, similarly to A. 
piscicola AH-3 (Chapter 1, figure 1.7). These studies may demonstrate that the Maf proteins 
are extremely specific enzymes, or perhaps glycosylation in bacteria that contain multiple Maf 
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proteins, and are known likely to modify their flagellins with a variety of sugars, require 
specific interactions between their Maf proteins, which Maf1 from A. caviae Sch3 is incapable 
of due to pseudaminic acid being the only sugar present in this system (Tabei et al., 2009). 
Continuing on from section 5.2.4, although Maf1 from A. caviae Sch3 could not glycosylate A. 
piscicola AH-3 and A. hydrophila ATCC 7966 flagellins (FlaA), the effect of heterologously 
expressing H. pylori Maf proteins (Maf1 and Maf2) was investigated here due to H. pylori 
solely glycosylating its flagellins with pseudaminic acid, similarly to A. caviae Sch3 (Josenhans 
et al., 2002; Schirm et al., 2003). These studies were also carried out to give an indication as to 
whether A. caviae Sch3 is a good model for the study of O-linked glycosylation, as it grows well 
aerobically, and contains the smallest set of genes required for pseudaminic acid biosynthesis. 
Little is known about the Maf proteins from H. pylori, or why two proteins are present when 
the bacterium only modifies its flagella with pseudaminic acid; however H. pylori requires 
nutrient rich media and a microaerobic environment for growth, so other means of analysing 
the flagellin glycosylation process of this pathogen would be desirable. It is possible that both 
Maf proteins have a role in flagellin glycosylation in H. pylori; however, they may also have 
different roles within the cell. 
Maf2 from H. pylori was unable to restore the motility of an A. caviae maf1 mutant, and no 
evidence of flagellin glycosylation was observed. However, Maf1 from H. pylori was found to 
possibly, although inconsistently, recognise and modify A. caviae flagellins. This may show that 
Maf proteins from similar glycosylating systems, (ie. can only glycosylate with pseudaminic 
acid here) are able to compensate for one another. The preliminary results obtained, however, 
were extremely inconsistent and would require further investigation. The results are 
intriguing, as the flagellins from H. pylori are much larger than those from A. caviae, with their 
sequences showing only 37% identity (Fig. 5.15). These proteins do, however, share some 
identical runs of amino acids, such as ‘FQVGA’, located at the start of the A. caviae FlaA D2/D3 
region (Fig. 5.15). It was found in Chapter 4 of this work, that FlaB is glycosylated on residues 
that occur shortly after this sequence. It may be that this region is involved in Maf recognition 
of, and docking to, the flagellins; although this sequence is present in all the Aeromonas 
flagellins involved in the flagellin swapping studies here where glycosylation by A. caviae Sch3 
Maf1 was not detected. The position of maf1 in the H. pylori 26995 genome suggests it to be a 
flagellin specific glycosyltransferase as it is located next to the gene encoding flagellin B (FlaB) 
(Fig. 5.9). Whereas, maf2 is not associated with any genes for pseudaminic acid biosynthesis or  
 
194 
 
 
 
 
 
 
Figure 5.15 – Alignment of Aeromonas caviae Sch3 FlaA (Sch3) (accession: AAF19179) with 
FlaA from Helicobacter pylori 26695 (Tomb et al., 1997). The alignment was executed using 
CLUSTALW (Thompson et al., 1994) and displayed with box-shade. The D2/D3 domain of A. 
caviae Sch3 FlaA is highlighted. 
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polar flagellum assembly (Fig. 5.9), which may indicate that this protein is not required for 
flagellin modification at all and may target other proteins in H. pylori. Recent studies by Hopf 
et al. (2011) have demonstrated that although pseudaminic acid solely decorates H. pylori 
polar flagella, there is evidence that this bacterium is also capable of synthesising other 
pseudaminic acid derivatives, and possibly legionaminic acid. This work presented nine 
candidate glycoproteins that all reside either within the bacterial cytoplasm or embedded in 
the inner membrane (Hopf et al., 2011); however, the importance of glycosylation for these 
proteins has not yet been determined. Furthermore, Champasa et al. (2013) identified 125 
putative glycoproteins in H. pylori using metabolic glycan labelling studies. The proteins 
identified carry out a diverse range of functions within the cell and reside in a variety of 
cellular locations (such as, the cytoplasm, the periplasm, and the inner and outer membranes) 
(Champasa et al., 2013). It is therefore possible that Maf2 from H. pylori does not target the 
flagellins, and is targeting another protein for glycosylation. It is clear from these investigations 
that there is still much to discover about protein glycosylation in this microorganism. However, 
there have not yet been reports in any other bacteria of the Maf proteins having alternative 
target proteins to the flagellins.  
To follow on from these studies, both maf homologues could be expressed in A. caviae, to see 
whether both of these proteins are required for efficient flagellin glycosylation. Also, as A. 
caviae is genetically amenable and easy to culture, it could be a good tool in the future to 
study how H. plylori glycosylates its own flagellins, by expressing H. pylori Maf proteins and 
flagellins in A. caviae. Although these are very preliminary studies, they show promise that A. 
caviae Sch3 may be used and manipulated as a model organism for the study of glycosylation 
in the future. 
This work has therefore provided evidence, together with the studies from Parker et al. (2014), 
that Maf1 functions in the cytoplasm to glycosylate target flagellins before chaperone binding 
and export (Fig. 5.14). As Maf1 is a cytoplasmic enzyme, it may be of use in the future for the 
glycosylation of therapeutic proteins, or may itself be a useful antimicrobial target; however, 
further work is required to fully understand how these enzymes identify and glycosylate their 
target proteins, and their precise mechanism of action. This work (and the work from Chapter 
4) has raised many questions as to the site on the flagellins for Maf1 recognition and docking.  
The interaction studies carried out here, together with the D2/D3 domain swapping studies, 
suggest this site to reside upstream of the D2/D3 domain. Maf1 binding investigations to N-
terminal flagellin regions, along with site-directed mutational studies of the flagellins, would 
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allow the region of Maf1 docking to be further explored. In addition, structural studies with 
the Maf proteins would reveal the protein domains present, perhaps pockets for pseudaminic  
acid binding, and would provide information that could be used to create a model of Maf1 
mechanism of action. Moreover, putative thiamine pyrophosphokinase (TPK) domains have 
been previously found to be highly conserved amongst the Maf proteins, which suggests that 
this domain has an important role (Parker et al., 2012). TPK domains catalyse the transfer of 
phosphate groups from a nucleoside triphosphate (ie. ATP) to the thiamine hydroxyl group, 
producing thiamine pyrophosphate, and it would be interesting to explore the specific role of 
this domain in Maf1 also. 
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Chapter 6: General Discussion 
 
6.1 – General discussion of results 
In this thesis, the pathway and role of flagellin glycosylation was explored in Aeromonas caviae 
Sch3, a clinically relevant aeromonad that requires pseudaminic acid for flagellation and 
virulence, and possesses the simplest set of genes currently known for glycosylation and polar 
flagellum assembly.  
In Chapter 3, the existence of a potential flagellin deglycosylation pathway was investigated 
due to a homologue of a putative flagellin deglycosylase (HP0518) from H. pylori (Asakura et 
al., 2010), being identified in the A. caviae Sch3 genome (AHA0618) (Lowry et al., 2014b). 
Although an A. caviae AHA0618 mutant was found to be hypermotile compared to the wild 
type strain [similarly to the findings in Asakura et al. (2010)], the mutation had no effect on 
flagellin glycosylation. Therefore the altered behaviour exhibited here was not due to flagellin 
glycosylation levels, which have been shown to have an effect on bacterial behaviour 
previously (with studies in Campylobacter) (Howard et al., 2009; van Alphen et al., 2008). An 
alternative function for HP0518 was suggested by Sycuro et al. (2013), as an L,D-
carboxypeptidase involved in peptidoglycan processing at the cell wall. The mutant also 
displayed a straight-rod morphology compared to the helical wild type (Sycuro et al., 2013). 
Bioinformatic analysis of AHA0618 revealed this protein to be in the YkuD superfamily of 
proteins, a family of L,D-transpeptidases involved in peptidoglycan processing, that contain a 
characteristic catalytic tetrad of amino acids in their active sites (Bielnicki et al., 2006), of 
which were present in both AHA0618 and HP0518. When the cell shape of an A. caviae 
AHA0618 mutant was analysed here, it was concluded that the mutant is significantly shorter 
than the wild type strain; a phenomenon that could be complemented by either AHA0618 or 
HP0518 expressed in the mutant, demonstrating that HP0518 is having a similar effect to 
AHA0618 in A. caviae. Although preliminary studies did not identify any differences between 
the muropeptide profiles of the wild type and AHA0618 mutant strains, these data still suggest 
that AHA0618 is not involved in a flagellin deglycosylation pathway, but instead it is the cell 
shape which is responsible for the differences in bacterial behaviour observed between the 
strains analysed. The results obtained demonstrate that even the subtlest changes in cellular 
morphology can affect bacterial behaviour, an observation which has been documented from 
the study of a number of other bacterial cell-wall enzyme mutants also. For example, in the 
Gram-positive bacterium Bacillus cereus, mutants of the cell wall peptidase, CwpFM, were 
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found to be larger than the wild type, and as a result were less motile (Tran et al., 2010). 
Likewise, when the carboxypeptidase, Pgp2, was mutated in C. jejuni, the straight rod cellular 
morphology that resulted affected bacterial motility and biofilm formation (Frirdich et al., 
2014).  
Although no flagellin deglycosylation pathway has been identified in A. caviae to alter flagellin 
glycosylation levels, it has been suggested that Campylobacter strains may regulate the 
expression of their Maf proteins in order to do this. The presence of different sugars have 
been shown to provide C. jejuni with diverse abilities, such as the presence of legionaminic 
acid on the polar flagellum enables this pathogen to efficiently colonise chickens compared to 
when this sugar is absent (Howard et al., 2009). Therefore, it is intriguing as to whether 
alternative mechanisms of tailoring bacterial flagellin glycosylation are present in bacteria that 
solely modify their flagellins with one sugar, and do not possesses a vast array of Maf proteins, 
such as in H. pylori and A. caviae (Parker et al., 2012; Schirm et al., 2003) (Tabei et al., 2009). 
Chapter 4 of this work has unequivocally identified for the first time, using mass spectrometric 
methods, sites of glycosylation at the very start of the D2/D3 domain of the flagellin, FlaB, 
from A. caviae Sch3. It was determined that one or two sugars are able to decorate the FlaB 
peptide [146-173], and in addition, these sites of glycosylation can vary from peptide to 
peptide. However, two sites in particular (serine 159 and 161) were found to be predominantly 
co-modified in the wild type strain. These results show that although no consensus sequence 
for O-linked protein glycosylation has been identified, there is partial selectivity to the Maf1-
dependent flagellin glycosylation process. This has also been observed in Campylobacter and 
Helicobacter where the sites of glycosylation identified were found to be ‘usually’ glycosylated 
(Schirm et al., 2003; Thibault et al., 2001). Furthermore, this work also agrees with the studies 
in these bacteria, that glycosylation may occur in regions of local hydrophobicity within the 
D2/D3 domain of the flagellin (Schirm et al., 2003; Thibault et al., 2001). It was particularly 
observed in C. jejuni that the sites of glycosylation are more commonly preceded by runs of 
hydrophobic amino acids. All of the serine residues present on the A. caviae FlaB [146-173] 
peptide are surrounded by hydrophobic amino acids, the mutation of which had a detrimental 
effect on A. caviae motility, demonstrating that these residues may indeed be the preferred 
targets on Maf1. Additionally, when all of the serine residues on this peptide were mutated at 
the same time, the mutant flagellin was unable to restore the motility of an A. caviae flaAB 
mutant. This flagellin was also smaller than the wild type flagellin, demonstrating that the 
glycosylation of this peptide is essential and cannot be made up for by the glycosylation of 
199 
 
 
alternative residues within the protein. The reason for the impaired motility phenotypes 
observed here are not yet clear. It is possible that impaired motility may result from the less 
efficient recognition of the flagellins by Maf1, which may have arisen from these mutations, or 
through the flagella having a different overall form when polymerised from the mutant 
monomers. In contrast, the mutation of threonine 155 on this same peptide, which is not 
preceded by hydrophobic amino acids, did not have a detrimental effect on A. caviae motility. 
Furthermore, the glycosylation status and level of this flagellin found in the A. caviae whole-
cell was comparable to that of wild type FlaB.  
As hydrophobicity appears to play a role in Maf1 flagellin glycosylation, the hydrophobic 
amino acids leucine 160 and isoleucine 168 were targeted for further mutagenesis studies. The 
individual mutation of these residues had a severely detrimental effect on A. caviae motility. 
Again it is possible that these mutated regions impede Maf1’s ability to dock to the flagellin, 
perhaps through decreasing the hydrophobicity of this region; although flagellins were still 
identified to be glycosylated. The effect of these mutations on flagellin glycosylation could not 
be explored here as all attempts to pellet any flagella formed from these mutant flagellins 
failed, suggesting that a flagellar filament cannot form, or any filaments that do form are 
fragile and break off before full length flagella are polymerised. 
Although it has been suggested that flagellin glycosylation may be coupled to export (Logan, 
2006), the interaction studies carried out in chapter 5, along with the recent work by Parker et 
al. (2014), have contributed towards determining that A. caviae Sch3 flagellin glycosylation by 
Maf1 is likely to occur in the cytoplasm, before chaperone binding and export (Chapter 5, 
figure 5.14). The lack of interactions observed between the flagellins and the flagellin-specific 
chaperone, Maf1, is likely to be due to the conclusions from Parker et al. (2014), that FlaJ has 
less affinity for the unglycosylated flagellin, which would therefore promote the export of the 
modified flagellin rather than the unmodified version. In addition, the ‘handover’ experiment 
carried out by Parker et al. (2014), suggests that Maf1 and FlaJ could come into contact within 
the cell to pass the glycosylated flagellin onto its chaperone, to prevent the premature folding 
and polymerisation of the flagellins within the cytoplasm. This may be why inconsistent 
interactions were observed here between Maf1 and FlaJ, further demonstrating that FlaJ is 
likely to take the flagellin from the glycosyltransferase after glycosylation has occurred (Parker 
et al., 2014).  Furthermore, as FlaJ is able to take the flagellin from Maf1, it is likely that these 
proteins are binding to different parts of the flagellin. The chaperone binding domain is 
essential for FlaJ binding and flagellin export, but not for glycosylation to occur (Parker et al., 
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2014), which therefore suggests another part of the protein is required for Maf1 docking 
(possibly the N-terminal region). These studies agree with work carried out in C. jejuni 81-176, 
demonstrating that mutant strains which are unable to produce basal body and hook proteins, 
and are therefore deficient in a flagellar export system, are still able to produce glycosylated 
flagellins, suggesting that glycosylation occurs before export (Ewing et al., 2009). Cytoplasmic 
Maf-dependent flagellin glycosylation is therefore likely to be occurring in other O-linked 
glycosylation pathways; although, how multiple Maf proteins fit into this pathway, for example 
in the case of Campylobacter species where up to seven Maf proteins can be present 
(Karlyshev et al., 2002; van Alphen et al., 2008), has not yet been investigated. 
Furthermore, the D2/D3 domain swapping investigations carried out here have called into 
question the specificity of the Maf proteins and the location on the flagellin to which these 
enzymes dock. Maf1 from A. caviae Sch3 was only found to recognise and glycosylate flagellin 
from A. caviae Ae398, of the Aeromonas flagellins investigated here, which may show that 
these enzymes are very specific for their target proteins; however, the D2/D3 domain of the A. 
caviae Ae398 FlaA, of which is the glycosylated region, only shares 58% identity with the A. 
caviae Sch3 FlaA. This therefore further suggests that the initial recognition of the flagellins 
may not involve the D2/D3 domain of the flagellin. Through the interaction studies carried out 
in Chapter 5, it was shown that Maf1 is likely to interact with the N-terminal region of the 
flagellin, and so it may be this region that is important for Maf1 flagellin recognition and 
docking. The N-terminus of A. caviae Sch3 FlaA was found to display the highest identity to the 
N-terminal region of FlaA from A. caviae Ae398, at 98%, of the flagellins examined, further 
demonstrating that this N-terminal region may be required for Maf1 docking.  
On the other hand, Maf1 from H. pylori 26695, appeared to show some promiscuity and was 
able to modify the much smaller flagellins of A. caviae Sch3 (although inconsistently). Although 
H. pylori possesses two maf homologues in its genome, it only modifies its polar flagella with 
pseudaminic acid (Josenhans et al., 2002; Schirm et al., 2003), similarly to A. caviae, which may 
be why we are seeing some cross over between these systems, even though flagellins from 
these bacteria only display 37% identity. Therefore, there is much still to be understood about 
the mechanism of action of these novel glycosyltransferases, that have a clear role in bacterial 
virulence.   
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6.2 – Future perspectives 
6.2.1 – Short-term perspectives 
In the short-term, there are a number of investigations that can be carried out to help answer 
some of the questions that have arisen from this work.  
With regards to Chapter 3, further muropeptide analysis could be carried out with the 
peptidoglycan from A. caviae Sch3 and the AHA0618 mutant, in order to investigate any subtle 
differences in the muropeptide profiles of these strains which may arise from the lack of 
AHA0618 in the mutant. Furthermore, the peptidoglycan from the complementation strains 
(the mutant containing either AHA0618 or HP0518 on an inducible vector) could also be 
analysed, as overexpression of these proteins in the mutant may have a more pronounced 
effect on the peptidoglycan, allowing any differences to be more clearly observed.  
To continue investigating the effect of the sites of glycosylation (identified in Chapter 4) on A. 
caviae Sch3 motility and flagellar assembly, transmission electron microscopy studies could be 
carried out with the A. caviae strains expressing the site-directed flagellin mutants created. 
Flagella shape can be altered due to a variety of factors, such as: the flagellin amino acid 
sequence, temperature and pH, which can change the wave form of the filament and alter 
how bacteria swim (Turner et al., 2000). The diminished motility visualised may therefore 
result from the mutant flagellins polymerising to form different shaped flagella than the wild 
type flagellins. Additionally, studies in P. syringae have demonstrated that the unglycosylated 
form of their flagella are less stable than the glycosylated versions (Taguchi et al., 2009), and 
studies on the sites of flagellin glycosylation in C. jejuni have shown that the mutation of 
specific sites lead to the production of truncated filaments, suggesting flagellar fragility (Ewing 
et al., 2009).  Therefore mutation of the glycosylation sites in A. caviae may also be producing 
more fragile flagella, resulting in decreased motility, which could also be explored by 
microscopy studies. To add to this, lower levels of mutated flagellins (FlaB with the following 
mutations: S159/161A; S167/169A; S159/161/167/169A; L160A; I168A) were observed in the 
A. caviae whole-cell, therefore half-life experiments could also be carried out to determine 
whether these flagellins are more unstable than the wild type, or whether they are being 
readily targeted for degradation by the bacterium, perhaps to prevent a build-up of 
glycosylated flagellins that are able to self-polymerise, in the cytoplasm of the cell, which could 
occur if the mutant flagellins are not exported and incorporated into a filament as efficiently.  
202 
 
 
In addition to exploring the role of these glycosylation sites on flagellar function, other sites of 
modification can also be investigated now this work has uncovered a reliable method of mass 
spectrometry for the analysis of A. caviae flagellin glycosylation. However, trypsin digestion of 
the flagellins resulted in the formation of large tryptic peptides from the D2/D3 domain, 
making it difficult for the sites of glycosylation to be analysed in this work. Therefore site-
directed mutagenesis of the flagellins, whereby lysine residues are engineered into the 
flagellins, may allow these proteins to be digested into more manageable pieces by trypsin for 
mass spectrometry analysis, allowing the sites of glycosylation on FlaA to also be examined. 
Both Chapters 4 and 5 have raised questions about the site of Maf1 docking to the flagellin 
and how partial selectivity observed in the process of Maf-dependent flagellin glycosylation is 
achieved without the existence of a specific consensus sequence within the protein, in 
contrast to N-linked protein glycosylation. From Chapter 4 it would now be interesting to look 
at whether the flagellin regions that underwent site-directed mutagenesis are important for 
Maf1 docking, as reduced ability of Maf1 to dock may also result in impaired motility through 
the slower modification of the flagellins, and therefore targeting to the cell surface for 
incorporation into the flagellar filament. This could be achieved through affinity binding 
studies of these mutant flagellins to Maf1, via a technique such as isothermal titration 
calorimetry (ITC), where interactions between proteins, or even peptides, can be quantified. 
Or as the mutations may alter the peptide hydrophobicity, and it is the local regions of 
hydrophobicity that Maf1 is targeting, then it is possible that this may be affecting the ability 
of Maf1 to scan and select residues in the D2/D3 domain to modify.  Furthermore, the 
interaction studies from Chapter 5, along with the D2/D3 domain swapping studies, and the 
work from Parker et al. (2014), suggest that a region for Maf1 recognition of the flagellin may 
reside within the N-terminal region. Further protein interaction studies, along with binding 
affinity studies, could be carried out with Maf1 and different N-terminal regions of the A. 
caviae flagellins, to assess whether there is a location upstream of the D2/D3 domain essential 
for Maf1 docking.  
Additionally, the Maf proteins contain a putative thiamine pyrophosphokinase (TPK) domain, 
likely to have an important role in Maf function due to their conservation amongst these 
proteins (Parker et al., 2012). This domain generally functions in nucleotide biosynthesis, and 
catalyses the transfer of phosphate from ATP to thiamine (producing thiamine 
pyrophosphate). As pseudaminic acid is nucleotide activated (with the addition of CMP) before 
it can be transferred onto the flagellins, this domain may function in binding to the nucleotide 
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activated sugar. Investigations into the ability of Maf1, and a variety of Maf1 site-directed 
mutants (mutated within this TPK domain), to interact with CMP-activated pseudaminic acid 
would give an indication as to whether this domain is operating as pseudaminic acid binding 
pocket. This could also be assessed by ITC as it allows the interactions between small 
molecules and proteins to be quantified. 
6.2.2 – Long-term perspectives  
The importance of bacterial flagellin glycosylation has been determined in a number of 
bacteria, with many showing specific sites to be essential for motility, virulence and particular 
bacterial behaviours (discussed throughout this work). However, the precise role of flagellar 
modification still remains unclear and further work is required to fully uncover why this 
modification has evolved. It is possible that this modification has alternative roles in different 
bacteria. Investigations, so far, have largely identified Gram-negative bacteria with polar 
flagella, such as Aeromonas, Campylobacter and Helicobacter species, to require this 
modification for flagellation and virulence. This therefore may show that this modification aids 
the ability of these microorganisms to colonise their specific gastrointestinal niche. The 
hydrophilic properties of the nonulosonic acids may allow these bacteria to produce 
favourable interactions with their environments and compete with other enteric pathogens, 
such as E. coli and Salmonella that possess peritrichous flagella. It is tempting to speculate that 
this modification may have evolved to be essential for flagellation as without it, these 
microorganisms would not be able to compete for a place in this niche. However, why H. pylori 
requires flagellin glycosylation, when they possess sheathed flagella, remains a mystery, as the 
sugars are unlikely to aid interactions with the external environment. However, it may have 
more of a structural role, by providing further stability to this appendage in the harsh 
environment of the stomach, perhaps by also interacting with the sheath for extra 
reinforcement. As previously mentioned glycosylation has also been reported to stabilise the 
P. syringae flagellum, where flagellin glycosylation is not essential for flagellation, but the 
enhanced stability provided by this modification enables flagellins to evade the host immune 
response (Taguchi et al., 2009). This modification also appears to augment the ability of this 
microorganism to colonise its plant host (Taguchi et al., 2006). In contrast, reports on P. 
aeruginosa flagellin glycosylation have indicated that this modification enhances interactions 
of the flagellins with the immune system, which may allow respiratory infections to progress 
(Verma et al., 2005).  In addition, the modification of P. aeruginosa flagellins have also been 
shown to aid bacterial colonisation (Arora et al., 2005).  
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Recently it was established that the receptor binding protein (Gp047) on the Campylobacter 
lytic phage (NCTC 12673) is able to specifically bind to acetamidino-modified pseudaminic acid 
linked to C. jejuni flagellins, and that binding is towards the C-terminus of the flagellins (Javed 
et al., 2015). It is therefore possible with regards to A. caviae that varying the sites of flagellin 
glycosylation may provide resistance to predation by bacteriophage. This theory, however, has 
not yet been investigated in A. caviae but would be an exciting prospect for future studies. 
In recent years there have also been increasing reports of flagellin glycosylation in Gram-
positive bacteria, and also in some non-pathogenic species, such as Shewanella (Bubendorfer 
et al., 2013; Sun et al., 2013). It is therefore clear that the modification of this appendage with 
sugars is extremely widespread, and therefore very important for the ability of bacteria to 
thrive in a variety of environments. Therefore, glycosylation may have a specific role to 
individual bacteria, allowing them to thrive in their specific niche. With regards to A. caviae, 
once all of the sites of flagellin glycosylation have been deduced, further mutational studies 
with the flagellins, such as analysis of: the flagella formed (if any flagella are formed at all as a 
result from the mutations), the levels of A. caviae motility, and their ability to adhere to 
mammalian cell lines, will allow the role of flagellin glycosylation in A. caviae to be fully 
explored.  
As glycosylation of flagellins, in particular with nonulosonic acids, is essential for the formation 
of flagella in a number of bacteria, this pathway has the potential to be a therapeutic target. 
Therefore, the structural and biochemical characterisation of the Maf proteins would allow the 
mechanism of action of these novel proteins to be investigated. This would allow the study of 
how Maf1 binds to pseudaminic acid, and the region of the protein responsible for this 
essential step in flagellin glycosylation. Pseudaminic acid structural analogues could be 
designed to compete with pseudaminic acid for the specific site of sugar binding on the Maf 
proteins, preventing flagellin modification from taking place, and therefore preventing 
bacterial flagellation. This may not only be a useful antimicrobial target for Gram-negative 
pathogens, but also for the clinically relevant Gram-positive species, such as C. botulinum, 
where the modification of their flagellins, in particular with nonulosonic acids, is likely to be 
involved in their ability to colonise humans (Twine et al., 2008).  
Glycosylation is also useful for increasing the stability of pharmaceutical proteins, such as 
antibodies (Sola and Griebenow, 2009). Therefore, in addition, characterisation of the Maf 
proteins could allow these novel enzymes to be used for the glycosylation of therapeutic 
proteins in the future. Currently, the bacterial N-linked glycosylation process is being 
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manipulated for increasing the stability of therapeutic proteins; however, this requires 
targeting the protein of interest to the periplasm before glycosylation can take place. 
Therefore, these cytoplasmic enzymes may be useful when more is known about how they 
recognise their target proteins and what in the flagellin peptide sequences allows the Maf 
proteins to select their glycosylation sites. 
The work carried out in this thesis has therefore provided a further understanding of the O-
linked flagellin glycosylation pathway, essential for the virulence of a number of pathogenic 
bacteria. Evidence has been provided here, and by Parker et al. (2014), that the Maf proteins 
are cytoplasmic enzymes and glycosylate the flagellins before chaperone binding, and 
subsequent export. In addition, this work has demonstrated that Maf1 shows partial selectivity 
for both its target proteins and the sites it modifies on these proteins, despite the lack of 
consensus sequence present. These studies have paved the way for the continued research of 
O-linked glycosylation pathways, in particular by raising questions about the mechanism of 
action of the glycosyltransferases involved, such as the Maf proteins, which show the exciting 
prospect of being novel therapeutic targets, or being manipulated for industrial and 
pharmaceutical purposes, in the future. 
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